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Abstract 
Regenerative medicine (RM) represents a promising enabling technology to revolutionize 
healthcare. This said there are still major gaps between the commercial promise and the reality 
of the cell therapy sector of regenerative medicine.  There is consensus to develop high through-
put, automated technologies for the manufacture of RM products. Imaging methods will have 
the capacity to contribute to this technological gap for cell therapies and are particularly 
attractive to provide non-destructive monitoring with high spatial and temporal resolution.  
This work applied an automated, non-invasive phase contrast imaging platform (Cell-IQ) to 
measure, analyse and ultimately quantify image derived metrics for human embryonic stem cells  
(hESCs) and haematopoietic stem cells (HSCs) as part of the colony forming unit (CFU) assay. 
This work has shown through thresholding and machine vision identification technology, 
imaging has the ability to improve the precision of current evaluation methods for cell culture, 
providing novel information regarding culture state and show image derived metrics to be 
predictive of future culture state. Building on this, differentiation through the addition of a 
growth factor cocktail highlighted how in-process monitoring enables protocol optimisation.  
After equilibrating the Cell-IQ incubator to a standard incubator, the progress of the CFU assay 
was monitored and image metrics representative of colony phenotype were analysed. Cell count, 
distance between cells and cell migration within individual colonies were identified to be 
informative and provide a degree of colony phenotype separation. Quantitative, novel, image 
derived metrics were identified that improve reliability through computer automation, cost by 
removing user verification and time by reducing the assay time from 14 days to 7 days.  
Non-invasive imaging provides a fantastic opportunity to create bespoke sampling frequencies to 
achieve desired precision for manufacturing cell therapies, this work has developed and shown 
improvement and a level of control to current culture process for ESCs and HSCs.  
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1 Introduction 
Regenerative medicine (RM) is used to refer to methods to replace or regenerate human cells, 
tissues or organs in order to restore or establish normal function. This includes cell therapies, 
tissue engineering, gene therapy and biomedical engineering techniques, as well as more 
traditional treatments involving pharmaceuticals, biologics and devices (1). RM has been evolving 
slowly and gathering pace from translational lab based experimental disciplines into a nascent 
industry (2,3). This growing industry is expected to move swiftly into the clinic within the next 
decade, meaning there will be a growing need for a diverse range of RM products many of which 
will incorporate living cells. This promotes a need for novel yet robust manufacturing processes 
for cell-based systems that are capable of meeting the stringent regulatory needs imposed on 
medical product manufacture (2–5). 
This requirement to manufacture cell based products poses a brand new challenge to the current 
industry and prior manufacturing processes which have only utilised cells in order to make a 
product, in contrast this evolving industry requires cells themselves to be the product rather than 
using the cells to produce the product, such as monoclonal antibodies and recombinant protein 
production (6). The challenges revolve around the complexity of a biologically living product 
where there is sensitivity and responses to the environment. By definition a life is "the condition 
that distinguishes organisms from inorganic objects and dead organisms, being manifested by 
growth through metabolism, reproduction, and the power of adaption to environment through 
changes originating internally” (7).  Also defined as “a living organism is an organized unit, which 
can carry out metabolic reactions, defend itself against injury, respond to stimuli, and has the 
capacity to be at least a partner in reproduction” (8) These definitions state that a living product  
is in a constant state of change in response to its environment, highlighting that the 
manufacturing process requires precise control. Koshland named the seven pillars of life in which 
one is adaptability, meaning there is an intrinsic feedback response to the environmental 
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changes within living organisms (8). Importantly there will always be some state of heterogeneity 
within a cell population due to changes in cell microenvironment which are currently even harder 
to control than the evolving macro environment (9).  
Many of the current solutions and technologies that have been developed within the 
conventional biologics manufacture cannot be applied to cell therapies (3). This is largely due to 
the adherent nature of the human cells required for transplantation, whereas traditional 
biochemical manufacture has used engineered suspension cell lines in large volume bioreactors. 
New or adapted technologies are also required for the finishing steps of a process where current 
downstream processing prevents the purification of viable cells as a final product. Living cells do 
not fall into any of the ‘common’ medical product categories such as stents, tablets or syringes; 
which has created a challenge for both regulators and commercial bodies (10). Numerous 
treatment strategies have been proposed and developed in the field of RM, however there is still 
a need for fundamental technologies and infrastructure to support this emerging industry and 
upkeep widespread adoption. The greater sensitivity and difficulty of cell product measurement 
emphasises the need for better process control and understanding within the field of RM (3,10).  
One current aspect of this need for improved process control is being tackled with statistical 
control. To reduce variability within a process Six Sigma was developed from conventional 
manufacturing disciplines by the global companies Motorola/Toyota. Prior to Six Sigma, in the 
1920’s, there had been a history of quality improvement running through statistical control. 
Following these developments a lean version of Six Sigma was subsequently developed in order 
to prevent and reduce waste. Mid-way through the 21st century design of experiments (DoE) was 
adopted to further improve quality within a process. This was later formalised into International 
Organization for Standardization (ISO’s) in the late 1900’s. This historical learning has since been 
built into an industry tailored system that borrows heavily from these historical developments 
and tools. More recently in 2004, the US Food and Drug Administration (FDA) produced Quality 
by Design (QbD) initiatives to promote pharmaceutical manufacture and product quality. 
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1.1 Quality by Design 
1.1.1 Introduction 
In 2000, the suboptimal drug manufacture process along with FDA’s out-dated review process 
prompted concern for the regulatory industry (11). As far as the pharmaceutical industry was 
concerned the product quality was satisfactory, however there was a reluctance to embrace new 
technologies as the adoption by the regulators of such innovation was unknown. There was also 
concern for the emphasis of drug manufacturing that was placed on final product quality and the 
manufacturing process itself was disregarded as immaterial. The material shared with the FDA 
was empirical with little model prediction or forecast for product variability based on upstream 
variation (11). All this showed an inability to analyse and predict root causes of variation in the 
final product of drug manufactures. In some cases the reported waste amount was as much as 
50% of the manufactured product (11). All of these issues led to higher manufacturing costs 
which the FDA determined were due to manufacturing inefficiencies and the difficulty regulators 
made implementing changes to an industrial process. Because of these concerns the FDA 
implemented more stringent oversight and monitoring of manufacturing processes which had a 
knock on effect causing delays in development of new drugs, and a large increase in 
supplementary applications for manufacturing changes. In 2007 alone the FDA received more 
than 5000 supplements for new drug applications, biological license applications and abbreviated 
new drug applications (11). The data required for both the supplementary and original 
applications was largely based on the chemistry with the engineering aspects largely 
disregarded, along with product development and processing. The FDA continued with further 
regulatory restrictions and guidance documents in 1996 and 1999 (12,13). By implementing these 
changes the industry were pressurised with increasing rules and laws to abide by to ensure 
product quality. These new documents along with new responsibilities for regulators, such as 
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counterterrorism and pandemic oversight, meant increased review times and put a real burden 
on the FDA’s resources (11). 
In 2002, the FDA addressed these issues by releasing a document entitled “Pharmaceutical cGMP 
([current] good manufacturing practice)  for the 21st Century – A Risk-Based Approach” with the 
goal to ‘enhance and modernize the regulation of pharmaceutical manufacturing and product 
quality – to bring a 21st century focus to this critical FDA responsibility’ (14). In-line with this 
document, the International Conference on Harmonization (ICH) published guidelines stating 
suggested contents for the Pharmaceutical Development section of a regulatory submission, Q8 
Pharmaceutical Development (15).  
Finally, Quality by Design (QbD) was first introduced into the chemistry, manufacturing and 
controls review process in 2004 as a result of the Pharmaceutical cGMP for the 21st Century 
initiative. 
1.1.2 Quality by Design Definition 
QbD has become an important paradigm in the pharmaceutical industry since its introduction by 
the FDA in the aforementioned documents (Section ‎1.1.1). It was the answer for the FDA to move 
towards a more scientific, risk-based, holistic and proactive approach to pharmaceutical 
development (11). The global goal of QbD is to embed quality into pharmaceutical products to 
ultimately protect the health of the public (16), which is the FDA’s primary commitment. This 
notion promotes industries knowledge of both their product and the process used to achieve the 
said product starting with process development all the way through to the final product. The ICH 
declares that the desired state for pharmaceutical manufacturing is ‘product quality and 
performance achieved and assured by design of effective and efficient manufacturing processes’ 
(15). This is achieved by incorporating quality by design throughout the lifecycle of a products 
development with companies defining desired product performance, identifying critical quality 
attributes (CQAs) and operating within a defined design space (16). With this information in 
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hand, a company should be able to tailor the product formulation and process to meet these 
specified product requirements. This leads to the necessary understanding of raw material 
attributes and process parameters effects on CQAs along with the variability sources. With this as 
common knowledge a company then has the ability to continually monitor and improve its 
manufacturing process in order to ensure product quality and ultimately patient safety. This 
systematic approach draws away from the traditional, empirical approach that was mentioned 
previously and highlighted below in ‎Table 1. In conclusion the ICH define quality by design as ‘a 
systematic approach to development that begins with predefined objectives and emphasizes 
product and process understanding and process control, based on sound science and quality risk 
management’ (15). 
Table 1. Quality by Design (QbD) approach versus the traditional approach (17,18) This 
table compares and contrasts how the traditional approaches to manufacturing have been modified 
to produce a Quality by Design approach to manufacturing that reduces risk by having a science 
platform to work and learn from.  
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1.1.3 QbD Implementation 
In order to successfully implement QbD into a biotech product, a number of steps must be 
followed (‎Figure 1). The process begins with identifying the customer and the need, and ends 
with process validation and continual monitoring. Throughout the process a number of risk 
assessment steps are carried out which aid process characterisation. These steps have all been an 
improvement from the traditional Six Sigma model. Motorola ‘invented’ the Six Sigma strategy, 
which is named for a statistical measure of variation (the standard deviation of a normal 
distribution). Six Sigma was adopted in order to set process tolerance limits to ensure defective 
products fall to the required low level (19). These process limits are set to include observations 
within 6 standard deviations of the mean, or Six Sigma. Setting tolerance limits at lower levels of 
sigma results in higher rates of defects. The Six Sigma design process is shown in ‎Table 2. 
Table 2. Six sigma 5 steps for designing a process (20) Six sigma provides a statistical 
measure of variation, and is carried out through 5 steps, define; measure; analyse; design and verify. 
Quality by design approaches build on the six sigma base level to further improve manufacturing.  
 
QbD relates an industry specific adaptation of historic quality principles by introducing further 
steps to achieve specified product quality. By increasing the 5 core steps of Six Sigma into a flow 
diagram QbD is better defined by breaking down each step into more defined areas. This is 
shown in ‎Figure 1. 
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 Key steps required to implement the QbD approach for a biotech product (11) In Figure 1.
contrast to six sigma, QbD builds on these principles to create a more detailed process map for 
manufacturing by expanding on each of the 5 six sigma steps.  
There currently lies a huge dilemma within the biotech industry, either a company can invest 
comprehensively in product and process characterisation at an early stage, which QbD strongly 
suggests, or wait until the market success of the product can be better assessed. The first 
approach requires a large amount of initial investment but eventually yields a more reproducible, 
lower risk product. However in order to implement QbD a large upfront work load is required at a 
time where evidence may not be sufficient to justify the investment, the following sections 
highlight some of the key required capacity. 
1.1.3.1 Identify Critical Quality Attributes (CQA) 
Once the need and profile of the product has been recorded, the next step is to express the 
Critical Quality Attributes (CQAs). These are defined as ‘a physical, chemical, biological or 
microbiological property or characteristic that should be within a range or distribution to ensure 
Identify Critical Quality 
Attributes
Define Product Design 
Space
Define Process Design 
Space
Refine Product Design 
Space
Define Control Strategy
Process Validation
Process Monitoring
Filing
Risk Assessment
Process Characterisation
Risk Assessment
Risk Assessment
Identify the Customer and 
the Need
Identify Target Product 
Profile 
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desired product quality is achieved’ (15). The CQAs are defined through the use of a risk 
assessment, previous laboratory knowledge, along with clinical experience and are essential to 
successfully implement this stage of the QbD process. The CQAs help relate safety to efficacy for 
the given biotech product, and a completed risk assessment will rank the CQAs in order of 
importance. Key factors that the risk assessment will highlight include sources of variation, 
likelihood of deviation from a set range, certainty that the deviation will have an impact on the 
process or end product, and severity of the change in product quality. CQAs by name are a new 
concept under the QbD tree, however as part of Six Sigma a key aspect was to analyse why there 
were ‘failures’ and prioritise the factors or attributes based on severity, the same as CQA’s just 
not named such under Six Sigma (19,21). 
1.1.3.2 Define Product Design Space 
After the critical quality attributes have been defined it is possible to set the design space which 
will determine the probability of achieving the required CQA values. The design space is defined 
by the ICH as, 
 ‘The multidimensional combination and interaction of input variables and process parameters that 
have been demonstrated to provide assurance of quality. Working within the design space is not 
considered as a change. Movement out of the design space is considered to be a change and would 
normally initiate a regulatory post approval change process. Design space is proposed by the 
applicant and is subject to regulatory assessment and approval.’(15)  
Thus by using the CQAs that were previously defined, the design space can be expressed in 
relation to these stipulating maximum and minimum values. By operating the process within this 
defined range fluctuations are tolerable and yet the process can still be controlled. Also changes 
to the process can easily be implemented under the same filing as long as the process remains 
within the defined design space (22).  
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In QbD an improved understanding of how the CQAs link with the safety and efficacy of a 
product is required, and identifies the importance of analytical, non-clinical and animal studies in 
creating these linkages (23). 
1.1.3.3 Define Process Design Space 
Using the same definition described previously (Section ‎1.1.3.2), the design space of the process 
can be characterised similarly to the product design space approach shown in ‎Figure 2. Firstly a 
risk assessment will identify the parameters which need to be characterised or optimised within a 
process. Following this, design of experiments (DoE), can be implemented to help understand 
the relationship between such factors and therefore design the space which the process must 
operate within to deliver the defined product quality range. Failure mode and effects analysis 
(FMEA) can then be utilised to assess the potential degree of risk for every operating parameter. 
This leads to prioritisation of factors in order to understand the impact they can hold on the 
performance of a process. The outcome of the FMEA is a risk priority number which identifies the 
main operating parameters that may require further consideration. By taking the outcomes from 
these tests there is then often a scale up correlation that is applied to translate operating 
conditions between different scales or equipment. 
Both FMEA and DoE are not novel analysis tools for the biotech industry however their use in 
linking CQAs to design space within the RM industry is. 
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 Diagram to define the process design space, which sits within knowledge space. Figure 2.
Within QbD a key part is to define the design space in which a process operates. This diagram 
illustrates the how the knowledge space provides the characterisation. Within the knowledge space 
will be the design space or the acceptable range for a process to operate. Within the design space 
sits the operating range, either side of the set-point for a process. By defining the operating, 
acceptable and characterisation ranges then the alert limits, action limits, and edge of failures are 
defined.  
1.1.3.4 Define Control Strategy 
The FDA defines control strategy as ‘a planned set of controls, derived from current product and 
process understanding that assures process performance and product quality’(24).  Within the 
QbD paradigm, the risk assessment will establish the control strategy based on the CQAs and 
process capability. The control strategy can involve some of the following elements: in-process 
control, lot release tests, process monitoring and characterisation testing (11). The use of risk 
assessments to identify the control strategy is a novel concept unique to the QbD notion. By 
using the DoE approach and the process design space, this allows an assessment of precision and 
accuracy within which the operating variables need to be controlled, allowing the control 
strategy to be scientifically designed. 
Design Space
Acceptable Range
Operating Range
Characterisation Range
Set Point
Knowledge 
Space
Alert Limit
Action Limit
Edge of Failure
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1.1.4 Process Monitoring 
After filing, the CQAs are continually monitored to ensure the process is operating within the 
defined space that was submitted to the regulators. Within the QbD paradigm any process 
changes that occur within the defined design space are not required to be reviewed or assessed 
as process changes. This therefore allows process changes without approval submissions, 
allowing more flexibility whilst maintaining product quality. However in building a QbD system 
the process has to show robustness towards quality with respect to four key elements (11);  
 Process performance/product quality monitoring 
 Preventative/corrective action 
 Change management  
 Management review of process performance and product quality  
These steps require optimisation in order to obtain an overall best process; process monitoring. 
Process analytical technology (PAT) is the name given to such technologies, which are discussed 
in the following section. 
1.2 Process Analytical Technology (PAT)  
Biological products are very sensitive to the effects of process perturbations including variations 
in the raw materials as well as unknown effects of process parameters. These deviations may 
result in variability, therefore as a consequence the product becomes ‘out of specification.’ These 
undesired products can then have an unwanted effect on patients receiving treatment whether it 
be safety, efficacy or undesired responses. Therefore in order to develop a biological therapy for 
use in patients, the key objective is to create a controlled process that delivers a consistently high 
quality product by remaining within the design space and therefore meeting the accepted criteria 
(18). 
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The development, qualification and validation of analytical methods are extremely important 
aspects of reliable safe biological manufacture. Such systems that are used for designing, 
analysing and controlling manufacturing to make timely measurements or critical quality and 
performance attributes are known as PAT or Process Analytical Technologies. They are also 
common practice for validating processes and elucidating the cause and effects of variability 
seen within a production line (25). Such culture attributes may pose a significant challenge 
because of their complexities and difficulties, and furthermore analytical tools are expensive but 
yet a vital aspect for product analysis. 
Significant progress has been made recently to develop novel analytical tools for identification, 
however certain culture attributes are still not well understood (26). Consequently there is still 
undetected variability within raw materials which may be expressed into a final product. 
Especially within the RM industry it may never be possible to measure all the required attributes 
for a comprehensive guarantee of quality, and therefore we only may be able to take a QbD 
‘spirit’ approach. Wrong CQAs can be as bad, if not worse, than no CQAs as they portray a false 
confidence. It is therefore imperative that the Critical Process Parameters (CPP) which may affect 
the CQAs within a manufacturing process can be measured. A key point to also acknowledge is 
that the principle of Process Analytical Technology umbrellas this as a ‘mechanism to design, 
analyse and control…manufacturing processes’ (26). The goal of PAT is to define and provide the 
measurement capability to design and develop processes that consistently ensure a product of 
required quality, with the ambition to continually improve efficiency through real time or 
improved product release tests (26). Through PAT there is the ability for continuous quality 
assurance resulting in improved operational control and compliance, ultimately leading to more 
reliable product quality (27). Essentially PAT are the tools required to achieve a QbD based 
process; there are critical attributes that determine process and product success, these attributes 
need to be measured with well-designed assays, the system as a whole is known as Process 
Analytical Technologies. 
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1.3 Benefits of QbD/PAT 
One of the primary advantages for incorporating QbD paradigm into current manufacturing 
processes, whether they are in development or fully functioning is the lower regulatory burdens 
and greater flexibility in decision making based on science rather than empirical data.  This 
ensures a more efficient, quicker review process, resulting in quicker approval as well as reducing 
the number of manufacturing supplements required for post-market changes (28).  
QbD can also reduce manufacturing costs by reducing waste and improving product quality. For 
example, by holding a better understanding of both the product or active ingredients and your 
process, it is possible to fully understand the impact of the process on your active ingredients. 
This means as well as reducing your waste, there is a possibility to reduce your raw material costs 
whilst maintaining or even improving your final product quality. This leads directly into an overall 
lower economic risk due to less probability of patient harm, unforeseen events, failure to 
manufacture product and therefore failure to deliver the product. 
The ultimate goal of PAT is the ability for real time product release, whereby quality is based on a 
few in-process monitoring tools of process characteristics, and the need for final product release 
tests are redundant. Due to the QbD framework, right first time quality can also be achieved, 
rather than the current development that requires constant refining until the optimum can be 
achieved. The benefits of using PAT under the QbD paradigm are summarised in ‎Figure 3.  
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 The key business drivers for QbD and PAT  (18) There are many benefits to Figure 3.
utilising QbD approaches within a process. This diagram highlights some of the key drivers for 
businesses to adopt QbD grouped into 6 categories ranging from validation benefits to product 
development and site transfer.  
For these goals to become realistic both QbD and PAT need to be embedded within the 
development of a process as well as the final manufacturing process. Therefore it is important at 
this stage to begin developing future tools that are capable of allowing QbD to be implemented 
into the manufacturing process. Although assays are a major part of the analytical toolbox 
available, to successfully characterise product quality and safety there is a need to discover new 
tools that can non-invasively produce either similar or improved results. 
1.4 A Novel Analytical Tool  
Within RM both safety and efficacy requirements must be stringently upheld. This has been 
possible within conventional chemical-based pharmaceutical drugs through adherence to strict 
regulations and the ability to monitor processes and complete timely end point assays. However 
for cell-based material different strategies will be required to evaluate their quality (10,29). 
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These quality assessment criteria are currently regulated by individual nations and therefore have 
varying degrees of level and scope when determining quality. Some of the more common 
referred references are ‘Current Good Tissue Practice,’ (30) ’21 Code of Federal Regulations (CFR) 
Parts 1270 and 1271 of U.S. Food and Drug Administration (FDA)’ (31). These documents attempt 
to mitigate the risk associated with cellular products mainly in two key areas, cellular 
contamination and non-cellular contamination. However there are still very few documents that 
require a control of cell quality and this is often at the discrimination of the manufacturer to 
advise and provide evidence of conventional cell quality evaluation techniques. These include 
biomarker tests like RT-PCR or immunostaining; safety assessments in animal implant tests; and 
chromosomal tests for tumorigenic risk, which all require cell destruction processing such as 
those associated with fixation reagents or cell-lysis buffers. In order to fulfil quality assessments 
and provide both examined and non-examined cells to be used for therapy there is a need to 
develop tools capable of overcoming key problems associated with conventional quality 
assessments (2,10,28). These problems include invasiveness; lack of exhaustive characterization, 
time limitations and instability of cell quality markers. 
Cells prepared for therapeutic use need to maintain viability and perform as required. The current 
use of artificial probes, markers and gene transfer for example could all trigger cellular 
abnormalities (10) and therefore it is advantageous to develop analysis techniques that do not 
require any invasive mechanism. Another advantage to a non-invasive application is the limited 
number of cells that are often produced, especially for autologous therapies due to the constraint 
of the cell source material. This lack of cellular product also means that sampling is undesirable, 
due to the considerable cost of the product. By removing a sample, there is a reduction in the 
total product. Compared to conventional chemical compound manufacturing, human cells also 
exhibit huge variances often unattainable to process control (32). Therefore the variation in the 
product cannot be controlled through pre-determined fixed process variables (due to sensitivity 
of product and dimensions of plasticity) and therefore a method of adaptive process control is 
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required that monitors and responds to product.  Sampling therefore does not always assure the 
total quality of the product and the requirement for constant, large samples further combine to 
the current lack of cell source material as discussed previously. 
Alongside a non-invasive, complete characterisation technique there is also a desire to produce a 
real-time platform. Current processes often require days or weeks before results are obtained, at 
which point further processing costs have already been associated, which may even include 
administration of the cells to a patient. This implies that patients could have cells injected prior to 
a full analysis being completed. Thus the requirement for a real-time or at least a short term 
assay is valued. The ability to measure the product immediately before administration currently 
is not achieved and as is well documented the stability of cells through culture can rapidly change 
(33). Such stability includes contamination which can take over a culture within hours. This is why 
end point assays are commonly associated with high error rates as individual cells often differ in 
their characterisation with respect to differentiation, mobility, size, shape and production 
activity, to name but a few. 
The final point is providing a reproducible characterisation procedure. Many of the 
characterisation assays commonly used are subjective and user-defined. Process automation has 
been instrumental in achieving defined, standardised processes in many manufacturing 
industries (3,5,28). Automation also allows scale-out of processes by increasing the number of 
units within the production process, with predictable process variation and predictable costs. The 
afore mentioned systematic process improvement methods such as Six Sigma and QbD have 
been successfully developed and utilised within electronic and automotive industries within 
automated processes. Automation is central to using these systematic tools efficiently and 
effectively by reducing user variation and achieving predictable process variation as mentioned 
previously (34–36). 
Currently there are no automated, non-invasive, real-time technologies used within the RM 
industry that are capable of accurately and reliably measuring the key critical attributes and 
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therefore there is no way of relating this to whether a process is operating within specification. 
This is an important issue currently for cellular therapies where many of the assays are invasive 
and often include attaching fluorescence probes, which are likely to alter the phenotype of the 
cells. It is therefore essential to include automation within a novel analytical tool (4,34). 
1.5 Current Imaging Techniques 
Imaging provides a real-time analysis method for cell therapies. Various imaging modalities are 
now used within research laboratories, the more common are further discussed in this section 
highlighting their potential for use in a manufacturing setting for the RM industry. 
1.5.1 Raman Spectroscopy 
Raman spectroscopy is a technique used to observe vibrational, rotational and other low 
frequency modes in a system. It relies on an inelastic scattering of monochromatic light. The light 
source, often a laser, interacts with the molecular vibrations resulting in the energy of the laser 
being shifted either up or down. This shift in energy provides information related to the 
vibrational modes of the system. Based on this scattering of photons, their biomolecular 
composition and structural conformations of macromolecules in living cells can be distinguished 
(37). 
Raman spectroscopy allows functional imaging of live cells non-invasively without labelling or 
sample preparation however spatial resolution is still a drawback (38,39). Current techniques 
create a low scattering of light and therefore there is a lack of resolution, this is overcome using  
ultraviolet (UV) resonance Raman spectroscopy, but this cannot be carried out on live cells due to 
the UV damage that would be caused (39).  
Another drawback of this current technique is acquisition time which is related to the low 
scattering of light and uncorrelated noise (38). Acquisition times of 2-10 minutes per cell are 
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commonly reported in literature (37,38,40). This long acquisition time deems Raman 
spectroscopy currently impractical within a manufacturing setting where large cell numbers 
require non-invasive analysis, and therefore prevents widespread adoption in both biological 
research and clinical practice (41). 
1.5.2 Magnetic Resonance Imaging (MRI) 
Magnetic resonance imaging (MRI) is used primarily in medical settings to produce high quality 
images in vivo (42). The underlying principle is nuclear magnetic resonance; a fundamental 
property of elementary particles is their nuclear spin or rotation. All particles have a spin and this 
nuclear spin results in a magnetic moment, but only the atoms with an uneven spin are 
magnetically susceptible and therefore suitable for MRI (43).  
Firstly, to form a magnetic resonance image a strong magnetic field is applied. This causes the 
spins of all atoms to align with the external magnetic field. Following this, a radio frequency pulse 
is induced which flips the spins out of alignment. Once the radio frequency is terminated, the 
spins relax back to their original state, aligning with the external magnetic field. During the 
relaxation stage, the energy released is recorded and forms an image. In order to build 3D 
images, magnetic fields are applied in all 3 dimensions with the results collated. 
In general the limited sensitivity and high cost of MRI restricts its use for in vitro cell imaging 
applications. Often to increase sensitivity contrast agents are added such as iron oxide 
nanoparticles (44) or low molecular weight compounds containing lanthanide such as gadolinium 
(42). Research continues to find toxic free contrast agents such as an engineered transferrin 
receptor that recently has been used in vitro (45), but currently the addition of such contrast 
agents and the capital cost prevent the use of these cells post manufacturing and therefore 
deems MRI a non-viable form of non-invasive quality control.   
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1.5.3 Optical Microscopy - Phase Contrast 
The description and classification of cells has, in the past, always derived from visual criteria (46). 
Therefore, developments were made to improve the visualisation of shape and cellular detail, as 
early cytochemical tests were used primarily for making cellular detail more distinct (46). 
One method that has real promise to help fill this gap in technology is phase contrast 
microscopy. Imaging is cited as a specific opportunity within the FDA’s Critical Path to New 
Medical Products (47), noting that ‘‘new imaging techniques will ultimately contribute important 
biomarkers and surrogate endpoints, but how soon these new tools will be available for use will 
depend on the effort invested in developing them specifically for this purpose.’’ Imaging also 
forms a large subgroup of the current cell characterisation techniques outlined by the British 
Standards Institution (BSI) in PAS93:2011 (29). Furthermore imaging is a particularly attractive, 
enabling technology for biomarker development because of its capacity to provide non-
destructive monitoring with high spatial and temporal resolution (48). While biomarkers are 
widely acknowledged as being enabling, it should also be recognized that the continuum from 
discovery to utility of a biomarker could be quite involved and challenging. Critical elements of 
that continuum include the validation and qualification of a relevant biomarker (48). 
The word microscope comes from the Greek micros meaning ‘small’ and skopein meaning ‘to 
look’ (49). Using the definition of a microscope as ‘an instrument that enables the visualisation of 
objects or structures that are usually invisible to the naked eye’, then microscopes appeared at 
the end of the sixteenth century (50). The properties of concave and convex lenses were first 
described around the year 1000, although magnifiers in the form of lens-shaped crystals or glass 
may have been used much earlier. Spectacles were invented around 1300 and became widely 
used across Europe (50). There are many different names assigned to the microscope inventor 
including Zaccharias Janssen, Anthony Leeuwenhoek and Robert Hooke (51,52). The first 
published work from a microscope appeared in 1665 by Robert Hooke, and therefore it is often 
Hooke’s name that is assigned to the inventor of the microscope. Although small breakthroughs 
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occurred up to the 18th century is wasn’t until 1934 when Dutch physicist Frits Zernike first 
described phase contrast microscopy (53). Phase contrast is defined as ‘a contrast-enhancing 
optical technique that can be utilized to produce high-contrast images of transparent specimens, 
such as living cells (usually in culture), microorganisms, thin tissue slices, lithographic patterns, 
fibres, latex dispersions, glass fragments, and subcellular particles (including nuclei and other 
organelles)’ (54). Frits Zernike later went on to receive the Nobel Prize in Physics for his phase 
contrast microscope invention. 
In effect, the phase contrast technique employs an optical mechanism to translate minute 
variations in phase into corresponding changes in amplitude, which can be visualized as 
differences in image contrast (55). This technique exploits interference effects to make 
transparent objects (such as cells) visible against a transparent background (such as culture 
media) (54).  
Many biological structures can be revealed by using phase contrast that were not visible with a 
simpler brightfield microscope (29), the simplest microscopy technique that illuminates 
specimens using bright light, with contrast caused by more dense objects absorbing the light 
(29,55). One of the major advantages of phase contrast microscopy is that living cells can be 
examined in their natural state, whereas previously these structures were only seen by killing, 
fixing, and staining specimens (29). As a result, the dynamics of on-going biological processes 
can be observed and recorded in high contrast with sharp clarity of minute specimen detail (55). 
This therefore provides a technique capable of being exploited for the manufacture of living cells 
within the RM industry and is further deliberated in the following sections. 
1.5.3.1 Phase Contrast Microscope Configuration 
Presented in ‎Figure 4 is a cut-away diagram of a modern upright phase contrast microscope, 
including a schematic illustration of the phase contrast optical train. Partially coherent 
illumination produced by the tungsten-halogen lamp is directed through a collector lens and 
Chapter 1 
22 | P a g e  
 
focused on a condenser annulus. Wavefronts passing through the annulus illuminate the 
specimen and either pass through undeviated or are diffracted and retarded in phase by 
structures and phase gradients present in the specimen (55,56). Undeviated and diffracted light 
collected by the objective is segregated at the rear focal plane by a phase ring and focused at the 
intermediate image plane to form the final phase contrast image observed in the eyepieces. 
 
 Diagram of a modern upright phase contrast microscope  A) Phase Contrast Figure 4.
light path(56) and B) Phase Contrast microscope (55). Phase contrast microscopy  improves the 
contrast of cells compared to brightfield imaging. This is completed by the addition of a phase ring 
that causes the diffracted light to change its amplitude and therefore improve the contrast of the 
diffracted light when compared to the undiffracted light.  
The addition of phase contrast optical accessories to a standard brightfield microscope can be 
employed as a technique to render a contrast-enhancing effect in transparent specimens that is 
reminiscent of optical staining (55). The only addition to brightfield microscopes are the annular 
ring (also known as the condenser annulus) and the phase ring (or phase plate) (29).  
1.5.3.2 How Phase Contrast Works 
Unstained specimens that do not absorb light are known as ‘phase objects’ as they alter the 
phase of the diffracted light by about ¼ wavelength compared to the undeviated light that 
passes through or around the specimen unaltered. However, our eyes are unable to detect these 
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phases differences as the eye is only sensitive to colour changes (light frequency) and to differing 
levels of light intensity (wave brightness). 
In phase specimens the light either passes unaffected through the specimen or is diffracted. This 
diffracted light is not reduced in amplitude (which the eye can acknowledge) but is phase delayed 
by the specimen due to the specimen’s refractive index. The diffracted light, which has now been 
phase shifted by -90° to the undiffracted or background light, arrives at the image plane out of 
phase with the undiffracted light but essentially with the same intensity. 
In the Zernike phase contrast microscope, the light waves that are diffracted and shifted in phase 
by the specimen can be transformed by phase contrast into amplitude differences that are 
observable in the eyepieces. Frits Zernike achieved this transformation of converting essentially 
a phase shift into an amplitude difference. This is achieved by a further phase shift of -90° of the 
undiffracted light which as a result the direct and diffracted light arriving at the image level 
would be able to produce destructive interference. This results in an image appearing darker 
against a lighter background, known as ‘dark’ or ‘positive contrast’. The opposite of this, phase 
shifting by +90°, causing the direct and diffracted light to arrive at the image level 
simultaneously, causes constructive interference. This is where the image appears bright against 
a darker background, and is known as ‘negative’ or ‘bright contrast’. 
The next step is to separate the direct light from the diffracted light. This is completed with the 
use of an annulus ring, as mentioned in Section ‎1.5.3.1. As the light passes through the annulus 
ring, a hollow cone of light is emitted on to the specimen, the direct un-diffracted light passes 
through the specimen undeviated and therefore arrives at the focal plane in the shape of a ring. 
The diffracted light is spread over the entire focal plane. With this set-up the diffracted light has 
roughly the same amplitude and is 90° phase shifted. This would result in little contrast, 
therefore as stipulated earlier the background light is phase shifted by 90°. This is achieved 
through the use of a phase ring at the focal plane. The narrow area of the phase ring, where the 
hollow cone of direct light passes is optically thinner than the rest of the plate and as a result the 
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undiffracted light is shifted -90° in traversing the glass of the objective than the diffracted light. 
This causes the direct light to be phase shifted resulting destructive interference providing 
positive contrast. If the narrow area of the phase ring is thicker than the direct light is shifted -90° 
and constructive interference occurs. This is shown in ‎Figure 5. 
 
 Working principle of phase contrast microscopy. Diagram to show how the Figure 5.
condenser annulus and phase rings work in harmony to improve resolution of brightfield microscopy 
to provide phase contrast microscopy (57).  
The performance of modern phase contrast microscopes is so refined that it enables specimens 
containing very small internal structures, or even just a few protein molecules, to be detected 
when the technology is coupled to electronic enhancement and post-acquisition image 
processing (55). 
By introducing the ring aperture for illumination and a corresponding phase ring for phase 
retardation of the undiffracted component of the object wave, a higher lateral resolution and 
lower noise level are experienced when compared to traditional brightfield microscopy (this can 
be seen in ‎Figure 6). However, one disadvantage of introducing the phase ring a halo and shade-
off effect appear. In a typical Zernike phase contrast microscope the undiffracted component and 
part of the diffracted component lie on a continuous phase ring in the Fourier plane. When the 
diffracted component is phase shifted erroneously by the phase ring, the halo, and shade off 
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effects appear (58). The halo effect can be seen in ‎Figure 6 as a bright boundary around the dark 
regions of the image, in this case the cells themselves (55). The shade-off effect corresponds to 
the misleading drop-off of the image intensity in the centre of extended bright areas or the 
increased intensity in the centre of dark regions (58).  
Another effect of using phase contrast microscopy compared to brightfield microscopy is that 
the use of the phase annulus means the working numerical aperture is limited, this causes a small 
often negligible effect on resolution of phase contrast images (56). 
1.5.3.3 Image Appearance 
Presented in ‎Figure 6 is a comparison of living cells in culture imaged in both brightfield and 
phase contrast illumination. The cells are human glial brain tissue grown in monolayer culture 
bathed with a nutrient medium containing amino acids, vitamins, mineral salts, and fetal calf 
serum. In brightfield illumination (‎Figure 6 (left)), the cells appear semi-transparent with only 
highly refractive regions, such as the membrane, nucleus, and unattached cells (rounded or 
spherical) are visible. When observed using phase contrast optical accessories, the same field of 
view reveals significantly more structural detail (‎Figure 6 (right)). Cellular attachments become 
discernable, as does much of the internal structure. In addition, the contrast range of the image 
taken using phase contrast is dramatically improved.  
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 Comparison of Brightfield image and Phase Contrast image (55) Phase contrast Figure 6.
microscopy enhances the difference between cells and media. The phase shift that occurs in phase 
contrast microscopes (right image) provides increased detail that is unattained with brightfield 
imaging (left image), 10 µm scale bars.   
The phase shifts described in Section ‎1.5.3.2 are dependent on the illuminating lights 
wavelength, and from this the colours seen in ‎Figure 6 are a result of large phase shifts. Phase 
contrast is only linear for small changes in phase, and the changes noted here represent much 
larger changes in phase. This said the comparison of brightfield to phase image in ‎Figure 6 
highlights the contrast enhancement using phase contrast microscopy to brightfield. Zernike's 
development of phase contrast optical theory is an excellent example of how research resulting 
from a highly specialized field such as optical physics can yield innovative new developments in 
seemingly unrelated disciplines, such as biology and medicine. During the Second World War, 
the Zeiss Optical Works in Jena, Germany, was the first manufacturer to incorporate practical 
phase contrast optics into their microscopes (55). The immediate impact on biological research 
was significant, and widespread application of the technique continues to the present day. 
Modern phase contrast objectives, designed and produced by optical manufacturers, are capable 
of operating in combination with auxiliary contrast-enhancing techniques, such as differential 
interference contrast, fluorescence, and polarized light (55). These objectives are available with 
internal phase plates that have varying levels of absorption and phase displacement of the 
surround (undiffracted) illumination to produce a wide spectrum of specimen contrast and 
background intensity choices for phase contrast microscopy.  
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1.6 Automated, Non-invasive Phase Contrast Microscope as a Process 
Analytical Tool 
Phase contrast is an excellent method for enhancing the contrast of thin, transparent specimens 
with a trivial loss of resolution, and has proven to be a valuable tool in the study of dynamic 
events in living cells. Prior to the introduction of phase contrast optical systems, cells and other 
semi-transparent specimens were rendered visible in brightfield microscopy by artificial staining 
techniques (56). Although these specimens can be observed and recorded with darkfield and 
oblique illumination, or by defocusing a brightfield microscope, this methodology has proven 
unreliable in providing critical information about cellular structure and function (55). 
The technique of phase contrast is widely applied in biological and medical research, especially 
throughout the fields of cytology and histology. As such, the methodology is utilized to examine 
living cells, tissues, and microorganisms that are transparent under brightfield illumination. 
Phase contrast enables internal cellular components, such as the membrane, nuclei, 
mitochondria, spindles, mitotic apparatus, chromosomes, Golgi apparatus, and cytoplasmic 
granules from both plant and animal cells and tissues to be readily visualized (55). In addition, 
phase contrast microscopy is widely employed in diagnosis of tumour cells and the growth, 
dynamics, and behaviour of a wide variety of living cells in culture. Specialized long-working 
distance phase contrast optical systems have been developed for inverted microscopes 
employed for tissue culture investigations (55). 
Industrial and chemical applications for phase contrast include mineralogy, crystallography, and 
polymer morphology investigations. Colourless microcrystals, powders, particulate solids, and 
crystalline polymers, have a refractive index that differs only slightly from that of the surrounding 
immersion liquid, and thus are often easily observed using phase contrast microscopy. In fact, 
quantitative refractometry is often utilized to obtain refractive index values and for identification 
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purposes. Other commercial products scrutinized by phase contrast optical techniques include 
clays, fats, oils, soaps, paints, pigments, foods, drugs, textiles and other fibres (55,56). 
Reduction in halo and shading-off artefacts remains a primary concern in phase contrast 
microscopy. Apodized phase plates are useful for reducing the severity of halo, and specialized 
variable phase contrast systems can be fine-tuned to control these effects in order to optimize 
image quality and the fidelity of information obtained by the technique (55). There is also 
considerable interest in the development of advanced phase contrast systems that provide 
accurate measurements of phase specimens with large optical path differences, as well as 
combined observations with other contrast-enhancing techniques. In particular, phase contrast is 
often utilized by overlapping images with fluorescence imaging to determine the locations of 
fluorophores, and shows promise for enhancing contrast in scanning optical microscopy with 
well-understood biological targets. 
Already possible are detailed views of how proteins and lipids interact within a cell in order to 
govern generation, maintenance, and functionality of that cell. This is achieved from biochemical 
and genetic experiments spanning diverse approaches from reconstructing the cellular processes 
to atomic resolution imaging (59). However this cellular activity is commonly assessed as only a 
snap shot, one point in time. Recently it is becoming increasingly possible to view these 
processes in real time as they happen, with light microscopy adding a vital dimension to the 
analysis of cellular function (60). One such example was the discovery of kinesin after video light 
microscopy formed the basis of a motility assay in 1985 (61). Further discoveries of such proteins 
have transferred our understanding of how mitosis is achieved. In order for live phase contrast 
imaging to be utilised as a reliable process analytical tool the environment in which the cells are 
placed in order to capture high quality images is crucial.   
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1.7 Cell Environment 
To successfully image cellular processes in living cells, the cells must be kept in an environment 
that does not induce stress responses, which can alter the cellular processes of interest (62). 
Some of the key factors to consider are the type of culture medium and its contents and the 
temperature of the sample, which must be kept stable at 37°C for mammalian cells. Moreover, 
the pH of the sample must be maintained at a physiological level and evaporation of the medium 
must be minimized to avoid changes in osmolarity (63). 
1.7.1 Media 
Mammalian cells require CO2 purged bicarbonate-based media to maintain pH levels. Cells 
grown without this CO2 environment rapidly enter apoptosis unless there is a suitable buffer 
replacing the role of CO2, such as HEPES. HEPES maintains the physiological pH range of ~7.4, 
and therefore creates an environment for cell proliferation. Carbonate is an essential product for 
many cellular processes as well as buffering a solution, such ions as Ca+, Na+, Cl- are related to the 
carbonate solutions and play pivotal roles as exchangers and co-transporters (64). Importantly 
these buffers have no effect on image quality. 
1.7.2 Temperature 
Maintaining a constant temperature for the cells is crucial for successful cell culture (65). There 
are 4 core methods for maintaining temperature whilst also imaging the culture that are relevant 
if temporal or spatial resolution is required that prevents manual removal from an incubator. 
Each of these is further discussed regarding their advantages and disadvantages. 
1.7.2.1 Microscope Enclosures 
The majority of microscope manufacturers now produce large boxes to place around their 
microscopes to maintain a constant environment, known as microscope enclosures. Compared to 
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a standard incubator there is still a large fluctuation inherent to these designs, and often 
stabilization takes a prolonged period of time (65). This is due to the large heat loss to the room, 
which can itself cause significant room heating. Often these enclosures are similar to a plastic 
box with windows to allow the user access to the imaging plane, which itself can be cumbersome. 
However, as these adaptions are suitable for any existing microscope this live cell imaging 
platform does not require the expenditure of acquiring a new microscope system. 
1.7.2.2 Stage-top incubation chamber 
A stage top incubation chamber heats only the area where the cells are confined to and is 
therefore subjective to room temperature fluctuations greater than the enclosures mentioned 
previously, shown in ‎Figure 7. Stage-top incubation chambers require objective heaters, which 
can have an effect on focusing as focus drift is a problem with any temperature fluctuations (56). 
Heated platforms can often restrict some objectives with short working distances, and even 
affect the light paths if not properly designed. Despite this, access to the incubated vessel is easy 
and allows for perfusion systems to be implemented, and like the enclosures this can be an 
addition to most microscopes (66). 
 
 Bioptechs, Inc. Delta T Culture Dish System (67).This is designed to simulate Figure 7.
host conditions on the stage of a microscope and provide an optimal optical environment for 
microscopy. This two-step system allows you to plate your cells and observe them without having to 
transfer them to another structure   
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1.7.2.3 Small Microscope designed to fit within a standard incubator  
A number of manufacturers currently market systems designed for incubators, such as GE’s JuLi  
(68) and Essen Bioscience’s Incucyte (69). These microscopes utilise incubators that are found in 
all cell culture labs and therefore reduce the microscope cost. 
1.7.2.4 Incubator / Microscope combination 
Currently on the market are a few versions of combining the microscope and incubator. These 
are shown in ‎Table 3 below along with commercially available products and their advantages and 
disadvantages for each method. 
Table 3. Advantages and disadvantages of available microscope and incubator 
combinations. This table highlights some of the common problems associated with commercially 
available temperature control mechanisms as well as benefits that show which combination is most 
suitable for individual applications.  
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1.8  Commercially Available Phase Contrast Imaging Platforms  
Traditionally, cell cultures are monitored by time consuming microscopy, manual imaging and 
image processing. Conventional time-lapse recordings have provided new data regarding living 
cell behaviour and growth. Despite the advantages the technique does have drawbacks, notably 
user variation, length of follow-up time and non-automation of analysis. This has led to a need in 
the market for an automated microscope within a culturing system. Such systems incorporate 
software enabling remote control of image acquisition. This new generation of live-cell imaging 
microscopes increases throughput and flexibility of examining the dynamic cellular processes 
(61). There are three vital aspects to live cell imaging platforms, sensitivity of detection, speed of 
acquisition and viability of the specimen. In this section a range of market available platforms 
bearing in mind these three crucial points whilst touching on other factors such as light 
wavelengths, image analysis, and conjunction with fluorescence, which are compared in ‎Table 4. 
1.8.1 Cell-IQ™ (Chipman Technologies) 
The Cell-IQ™ system (CM-Technologies Ltd, Tampere, Finland) provides the basis for the 
imaging work in this thesis. Combining long term cell incubation conditions with phase contrast 
and fluorescence imaging utilising Machine Vision Technology to automatically identify, analyse 
and quantify cell morphological features (70) the Cell-IQ™ offers the ability to detect and 
quantitate ‘biomarkers’ (5,71).  While many of these techniques are used independently already in 
cell biology, Cell-IQ™ is the first system that has combined cell visualisation with Machine Vision 
Technology for quantitation (70,72). 
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 CM-Technologies live cell imaging platform, Cell-IQ™  (70) This is a fully Figure 8.
integrated continuous live cell imaging and analysis platform incorporating phase contrast and 
brightfield imaging capabilities with its on-board Analyser software package for the quantification 
of image data.  The Cell-IQ offers researchers label free imaging and automated analysis, allowing a 
multitude of kinetic assays from cell proliferation through to tubule formation to be studied.  
The system includes an automated optics module, integrated incubator, 2 incubation gas 
controllers, precision movement stage all controlled through machine vision based software (35). 
Cells are maintained in the appropriate environment of temperature, humidity and gas that 
makes long term observation possible (5,35).  Micro-plates, flasks or other culture vessels can be 
placed in the Cell-IQ™ for sequential analysis (35).  The software enables the user to select 
the location and area to be imaged within each well, specify how long to measure and how often 
to cycle through the plate or entire plates.  This is accomplished automatically by using accurate 
plate positioning and automatic "all-in-one" focusing that compensates for any variation in the 
plate structure. 
The use of machine vision based training within the Imagen analysis package provides a flexible 
approach to monitoring proportions with distinct phenotypes within complex systems such as 
kinetic drug response studies within co-culture. 
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Although the Cell-IQ™ is one of the more expensive live cell imaging platforms currently on the 
market, the stand alone kit allows it to be placed anywhere within the lab and comes fully 
equipped with high specification analysis software. There is no need for other equipment such as 
incubators or software.  
1.8.2 IncuCyte™ (Essen Bioscience) 
 
 Essen Bioscience compact microscope, IncuCyte  (69) The Incucyte system Figure 9.
allows you to place a microscope within an incubator. With configurable trays a wide variety of 
culture vessels can be used within the system to provide long-term live cell imaging.  
The Incucyte™ (Essen Bioscience, Welwyn Garden City, UK) system is a fully automated, 
fluorescence and brightfield compact microscope that can be incorporated within a standard 
tissue culture incubator enabling live long term culture imaging (61). The standard Incucyte can 
hold 6 well plates with custom designed consumables and includes a suite of specific application 
modules compromising of image analysis algorithms (61). This platform also incorporates a suite 
of defined analysis algorithms to include cell migration, and apoptosis (61). 
A major selling point of this equipment is that it fits into an incubator of which many laboratories 
already have, and therefore compared to the Cell-IQ system this is much cheaper. Unlike the 
Cell-IQ however the Incucyte has an automated microscope rather than an automated stage, 
allowing the system to have a smaller footprint.  
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1.8.3 Cell Observer (Carl Zeiss) 
 
 Carl Zeiss live cell imager, Cell Observer (73) This microscope allows for rapid Figure 10.
acquisition of images and can combine up to 5 channels with any number of positions within a single 
culture vessel. The Cell Observer has an imaging speed of up to 85 images/second and an 
automatically controlled environmental to acquire dynamic processes in a wide variety of 
applications  
 Cell Observer (Carl Zeiss, Germany) allows short time lapse imaging at very high speed as well as 
long-term experiments lasting several days and involving a number of different fluorescence 
channels, z-planes and positions (74). This microscope system allows the range from simple 
observation and documentation to the quantitative analysis of slow and rapid processes. The 
Perspex container around the microscope allows for a controlled habitat for the cells with both 
temperature and CO2 control, however creating a homogeneous environment over a long period 
of time is difficult with large heat/gas loss and poor heating mechanisms (74).  
Although the system has a Perspex chamber to maintain temperature and CO2 there is poor 
humidity control with only evaporation from the culture vessel providing humidity. The 
environmental chamber also has poor environmental regulation with large deviations from a set-
point. This is un-surprising as this is a standard microscope that has been adapted for live cell 
imaging, whereas the other commercial products have all been designed for live cell imaging.  
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1.8.4 BioStation CT (Nikon) 
Increasingly researchers are using live-cell imaging to study cellular functions. The BioStation, a 
smart fluorescent cell analyser, was developed to easily view and capture images from live-cell 
experiments (75). 
 
 
 Nikon , cell culture observation system, BioStation (68) The BioStation CT Figure 11.
provides a stand-alone incubator and microscope combination able to hold 30 flasks at one time. 
With phase and fluorescence capabilities the BioStation provides a stable environment for live cell 
imaging.  
The Nikon BioStation CT allows imaging experiments to be conducted without ever removing 
the cells from the incubator. Consisting of a standard sized tissue culture incubator with 
an inverted microscope inside, BioStation CT holds 30 vessels ranging from 96 well plates to 
75cm2 flasks, which are moved between the microscope stage and the vessel rack via a robotic 
device. BioStation CT provides images from 2 x to 40 x phase images with apodized phase 
contrast optics and fluorescence images with three colour LED illumination. A bird's eye colour 
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macro view allows the entire vessel to be viewed from above. Complete security is provided: 
users access only the samples for which they have clearance. Experimental results are reliably 
traced and can be accessed remotely via an internet connection or local area network. The 
BioStation is the first commercially available multi-objective fluorescent and phase contrast 
microscope integrated with automated plate handling robotics all within a cell culture incubator 
(61). However this comes at a price that is more than double that of the other systems reviewed 
here. The availability of holding up to 30 flasks means that at capacity the time between imaging 
each flask is much greater than the other products noted here. This therefore moves the 
BioStation towards a more manufacturing focus rather than research based, paralleled in its cost. 
Due to the robotic arm selecting the plate, and placing it on the microscope stage, the time for 
imaging is much higher than the other platforms, with the advantage of holding more culture 
vessels. However this comes at a cost to the environment. Due to the large incubator which holds 
the culture vessels, robotic arm, microscope and stage the BioStation has a large footprint and 
subsequent environmentally controlled incubator. This incubator exhibits large environmental 
difference between culture positions and on opening the door takes up to 4 hours to return to 
humidity set-point. ‎Table 4 gives an overview and some numbers to these observations.  
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1.8.5 IN Cell Analyzer (GE Healthcare) 
GE’s IN Cell Analyzer 2200 delivers a widefield cell imaging system with increased acquisition 
speed to provide high-content imaging workflow (76).  
 
 IN Cell Analyzer 2200, GE Healthcare (77) The IN Cell Analyzer allows high Figure 12.
content screening and analysis of both fixed and live cells within an environmentally controlled 
chamber capable of holding a single culture vessel.  
The IN Cell Analyser 2200 brings flexibility with each system capable of holding bespoke 
instruments for individual research needs. It also offers a higher resolution within the 
fluorescence imaging one of its major selling points. This is completed by using a 2 million pixel 
camera to capture high resolution images (77). Another aspect is the speed of acquisition, the 
ability to complete a 96 well plate with 2 channels in less than 2.5 minutes. This does however 
mean that the stage movement is fast which could disturb live cells.  
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Table 4. Summary of commercially available imaging platforms 
 
* 96 well plate, 10x objective, 2 channels (Phase and fluorescence channel), 1 image per well 
** 20 x objective 1280*960, ***measured on system at Loughborough University 01/04/2014 
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1.9 The Potential of Automated Phase Contrast Imaging as a Process 
Analytical Tool 
As discussed previously, there is a growing need for a non-invasive, label free measurement system 
to compliment the Quality by Design paradigm, in order to use systematic process development 
tools. Phase contrast microscopy shows real promise in filling this current technology gap, and 
through the use of automating the current user defined analysis using one of the reviewed systems, 
the cellular therapy industry can benefit through time, cost and regulation. 
The Cell-IQ forms the basis of this thesis, which integrates an environmental chamber with a 
microscope whilst also providing analysis software. This set-up then allows cell culture to be 
continually imaged to provide information relating to culture state followed by analysis of the 
images to automate quality assessment. The Cell-IQ provides the best commercial equipment for 
this compared to the other kit summarised here. 
1.10 Thesis Objectives 
The work described here will identify how phase contrast image analysis can be utilised to identify 
and control variable cell culture process in a novel, automated and non-invasive manner. For image-
based quality assessment of cells there are five recognised steps for successful implementation. The 
first being raw image collection, image processing, experimental data collection, data analysis and 
finally prediction of culture state. This thesis will therefore follow these five steps to develop an 
enabling tool to measure, define and predict cell culture state in a manner that is useable to 
improve process control. In order to achieve this exemplars of human Embryonic Stem Cells 
(hESC’s), human Haematopoietic Stem Cells (HSC’s) and their respective differentiated states will 
be assessed. Following the collection of raw images using the Cell-IQ™ there is an identification 
package of potential attributes that may relate to quality. The analysis of the raw images will 
Chapter 1 
41 | P a g e  
 
determine image based metrics of features that can be related to quality. Alongside this an 
understanding of the statistical attributes of the assay will be addressed in order to evaluate the 
potential for process control and prediction. Following imaging of the cultures common 
characterisation techniques will also be performed as a comparison and verification of any 
characterisation changes that are seen within the images. 
Whilst imaging and analysing images it is imperative to ensure that the optimum environmental 
conditions are met. This includes verifying the gas composition, temperature and humidity of the 
culture system and mimicking that found in a conventional culture system. 
Also conducted is a process overview using the image derived metrics to make process decision and 
therefore prove utility of a non-invasive tool for quantifying quality and controlling a manufacturing 
process for cell based therapies. 
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2.  MATERIALS  AND METHODS  
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2 Materials and Methods 
Much of the work discussed in the following chapters is method development work and therefore is 
presented in later result chapters. This method section identifies generic methods of cell culture 
and analysis that have been utilised throughout the work. Firstly embryonic culture is described 
relating to maintaining pluripotency, measuring pluripotency as well as differentiation protocols. 
Further work has utilised cord blood from which CD34+ cells are purified before culturing and then 
the haematopoietic progenitor population was measured using the colony forming unit (CFU) 
assay. Alongside this flow cytometry is utilised to check for purity and maturity of haematopoietic 
stem cells. 
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2.1 Materials 
Listed here are tables with all the reagents that have been used within this work. 
Table 5. Embryonic Culture materials used in this work. *mTeSR-1  comes in 2 parts, a 
refrigerated base medium and a frozen supplement.  
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Table 6. Haematopoietic culture materials used in this work.  *Mother had a blood 
transplant.  
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Table 7. Flow Cytometry antibodies used in this work (right) 
Table 8. Immunostaining antibodies used in this work (left)  
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Table 9. List of equipment used throughout this work. 
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2.2 Embryonic Cell Culture 
The human embryonic stem cell (hESC) line H9 was purchased from WiCell, Madison. H9 cells were 
cultured as colonies on Matrigel (BD Biosciences, Oxford, UK) in the commercially available defined 
culture medium; mTeSR-1  (StemCell Technologies, Canada). 3 separate batch lots of mTeSR-1 
were utilised in this work, each comparable as measured by the manufacturer. mTeSR-1 contains 
Bovine Serum Albumin, rh bFGF, rh TGFβ, Lithium Chloride, Pipecolic acid and GABA. Cells were 
cultured in standard cell culture conditions at 37°C, in an environment containing 5% CO2 in Nunc t-
25, Nunc t-75 or Nunc 6-well plates. Unless otherwise stated, cells were fed every 24 hours by 
aspirating off the spent medium in the well and replacing with an equal volume of fresh, pre-
warmed media. The volumes used for culture are shown in ‎Table 10 with the relevant culture 
vessels. 
Table 10. Medium volumes for the culture of H9 cells. This table summarises the volumes of 
mTeSR-1 that were used during culture of hESC’s for various tissue culture vessels.  
 
2.2.1 Matrigel Preparation 
hESC-qualified Matrigel (BD Bioscience) was used for coating tissue culture surfaces. As stated from 
the supplier, this Matrigel has been qualified as compatible with mTeSR-1  by Stem Cell 
Technologies, thus neglecting any screening for media and surface coating compatible mixtures 
(78). The purchased stem cell line H9 was also cultured on matrigel with mTeSR-1. 
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Matrigel was used as per the manufacturer’s instructions. Briefly, stock bottles of Matrigel were 
thawed overnight at 4°C. The bottle was well swirled to ensure a good mix and kept in a chill bucket 
containing Lab Armor beads (Lab Armor) to maintain a low temperature. All consumables that were 
in direct contact with Matrigel were pre-chilled to -20°C, including, pipettes, stripettes, cryovials 
and plates/flasks. The stock solution of matrigel was aliquoted into the manufacturer’s lot specific 
quantities. This varied depending on the protein concentration of the stock but was typically 
between 290-320 µL for each aliquot. Stock aliquots were stored at -80°C for up to 6 months. Prior 
to coating, Matrigel aliquots were thawed at 4°C and diluted in 25 mL of cold DMEM (Life 
Technologies). To coat pre-chilled tissue culture flasks and plates the surface was covered with 
excess matrigel solution, as shown in ‎Table 11. 
Table 11. Matrigel coating volumes for the culture of H9 Cells.  This table summarises the 
quantities of matrigel that were used to coated various culture vessel platforms  
 
Coated vessels were stored at 4°C for up to 2 weeks prior use. Just before use the coated plates 
were left at room temperature for 45 minutes to ensure polymerisation of the Matrigel had 
occurred. Excess Matrigel solution was then aspirated prior to hESC plating and replenished with an 
equal volume of warmed media. 
2.2.2 Thawing of Cryopreserved hESCs 
After removing a cryovial of frozen cells from storage in liquid nitrogen, the vial was thawed by 
gently swirling in a water bath set at 37°C. The cryovial was removed from the water bath when only 
a small ice crystal remained. The cryovial was then soaked in 70% (v/v) industrial methylated spirit 
(IMS) (Fisher Scientific) and allowed to air dry and sterilise prior to opening. The entire contents of 
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the vial were gently transferred using a P1000 pipette to a 15 mL centrifuge tube. Pre-warmed 
mTeSR-1 was added drop wise to the centrifuge tube containing the cells using a 5 mL stripette. An 
additional 1 mL of media is used to rinse the vial and then transferred to the centrifuge tube. 
After mixing the thawed cells and media gently the suspension was then centrifuged at 200 xg for 2 
minutes. The supernatant was aspirated and the pellet re-suspended in 4 mL of fresh warmed 
mTeSR-1. 2 mL of cell suspension was then added to Matrigel coated 6-well tissue culture plates, 
each already containing 1mL of mTeSR-1 as described in the Matrigel Preparation Section ‎2.2.1. 
The plate was then transferred to a standard incubator in which cells were maintained at 37°C in an 
environment containing 5% CO2, rocked on x and y axis (to ensure no swirling occurs). Cells were 
then maintained by feeding every 24 hours as described in Section ‎2.2.4. 
2.2.3 Passaging hESCs 
Prior to passage any areas of cell differentiation were identified and removed. This was completed 
by examining cultures under a 4x objective on a light microscope and marking areas of 
differentiation with a lens marker which created a small ring around the differentiated area. The 
spent media was then removed from the plate and the circulated areas of differentiated cells were 
also aspirated using a 300µL pipette tip on the end of an aspirator.  
The remaining undifferentiated cells were washed twice in DMEM (Life Technologies), which 
involved adding equal volumes of warmed DMEM to each plate, swirling and then aspirating the 
spent DMEM. This removes excess protein from the culture vessel so that enzymatic digestion 
occurs more efficiently at the cell attachment surface rather than by digesting protein in solution.  
Following the final removal of DMEM wash solution, dispase 1 mg/mL (Stem Cell Technologies, 
Canada) was added to each well and incubated at 37°C for 7-9 minutes. Dispase is a protease which 
cleaves fibronectin and collagen IV, thus causing cell detachment. After checking that the 
perimeters of the colonies were beginning to fold back the dispase was carefully aspirated and the 
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cells washed with DMEM as before. The DMEM wash solution was aspirated and the cells were 
covered with mTeSR-1. The culture vessel was then tapped to remove the adhered colonies, and if 
required a Cell Scraper (Corning) was used at this stage to remove any remaining attached cells. Cell 
scraping involved scraping the entire surface by first following the perimeter of the well and then 
scraping 3 times in one direction, rotating the plate 90° and scraping 3 more times. The cell 
suspension was then passed through a 40 µm filter (Millipore, USA) to remove any unwanted single 
cells and allow collection and purification of the colonies.  The filter was then washed using 10 mL of 
media to ensure all single cells had passed through, inverted over a fresh centrifuge tube and fresh , 
warmed mTeSR-1  was washed over the upside down filter. Completing a 1:6 split of the initial to 
final cell density, the cell suspension was distributed over each fresh matrigel coated well using a 
5mL stripette making sure the final mL in the stripette is never used, but recycled. The final mL in a 
stripette is often at a much higher cell density due to drag forces as the media moves faster than the 
colonies during dispensing. After placing the plates in the incubator the plate was rocked in the x 
and y axis direction, ensuring the plate was not swirled and then left for the cells to adhere. 
2.2.4 Maintenance of hESCs 
Cells were fed by a 100% media change every 24 hours (unless stated) and passaging was 
completed every 5-7 days when approximately 75% confluency was reached. At this stage 
confluency was assessed under a light microscope, 75% confluency was judged to be complete 
when colonies began to interact with one another. The daily media change was completed by 
aspirating the spent media from one corner of a well, adding fresh pre-warmed mTeSR-1 and 
returning the plate to the incubator. The hESC H9 cell line was routinely characterised with 
karyotype analysis (Section ‎2.8) and expression of pluripotent markers (Section ‎2.5 and ‎2.6).  
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2.2.5 Cryopreservation of hESCs 
Cryopreservation of hESC cultures was carried out 1-2 days prior to passaging. Colonies were 
removed as described in Section ‎0‎2.2.3 Passaging hESCs. Colonies were pooled and were 
centrifuged at 200 xg for 2 minutes, the supernatant removed and the cell pellet re-suspended in 
commercially available freeze media; mFreSR (StemCell Technologies) containing dimethyl 
sulfoxide (DMSO). Colonies were cryopreserved at each 9.6cm2 by resuspending the cells in 1 mL of 
freeze media per cryovial, which equated to one well of a 6-well plate per cryovial. Each vial was 
then thawed as described in Section ‎2.2.2 prior to use. 
2.3 Differentiation of hESCs to the Mesoderm Lineage  
hESCs were seeded onto Matrigel coated vessels as described in Section ‎2.2. After 24 hours of 
culture in pluripotent media the mTeSR-1 was replace with mesoderm differentiation media. This 
was mTeSR-1 supplemented with 10 ng/mL BMP-4 (R&D Biosystems), 10 ng/mL FGF (R&D 
Biosystems), 10 ng/mL VEGF (R&D Biosystems) and 10 ng/mL Activin-A (R&D Biosystems). A 
complete media change was carried out every 24 hours by removing the spent differentiation media 
and replacing it with fresh mTeSR-1 containing supplements. The cells were then assessed for early 
mesoderm markers as described in Section ‎2.6.  
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2.4 Cell Count and Viability Measurements  
The cell counts and viability measurements were conducted on a number of different automated 
platforms including the Cedex, the NucleoCounter, the Guava EasyCyte and the Countess. 
2.4.1 Cedex Cell Counter 
The Cedex (Roche Innovatis) is a fully automated, image based cell analyser providing information 
about cell concentration, viability, and aggregates. The analyser uses trypan blue exclusion method 
and a high resolution image scanner to analyse cells and objects (79). Single cell samples of 1 mL 
were added to the Cedex, which were then mixed with an equal volume of trypan blue 
automatically. The system was then set to automatically acquire and analyse 30 images to 
determine the population viability and cell concentration.  
2.4.2 NucleoCounter Cell Counter 
The NucleoCounter (Chemometec) is a compact image based cell counter utilising the detection of 
fluorescence from DNA bound fluorescent dye propidium iodide (PI). Briefly the method involves 
first the lysis of cells to generate free nuclei. To achieve this cells were mixed in equal volumes with 
Solution A (Chemometec); a lysis buffer. After vortexing this mixture was then supplemented with 
Solution B (Chemometec); stabilising buffer in the same volume as Solution A. This 3x diluted 
solution of cells was then loaded onto a disposable cassette which comes prepared with PI stain 
within, shown in ‎Figure 13. 
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 NucleoCounter disposable cassette.  This cassette comes pre-loaded with Figure 13.
propidium iodide (PI). Cells are sucked up using the cassettes piston and after loading into the 
NucleoCounter the cells are mixed with the PI solution generating a count (80).  
The cassette is then inserted into the NucleoCounter where the lysed cells and PI are mixed. The 
NucleoCounter then counts the total number of cells. Another cassette is loaded with pure cell 
solution without the lysis buffer treatment to calculate the dead cells. The percentage of viable cells 
can then be calculated from the difference between total and dead cells. 
 
 Chemometec NucleoCounter NC-100. A compact cell counter using pre-loaded Figure 14.
propidium iodide cassettes to determine count and viability of a sample (80).   
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2.4.3 Guava Easycyte Cell Counter Application 
The Guava EasyCyte (Millipore) is a microcapillary flow cytometer that has the ability to perform 
cell counts and viability measurements through its ViaCount assay. This involves mixing the single 
cell suspension with ViaCount (Millipore). ViaCount is composed of two DNA-binding dyes, one 
binding to nucleated cells the other to apoptotic cells. This allows the total, dead and viable cells to 
be calculated. 
 
 Example figure from Guava EasyCyte counting method Viable cells on the left are Figure 15.
separated from dead and apoptotic cells (81).  
2.4.4 Countess Cell Counter 
The Countess (Life Technologies) is an automated cell counter which similar to the Cedex uses 
trypan blue exclusion along with image analysis to measure viability and cell concentration. Unlike 
the Cedex, the Countess requires manual mixing of the cell stock and trypan blue prior to pipetting 
20 µL of the solution onto a Countess slide. The disposable slide is then inserted into the machine 
and the results displayed. 
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 Life Technologies Countess, automated cell counter. The Countess uses prepared Figure 16.
slides containing cell sample and trypan blue, then uses image analysis to measure viable and non-
viable cells (82).  
2.5 Flow Cytometry Analysis  
Flow cytometry was carried out using the Guava Easycyte 8HT (Millipore) equipped with a 75 mW 
blue diode (488 nm) laser and a 40 mW red diode (635 nm) laser.  
2.5.1 Sample Preparation for Intracellular Markers 
Cell cultures were washed twice with room temperature phosphate buffer solution (PBS) prior to 
enzymatic detachment using Accutase (Sigma). Washing consisted of aspirating the spent media, 
adding equal volumes of PBS and swirling before aspirating the PBS. Accutase was pre-warmed and 
added to each culture vessel before incubating in a standard incubator at 37°C for 7-10 minutes. 
Single cells were then harvested by via pipetting up and down to achieve a single cell suspension, 
and centrifuged at 300 x g for 5 minutes before being re-suspended in Stain Buffer (BD Bioscience) 
containing 0.1% (w/v) bovine serum albumin (BSA) (Sigma).  A cell count was then completed using 
the NucleoCounter as described in Section ‎2.4.2. Cells were then centrifuged at 300 x g and re-
suspended in a single step permeabilisation and fixation with Cytofix/Cytoperm Buffer (BD 
Bioscience) at 107 cells /mL for 30 minutes at 4°C. During this incubation, respective antibody 
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solutions were aliquoted into wells of a deep 96-well plate. After permeabilisation and fixation of 
the cells, they were washed twice with 1X Perm Wash Buffer (PWB) (BD Bioscience) (centrifuging at 
300 xg for 5 minutes) before being resuspended to achieve a cell concentration of 107 cells/mL. Then 
100 µL aliquots of cell suspension (106 cells) were added directly into the relevant wells of the 96-
well plate containing prepared antibody solutions. Samples were incubated at room temperature, in 
the dark for 45 minutes. Cells were washed twice with PWB and resuspended in 1 mL Stain Buffer 
for analysis. All analysis was completed using GuavaSoft 2.6 software (Millipore). A list of all used 
antibodies is shown in ‎Table 7. 
2.5.2 Controls 
All flow cytometry assays were run with comparable controls of a cell only and isotype control 
(identified in ‎Table 7). The cell only sample was exposed to the same fixation, permeabilisation and 
wash steps as the stained cells, but was not exposed to any antibodies. These cells were used 
initially to verify the settings of the flow cytometer so that their signal was recorded within the first 
log decade. 
Isotype controls consisted of samples that were labelled with antibodies that matched the host 
species and isotype of the target antibodies used. Isotype antibodies are raised against an antigen 
that is not normally expressed in the target cells and use the same fluorophores as the target 
antibodies. They are used to measure the level of non-specific background signal caused by primary 
antibodies. All isotypes were used at the same concentrations as the target antibodies, and their 
signals were used to set a baseline at 95%, from which any signal above was considered to be 
specifically labelled with the target antibody. 
BD CompBead Plus positive and negative beads (BD Bioscience) were also used as controls to 
clearly identify positive and negative populations. These beads were either coated with antibodies 
that are able to bind to utilised antibodies (positive beads) or have no binding capacity (negative 
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beads). This allows the identification of distinct positive and negative populations for specific 
antibodies that can then be used for optimizing the photomultiplier tube settings and calculating 
the fluorescence compensation as discussed in section ‎2.5.3. 
2.5.3 Data Acquisition and Analysis 
All samples were acquired using the same gating strategy as outlined below in ‎Figure 17. 
 
 Gating Strategy for flow cytometry analysis.  Prior to acquiring flow cytometry data Figure 17.
the following this protocol is used to initially exclude doublets from the data before gating on just viable 
cells. This gate is then used to collect 10,000 data points. Following acquisition a gate is applied to each 
fluorescence channel representing 5% positive on the isotype control. The percentage positive is then 
recorded on the analysed sample.  
Doublets within the sample are often caused by inherent cell adhesion and/or by cross linking of 
cells by staining reagents. These doublets can lead to artefacts in measurements and therefore are 
removed first. This is achieved using pulse width analysis, which in practice assesses both the 
forward scatter width and area to determine doublets. It is then possible to view the forward 
against side scatter plot to remove any non-viable cells and debris. The gate that contains viable 
single cells is then used for analysis and 10,000 events are collected.  
Alongside all the isotype controls and target samples, BD CompBeads were acquired. During 
acquisition these beads provide a negative and positive population for the antibodies being used. 
This therefore allows the photomultiplier tube settings to be optimised prior to acquisition. This was 
completed for all new antibody lots, and checked for every time there after, although the settings 
were not altered to allow a comparison to be made between runs. 
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Once the samples had been acquired the fluorescence compensation was calculated. This initially 
was completed manually with the matrix of compensations being recorded as a guide. Following 
this the Guava Incyte software (Millipore) provides an automated compensation on the beads. This 
was then used to provide a consistent compensation matrix, with each time a comparison to the 
manually determined matrix to ensure consistency. 
Once these populations were analysed percentage positive and median values were recorded based 
on 5% positive gates placed on the corresponding isotype controls. Mean and median fluorescence 
intensity values of stained cells were normalised to the mean and median fluorescence intensity 
values of the isotype controls using the following equations: 
   ̅̅ ̅  
        
                 
 
and; 
       
           
                    
 
where:  ̅̅ ̅= mean fluorescence intensity and      = median fluorescence intensity. 
2.6 Immunocytochemistry 
Immunocytochemistry was instrumental in visualising the variation in population based on cellular 
proteins. All fluorescent images were acquired on a Nikon Eclipse Ti inverted epi-fluorescence 
microscope (Nikon) and a Coolpix 4500 camera (Nikon). Images were then further analysed with 
Nikon Elements Ar software (Nikon).  
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2.6.1 Conjugated Antibodies 
6-well tissue culture plates of hESCs were washed in equal volumes of PBS (Lonza) and fixed in PBS 
containing 4 % paraformaldehyde (Sigma) for 30 minutes at 4°C. Paraformaldehyde was quenched 
with 100 mM glycine (Sigma Aldrich) for 15 minutes at room temperature. After washing with PBS 
the cells were blocked and permeabilised with blocking buffer consisting of PBS, 10 % normal 
donkey serum, 0.3 % Triton X-100 and 1 % BSA for 30 minutes at 4°C. Cells were then incubated for 
3 hours at room temperature in the dark with antibodies at the manufacturer’s concentration 
diluted in blocking buffer. Dual and triple staining of cells was completed by pre-mixing the 
antibodies together after blocking. The cells were then washed 3 times with PBS, and then left in 
PBS ready for imaging. When required, counterstaining of the samples was completed by 
incubating the cells with 300 nM 4’,6-diamidino-2-phenylindole dilactate (DAPI) in PBS (Life 
Technologies) for 5 minutes at room temperature in the dark. Cells were then washed twice in PBS 
before being left in PBS for imaging. 
2.6.2 Non-Conjugated Antibodies 
6-well tissue culture plates containing hESCs were washed in PBS (SLS, UK) and then fixed in PBS 
containing 4 % paraformaldehyde (Sigma) for 30 minutes at 4°C. After washing with PBS the cells 
were then blocked and permeabilised with PBS containing 10 % normal donkey serum, 0.3 % Triton 
X-100 and 1 % BSA for 30 minutes at 4°C. The blocking buffer was then aspirated and the cells 
incubated overnight at 4°C with primary monoclonal antibodies diluted in PBS with 1% BSA and 
0.3% Triton X-100. After washing with blocking buffer, then PBS, the secondary antibody was 
added diluted in PBS. After incubating at room temperature for 1 hour, the cells were washed and 
imaged using a Fluorescence Microscope. 
Counterstaining was then completed were necessary as before in section ‎2.6.1. Control samples 
were performed by only using the secondary antibody to assess for non-specific binding. 
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2.7 Phase Contrast Imaging 
The Cell-IQ (CM-Technologies) is an automated phase contrast imaging platform. The system 
comprises of a controlled culture environment, phase contrast microscope (4x, 10x, 20x and 40x 
objectives) and a camera that is integrated into an automated cell monitoring and analysis system. 
The imaging system allows continuous monitoring of adherent cells in two plates in a specific plate 
holder.  
Incubation gases are pumped directly into the plate through perfusion holes in the lid. The holes are 
placed to maximise gas exchange within the plate. The gas is premixed sterile 5% CO2 gas that is 
automatically controlled though the software. The default setting uses 30 mL/min flow rate with 
cyclic perfusion of 5 minutes on and 20 minutes off. This was utilised for all experiments unless 
stated otherwise as it was manufacturer tested to keep cultures at 5% CO2 as required. 
The Cell-IQ utilises Machine Vision approaches that allow monitoring and analysis of cell cultures. 
Machine Vision is the term given to duplicating the effect of human vision by electronically 
perceiving and understanding an image (83). The classification module is based on statistical 
classifiers, which can be ‘taught’ to determine morphological changes occurring within the culture 
down to the single cell level. 
Through the use of a grid system, selected positions within the plate are selected, and the 
automatic stage moves between points at a stated time interval of 30-60 minutes unless stated. The 
recorded images are then saved as JPEG images in separate folders for analysis.  
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2.7.1 Phase Contrast Image Analysis 
After the successful capture of phase contrast images, each image is then analysed for metrics. 
There were three overall methods that were used during analysis with more bespoke methods 
mentioned within the core chapters of this work. 
2.7.1.1 Threshold Analysis for Embryonic Colonies 
Thresholding is the simplest method of image segmentation. From a greyscale image such as phase 
contrast, thresholding can be used to segment images into bands of similar pixel intensity. This 
therefore provides an analysis tool to segment cells from their background.  
Initially local contrast was computed to detect regions of high pixel intensity using a threshold value 
of 20, this highlighted all areas likely to contain cells. Small objects were then removed (value of 
40/100), followed by the filling in of any holes using a value of 68/100. 
2.7.1.2 Area Finder Analysis for Embryonic Colonies  
Area finder analysis is a more in-depth tool. It is formed from two parts, a segmentation phase and 
a sample library phase, which are run in this order during analysis. Segmentation, similar to the 
threshold analysis, first identifies interesting objects such as cells in the image. Next these objects 
are recognised into user defined classes that is created based on information in the sample library. 
The sample library is built from user defined areas of images that relate to each class of cells. For 
embryonic colony identification the sample library has examples of periphery core colony, dark 
colony and edge cell morphologies. An example of the sample library is illustrated in ‎Figure 18.  
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 Sample Library built using Area Finder tool. Examples of background, ‘normal’ Figure 18.
colony coverage, dark colony coverage and edge cell coverage are shown. The Area Finder analysis 
utilises a sample library to categorise all areas of interest such as cells into one of these user defined 
groups. 
2.7.1.3 Count/Classify Analysis for Haematopoietic Progenitors  
Count/Classify analysis tool within the Cell-IQ’s analyser package uses a similar technique to that 
mentioned in the Area Finder tool section. First libraries of images are created by selecting 
individual cells as shown in ‎Figure 19. 
 
 Count/Classify protocol building a library of progenitor images. By selecting Figure 19.
individual cells as shown by the yellow boxed circle, the picked sample (shown in the bottom right) is 
added the library shown in the top right.  
‎Figure 19 shows how a library of images of individual cells is built along with the background to 
allow identification of cells. Once a library is built this protocol can then be used to identify 
haematopoietic progenitors in further images. 
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2.8 Osteoblast Culture 
Single cell culture of an attached population was completed using HOST, osteoblast cell line. This 
was completed in t-25 flasks. A vial of osteoblasts were thawed as described in Section ‎2.2.2, and 
cultured in pre-warmed DMEM. A media change was completed every 48 hours by aspirating the 
spent media and adding fresh, warmed DMEM. 
2.9 Karyotype Analysis 
Karyotype analysis of hESCs was outside the analytical capabilities of the Centre for Biological 
Engineering where the majority of this study was based and was therefore outsourced to The 
Doctor’s Laboratory (TDL); a clinical pathology accredited laboratory. For all karyotype analyses live 
samples were shipped to TDL in T-25 flasks containing 70-80 % confluent cultures. The following 
protocol is a summary of the procedures carried out by TDL for karyotyping. Live samples were 
incubated at 37°C and 5 % CO2 overnight upon receipt. Cells were treated with colcemid, to hold 
cells in metaphase, for 20 minutes with 20 μL/mL of media. Following this, cells were enzymatically 
harvested with trypsin/Ethylenediaminetetraacetic acid (EDTA) and left in suspension in a 1:12 
solution of FBS in PBS for 25 minutes at 37°C. Cells were then pre-fixed in a 3:1 methanol:glacial 
acetic acid. Pre-fixed cells were centrifuged and re-fixed in this manner twice, discarding the 
supernatant before each new fixation step. At this stage, fixed cells were transferred to a wet slide 
to allow for the suspicion to spread across the surface. Samples were then air dried and aged in an 
oven at 92°C for 40 minutes or at 63°C overnight. The slides were then treated with a 1:50 solution 
of trypsin in PBS followed by quenching with serum. Finally, samples were stained with a 3:1 
leishman/giemsa solution before being washed in purified water, dried and mounted with 
coverslips. Sample analysis was performed using conventional bright field microscopy. 10-20 
metaphase spreads were examined for each analysis. 
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2.10 Isolating Mono-Nuclear Cells (MNC’s) from Cord Blood  
Fresh cord blood was sourced from Anthony Nolan, Nottingham. On arrival a cell count was 
performed using NucleoCounter (Total nuclear cell (TNC) count). The protocol for the ‘Isolation of 
mononuclear cells from human cord blood by density gradient centrifugation’ from Millipore, USA 
was then followed. Briefly, cord blood (stored at 4°C) was diluted with 3 x volume of MNC buffer 
containing PBS and 2mM EDTA (stored at 4°C). 35mL of the cord blood suspension was then 
layered over 15mL Ficoll-Paque (SLS, UK) in a conical tube. This was centrifuged for 35 minutes at 
400 x g without the use of a stopping brake; the upper layer (plasma) was aspirated and the second 
layer (MNC’s) transferred to a clean conical tube. The conical tube was filled with buffer and 
centrifuged at 300 xg for 10 minutes, after aspirating the supernatant the tube was filled with buffer 
and centrifuged again at 200 xg for 10 minutes. The supernatant was removed leaving the MNC 
population. 
2.11 Isolation of CD34+ Cells from the MNC Population  
The MNC’s were re-suspended in 300 µL of MNC buffer then 100 µL of FcR blocking reagent 
(Millipore) was added along with 100µL of CD34 microbeads (Millipore). This was incubated at 4°C 
for 30 minutes on a rotating platform. The cells were then washed by adding 5-10mL of buffer, 
centrifuged at 300 x g for 10 minutes and re-suspend in 500µL buffer. The cell suspension was then 
added to a Magnetic-activated cell sorting (MACS) column in the presence of a magnet to select for 
CD34+ cells. After the unlabelled cells had passed through, the column is removed from the magnet 
and using a plunger the labelled CD34+ cells were removed and transferred to a collection tube. 
Flow cytometry for CD34 was then performed on all isolated cells to test for purity as described in 
Section ‎2.5. 
2.12 Haematopoietic Cell Culture 
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CD34+ cells were cultured in upright orientated culture flasks in StemSpan (StemCell Technologies, 
Canada). A media change was completed every 48 hours by centrifuging the flask contents at 300 x 
g for 5 minutes, aspirating the spent media and re-suspending in fresh media.   
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2.13 Colony Forming Unit (CFU) Assay 
A cell count was completed on the haematopoietic culture prior to use using the NucleoCounter. 
150 cells were removed from the culture and re-suspended in the required volume of 250µL (10% of 
the CFU Assay Media) to ensure a good plating density of colonies. The cell suspension was then 
added to 2.5mL of MethoCult (Stem Cell Technologies, Vancouver) and vortexed to ensure the 
sample was well mixed. This was incubated at room temperature for 5 minutes to allow any bubbles 
to rise out of solution. Using a blunt-end needle the suspension was removed and plated into a 6-
well plate. Spare wells and the surrounding areas were filled with distilled water to help 
humidification of the plate. This was then placed in an incubator at 37°C in an environment 
containing 5% CO2 to allow gelation to occur, and was then either imaged in the Cell-IQ, or left for 
14 days in a standard incubator. 
After 14 days, the control plate from the incubator and the plate in the Cell-IQ were analysed for 
colony types using a 4x objective on the inverted Nikon Ti phase contrast microscope. The wells 
were divided into quarters and each quarter counted to get a total well count.  
2.14 Statistics 
All the statistical analysis was completed in Minitab 16 for Windows. 
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3 Quantitative Non-Invasive Image Analysis for 
Embryonic Colony Culture Assessment 
3.1 Introduction 
Embryonic stem cells are derived from the inner cell mass of the blastocyst stage embryo. Their 
ability to differentiate into any cell within the body deems them pluripotent (84). This characteristic 
along with the ability of self-renewal makes them a very exciting proposition for the regenerative 
medicine industry (85). Other stem cells include mesenchymal, haematopoietic and neural stem 
cells which are multipotent and termed ‘adult stem cells’ as they are found in a variety of tissues 
post birth (86). 
In 1964 the first embryonic cell was isolated from a teratocarcinoma, a tumour which is generated 
from a germ cell (87). These isolated cells had the ability to replicate in culture and grew similar to 
what is now termed a stem cell. Later it was concluded that in fact these isolated cells were 
embryonic carcinoma cells (88). These embryonic carcinoma cells were extensively studied and 
used for in vitro studies of early mouse development. However embryonic carcinoma cells harbour 
genetic mutations and abnormal karyotypes which only accumulated throughout development and 
culture. This work therefore emphasised the importance to be able to isolate embryonic cells from 
the inner cell mass of embryo development and prevent these genetic mutations arising during 
development and culture.  
17 years after the embryonic carcinoma was isolated Evans and Kaufman from Cambridge 
University managed to establish successful culture, without karyotype abnormalities, in vitro 
pluripotent cells from the inner mass of mice blastocysts (89). This work was heavily compared to 
the previous works using embryonic carcinoma cells which at the time was the benchmark. The cells 
isolated from the embryo of a mouse by Evans and Kaufman were termed ‘ES Cells’ (embryonic 
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stem cells) in order to distinguish them from the teratocarcinoma-derived pluripotent embryonal 
carcinoma cells (90). 
It took another 17 years to isolate human embryonic cells, this time involving both ground breaking 
research along with tackling ethical issues. Thomson et al were the first group to successfully isolate 
human embryonic stem cells (hESC’s). They proposed three main characteristics that were required 
for cells to be termed hESC’s (91): 
(i) derivation from the pre- implantation or peri-implantation human embryo,  
(ii) prolonged undifferentiated proliferation, and 
(iii) stable developmental potential to form derivatives of all three embryonic germ layers 
even after prolonged culture  
These 3 characteristic form the basis for the current definition of hESC’s. 
3.1.1 Definition of human Embryonic Stem Cell’s 
As discussed Thomson proposed three characteristics that began to define features required within 
a human embryonic stem cell (92). As research has advanced, more definitions to determine ESC’s 
have been developed and reported. Various research groups use different analysis methods in order 
to determine whether they have an embryonic culture. ‎Table 12 summarises some of the foremost 
techniques and outcomes which are commonly used to define and measure quality of embryonic 
cultures. 
The common analysis techniques shown in ‎Table 12 highlight those found to validate embryonic 
research in laboratories across the world. The work expressed in this thesis will also utilise some of 
these techniques to categorise and verify the cultured population. 
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Table 12. Current characteristics of embryonic stem cells. Table of properties and measurable 
characteristics for embryonic stem cells. These methods currently make up the core of analysis 
techniques frequently used to prove or disprove that a population is made up of embryonic stem cells. 
 
3.1.2 Clinical Relevance / Need / Problem 
Human embryonic stem cells (hESCs) are pluripotent cells and are therefore capable of 
differentiation into all 3 germ layers as well as self-renewal (35,93). Along with this differential 
potential hESCs are also immune privileged, meaning that hESCs possess mechanisms that 
counteract immune responses, thereby providing protection to hESC-derived allografts whilst 
allowing the immune system to respond to other foreign antigens (94). These two factors make 
hESC therapies very attractive for the regenerative medicine industry.  
In order for either direct transplantation or differentiation prior to implantation significantly large 
numbers of embryonic cells are required. The current culture methods practical for development so 
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far are not proficient at producing these required quantities at an acceptable quality and price for 
use as a cell therapy (95). In order to successfully improve upon current culture methods there is a 
growing need for non-invasive process monitoring, a key aspect of this is being able to accurately 
describe and control the heterogeneity of a culture population. 
Heterogeneity describes the mixture of cell populations with functional differences that arise from 
the self-renewal or differentiation of stem cells (96).  Pluripotent cells, such as the H9 human 
embryonic stem cell presented in this thesis,  make lineage fate ‘decisions’ and descend through a 
multitude of states before arriving at a fully differentiated cell (97). Therefore within a population of 
pluripotent stem cells there are numerous sub-populations of cells at varying lineage states. Current 
methods of identification of pluripotency are limited to key gene networks including Oct-4, Sox-2 
and Nanog. Mouse embryonic stem cells (mESC’s) closely resemble the inner cell mass of the 
blastocyst in terms of differentiation capacity and gene expression, although mouse epiblast stem 
cells show very different characteristics although are still deemed pluripotent (98). This suggests 
the existence of hierarchy within the pluripotent section.  
It is also important to highlight that there are still some major doubts over the in vivo use associated 
specifically with embryonic stem cells. Current in vivo injections of embryonic stem cells have 
shown the ability to form teratomas (99–101). Upon transplantation in vivo, undifferentiated hESCs 
generate large tumours called teratomas. These are (benign) masses of uncontrolled 
differentiation. When they also encompass a core of malignant undifferentiated cells, these 
tumours are defined as teratocarcinomas. These malignant undifferentiated cells are termed 
embryonic carcinoma (EC), and are the malignant counterparts of embryonic stem cells (100), the 
first embryonic cells cultured in 1964 as previously described. This has caused primary concern for 
the use of embryonic stem cells for cell therapies, and the potential need for purification of 
differentiated cells prior to transplantation. The world's first study of a human embryonic stem cell 
based therapy in man was carried out by Geron which showed safety data where no teratomas 
formation was found (102). Geron initiated a Phase I multi-centre trial designed to establish the 
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safety of their embryonic stem  cell line, GRNOPC1, in patients with "complete" American Spinal 
Injury Association (ASIA) grade A sub acute thoracic spinal cord injuries (102). Prior to this Geron 
submitted evidence of the safety, tolerability and efficacy of GRNOPC1 to the FDA in a 21,000-page 
IND application that described 24 separate animal studies requiring the production of more than 
five billion GRNOPC1 cells. Included in the safety package were studies that showed no evidence of 
teratoma formation 12 months after injection of clinical grade GRNOPC1 into the injured spinal 
cord of rats and mice (103). Although this trial was stopped, this was due to efficacy and cost rather 
than safety concerns raised by the study. 
Another poignant issue for the use of embryonic stem cells are those associated with ethics. Due to 
their derivation from early embryos there is a question over their acceptability for use (86). Their 
ontological status, equivalence to an embryo, is often debated with both sides offering valid 
arguments. The Human Fertilization and Embryology Act (1990) governed research on human 
embryos for reproductive health, but recently was extended.  In 2008 after public and parliamentary 
debate this act was modified to accommodate embryonic stem cell research and is now known as 
Human Fertilization and Embryology Act 2008 (104). Medical researchers can now apply  to the 
Human Fertilization and Embryology Authority (HFEA) for a licence under which embryonic 
research can take place using ‘spare’ embryos younger than 14 days (105). However once an embryo 
is disorganised and cells are grown to create cell lines the Human Tissue Authority (HTA) 
commences the regulatory authority. Therefore any organisation processing, testing, sorting or 
distributing embryonic stem cells must do so under the authority of an HTA licence for clinical 
application (106). To carry out non-clinical research on embryonic stem cell lines the approval is 
granted from the UK Stem Cell Bank steering committee, with which the work in this thesis is 
undertaken.  
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3.2 Chapter Objectives 
Embryonic stem cells have been defined according to various measures of quality, discussed in 
Section ‎3.1.1. The use of novel image analysis as a quality measurement tool allows for one of 2 
separate conclusions. Either the new quantitative metrics derived from image analysis can be 
directly related to known quality attributes (number, phenotype) to provide a non-invasive 
correlation for obtaining the same information, or do not directly correlate to the known quality 
attributes and therefore provide novel information, the significance of which would require further 
investigation. 
In order to evaluate image analysis as a tool for embryonic quality assessment a series of steps will 
be taken in this chapter.  The first stage is to evaluate the precision of image analysis and compare 
to a conventional technique using statistical evaluation, cell counting will be used due to its 
common use as a measurement of culture assessment (107). Following this, image derived metrics 
must be analysed for novel information alongside representation of culture state and correlation to 
conventional quality assessments. To develop a quality assessment tool these questions must be 
answered within the chapter: 
 What is the precision of a common quality assessment tool? 
 What is the precision of image analysis? 
 What metrics can be measured from phase contrast images? 
 What measured metrics can correlate to common quality assessment tools? 
 Do metrics provide novel information on a culture state? 
 Can metrics be used to predict culture state?  
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3.3 Does Invasive Cell Counting Correlate to Non-invasive Cell Coverage? 
Cell counting is often utilised as a control measure in order to make process decisions, such as the 
addition of growth factor at a concentration determined by cell number. However this is an invasive 
method which requires the sacrifice of cells (107). It therefore would be advantageous to replace 
this invasive method with a non-invasive technique for representing cell number. For this work 
being able to show a reliable comparison to cell counting with the ability to achieve it non-invasively 
would be of great advantage. The first step requires assessing a single cell counting method which is 
both reliable and precise. 
3.3.1 Selecting the Most Precise Invasive Cell Counting Method 
Initially the counting method with the lowest noise was determined. Each of 20 independent flasks, 
with a variety of confluence, were taken and counted by using 3 automated counting methods; 
Guava (Millipore), Cedex (Roche) and Countess (Invitrogen). Each flask was counted 6 independent 
times on each counter, allowing a coefficient of variance (CV) to be calculated for each flask. The 
averaged CV values for all 20 flasks are shown in ‎Figure 20. 
 
 Average coefficient of variance for 3 automated cell counting systems. 20 Figure 20.
independent flasks of colonies are dissociated with 6 samples from each flask being counted on each 
measurement machine (Guava’s (ViaCount), Cedex (trypan blue) and Countess (trypan blue). The CV 
can then be calculated for each flask on each counter and averaged to produce the average CV for each 
counting method. (n=20, counts repeated 6 times)  
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‎Figure 20 shows that the Cedex automated counter provides the most precise counts which are 
more reproducible then the Guava or Countess, with an average 7% CV. Of these three methods the 
Cedex uses the largest sample volume (1 mL/count) compared to the other two methods (20 
µl/count). This reduction in volume means that a homogeneous stock solution is essential to 
achieve a precise count. Deviation away from homogeneity could reduce precision, a common trait 
as cells begin to sediment during sampling. In order to prevent sedimentation the cells can be 
continually mixed through pipetting, although this can increase the shear stress applied to the cells 
and in turn cause cell damage. A balance between ensuring a well-mixed homogeneous stock 
solution whilst maintaining viability is required. Again for this instance an automated mixer is 
advantageous ensuring consistent mixing is achieved. The mean cell counts are similar for both the 
Cedex and Countess (460000 cells/cm2) which use trypan blue to conduct their respective counts, 
mixing the cell solution with trypan blue before taking images to determine a viable cell count 
based on membrane permeability. The mixing stage of trypan blue is conducted within the 
automation of the Cedex whereas the Countess requires a pre-mixed solution to be added to the 
machine, possibly adding further error from a laboratory user. This added non-automated step, 
which could account for variation in the samples, is not required in the more automated Cedex 
counter and therefore it is preferred to the Countess. The Guava counter also requires manual 
mixing although uses a different mode of action for staining prior to counting which could account 
for a much lower cell count (300000 cells/cm2). Instead of trypan blue, ViaCount, an assay that 
distinguishes viable and non-viable cells based on differential permeability to two DNA-binding 
dyes, a nuclear stain and a viability stain is utilised. The nuclear stain identifies only nucleated viable 
cells whereas the viability stain brightly stains dead and dying cells. Consequently viable cells are 
distinguished to those that are dead or apoptotic. Compared to the Cedex, the Guava includes 
apoptotic cells into the non-viable count, generating additional information regarding the future of 
the cell culture; however the lack of precision that is related to the Guava makes the Cedex counter 
the preferred counting instrument. Due to the difference in counting method a comparison of true 
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cell counts cannot be made between the instruments, only the variation in count measurement 
between counters. Having concluded on the Cedex as measuring the most reproducibly it is 
important to identify if there is a precision deviation dependent on the cell counts themselves. All 
counting equipment has operating parameters with regard to the concentration of cells, within 
which they can precisely count. By plotting the mean counts against their respective CV’s any bias 
within the operating parameters can be identified. ‎Figure 21 plots the 20 previous mean counts 
against their respective CV’s. 
 
 Relationship of coefficient of variance (CV) to Cell Counts  The mean cell count, of 6 Figure 21.
repeats, from 20 independent flasks, plotted against the respective CV value from the 6 counts taken 
for the Cedex Counter. This shows that the variation in precision is not biased given the number of cells 
per sample. (n=20)  
No correlation is made between mean cell counts and CV’s, proving that there is no bias in precision 
given the number of cells per sample. Taking ‎Figure 20 and ‎Figure 21 into consideration the Cedex 
counter out performs the other cell counters in terms of precision whilst also maintaining 
independence to cell number and therefore will be utilised for counting in this section.  
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3.3.2 Precision of Non-invasive Coverage Image Analysis 
A culture’s confluency or coverage is a fundamental measure in the field of biology, the ability to 
quantify confluency through coverage metrics provides extensive knowledge related to the culture 
state. Cell behaviour and kinetics are often affected by varying density levels (108), this is often 
shown by a change in morphology as cultures approach confluency (109). Therefore a method of 
automating the determination of confluency non-invasively allows culture state to be determined 
prior to any process actions. 
In order to correlate the cell counts discussed previously, an image based method for measuring the 
coverage of cell colonies in a culture vessel that produces a reproducible, precise value must be 
developed. Within the Cell-IQ’s Analyser software, regions of varying threshold can accurately be 
segmented. This simplest image segmentation method utilises pixel intensity to separate light to 
dark regions (110),  known as the Threshold Method in Analyser (‎Figure 22). For a cellular 
application this allows areas of background to be isolated from areas of cells which are denser and 
therefore have a higher threshold value. From observation of analysed images it is possible to 
acknowledge that the threshold method can be used to accurately measure confluency; 
representative exemplar images are shown in ‎Figure 23.  
Chapter 3 
79 | P a g e  
 
 
 Threshold Method for identifying areas of colony.  By optimising the threshold Figure 22.
level, areas of colonies can be isolated from the background as shown here encircled within a purple 
boundary. The area within the boundary can then be measured as shown in the top left of the image. 
 
 Analysed images of embryonic colonies. Image analysis of embryonic colonies Figure 23.
using the Cell-IQ’s analyser software to identify areas of higher threshold which relate to the cell 
colonies, shown enclosed within the purple boundary. These examples show the high accuracy of using 
the threshold to analyse total colony coverage.  
Using this non-invasive image platform it is possible to image the entire surface area of the culture 
vessel from which the ‘true coverage’ can be determined along with the standard deviation using 
the method in ‎Figure 22.  Normalising the standard deviation by the mean allows the coefficient of 
variation (CV) to be calculated. Subsequently it is then possible to determine if the culture vessel 
coverage influences the CV whilst identifying the coverage that produces the highest variation. This 
is shown in ‎Figure 24 for 30 flasks of varying coverage.  
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 Relationship of CV against cell coverage. The average coverage, from 400 images, Figure 24.
against the CV obtained from 400 images for 30 independent flasks. This shows that there is variation in 
precision based on the coverage within the culture vessel. At a high coverage image analysis is more 
precise then at low coverage values. (n=30)  
Increasing the coverage reduces the CV signifying that the measurement system is more precise at 
higher coverage values. During analysis it is possible to measure all coverage values between 0 and 
100%; this provides the range of coverage represented in the images. At low cell coverage there will 
be images with no cells in giving a value of 0%, and also images that fall directly onto a colony 
giving 100% coverage. At high cell coverage there is less chance of imaging an area of 0%, and 
therefore the range of measurements is the same but the probability of the lower coverage’s are 
reduced, giving an overall reduced CV. 
It is important to note that a low coverage produces the largest variation in a population, although it 
is unlikely that process decisions will be utilised for low coverage. However in building a tool it is 
imperative to know the limits of operation. Highlighting that at low coverage the tool is least 
precise allows a bottom limit to be provided with known error.  
This CV calculation is based on imaging 400 areas of the culture flask; however for a real time 
assessment taking a smaller sample would speed up both the acquisition and analysis.  By taking 
the standard deviation which occurs within the entire population the standard error of the mean 
(SEM) can be calculated using the below equation. 
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√ 
 
Where: 
SEM = standard error of the mean 
s.d. = standard deviation 
n = sample number 
 
For culture vessels of varying coverage the standard deviation is calculated, and thus by changing 
the sample size the relative SEM can be deduced. ‎Figure 25 shows the SEM reducing as sample size 
is increased as expected for various coverage values. 
 
 Relative standard error of the mean (SEM) against sample size for 4 flasks of Figure 25.
varying coverage values. This shows that the low coverage values have a higher standard error of the 
mean due to a larger standard deviation when compared to higher confluence values.  
‎Figure 25 shows that the highest SEM values are shown for the lowest coverage, as shown by the 
red circles representing a coverage of 20%. This agrees with ‎Figure 24 that showed the lowest 
coverage had the largest CV’s, demonstrating that low coverage provides the least precision. The 
purple diamonds identify the highest accuracy at 95% coverage. As explained previously at the 
higher coverage there is a near complete layer of cells covering the culture vessel, and therefore 
taking just a single image provides a close prediction to the true mean. 
Chapter 3 
82 | P a g e  
 
Statistical theory determines that the SEM decreases as the sample size increases. So the larger the 
sample sizes the more accurate the measurement will be. However it is important to choose a 
sample size where the SEM is less than the accepted error, whilst adjudging factors such as time to 
acquire and analyse the data.  
By setting the SEM, the sample size (n) can then be deduced for a given standard deviation. This 
allows a sample to be imaged rather than the entire flask, which is time consuming both in 
acquisition and analysis.  Selecting an error of less than 5% improves on the 7% error measured 
from the Cedex cell counter (seen in ‎Figure 20). The Cedex counter is taken as having a standard 
error rate for cell analysis, to which image analysis might be able to improve on. The next step is to 
determine a sample size where all coverage’s have an error under 5%. Thus from ‎Figure 25 a sample 
size of 50 has been chosen to be of sufficient precision to represent the entire population. Previous 
work has shown that coverage determination through visual inspection is subjective and prone to 
high inter-individual variability (108). Jaccard et al. conducted a survey from 14 experienced cell 
culture researchers which yielded a combined variability of 11.7% (111). Using embryonic stem cells 
in gel coated 6-well plates images were taken using an inverted phase contrast microscope. 20 
random images were captured per well and utilised for this experiment. Taking 7 separate sets over 
a range from 10% to 90% coverage the 14 researchers each had over one year experience of 
conducting coverage assessments highlighting the high variability of confluence estimations made 
by human operators. By selecting an error of less than 5% improves on this reported manual 
assessment of confluency. 
Having selected a satisfactory sample size the next step is to validate the sampling method. There 
are 3 methods of acquiring the images; cluster sampling, systematic sampling and random 
sampling. Due to hardware constraints the use of random sampling is not possible. A visual 
assessment of colonies in flasks suggested that systematic sampling was better than cluster 
sampling due to the macro distribution of colonies within the flask. Most notably the edges of the 
flask are not sampled during cluster sampling (‎Figure 26).  
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The extrapolation of SEM from a complete scan, as discussed previously, can be utilised for a 
reduced sample. This method carries no bias as the sampling method is a random sub selection of 
the full scan. This provides a sampling method and image number which can be used for flasks 
knowing that less than 5% error will be recorded. To verify this cluster and systematic sampling 
were compared to an entire flask with systematic sampling also carried out with the reduced sample 
size of 50; this is shown in ‎Figure 26. 
 
 Example flask comparing entire flask coverage to possible sampling techniques Figure 26.
Cluster and systematic sampling methods for estimating colony coverage compared to the entire 
population with heat maps identifying coverage values for each image. This shows that systematic 
sampling provides a better estimate of the true value comapred to cluster sampling. Taking this a step 
furtherusing a sample size of 50 as estimated from previous data, maintains the estimate wihtin 10% 
error as previously calculated.  
‎Figure 26 shows the true coverage given as 79.10%, which is calculated by imaging the entire flask 
region where cells are capable of growing. The sample pattern forms another important parameter 
that can affect the coverage estimate. From ‎Figure 26 it is possible to see that the cluster imaging 
oversights the low coverage edge (green area on ‎Figure 26) that is seen within the entire imaged 
flask as predicted. Therefore cluster sampling is only accurate when there is a reproducible pattern 
which falls within each cluster. Due to the variable colony size and seeding, cluster sampling 
provides an inaccurate estimation of coverage for the macro colony distribution. Systematic 
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sampling eradicates the need for a reproducible pattern as a snapshot from the entire surface is 
taken into account.  This therefore means that for this selection systematic sampling is more 
representative of the population then cluster sampling. By using a sample size of 50 with systematic 
sampling the standard error of the mean is less than 5%. This allows the measured coverage values 
to be compared to the corresponding cell counts which have a variation >5%, as shown from ‎Figure 
20. 
It is important to note that this sample size of 50 can be used for all culture vessel sizes although the 
data here was collected on t-75 culture flasks. The image size of 50 accurately represents the 
variation from the macro distribution of cell colonies, so unless this macro distribution changes 
significantly then a sample size of 50 can be used for all culture vessels for a standard error of less 
than 5% across all coverage values from 20%. 
3.3.3 Correlating Invasive Cell Counts to Non-invasive Coverage 
Having measured the statistical resolution of cell counts, and found an improved imaging platform 
precision, it is then possible to correlate the two metrics to one another. To carry this out 
systematic sample imaging with 50 images was completed on 30 t-75 culture flasks of varying 
confluence, followed by a sacrificial cell count. These are then plotted against one another to 
determine if there is a correlation as shown in ‎Figure 27. Also included is the point 0,0 as at 0 
coverage there will be no cells. This was verified through imaging a flask with solely media in, to 
check that image analysis correctly analysed this at zero coverage. This was successful, although 
the images are not shown here. The regression however is not forced through this origin point to 
ensure the best correlation can be made with the data rather than skewing the data.  
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 Relationship of Cell count against Coverage with plotted linear regression.   Linear Figure 27.
regression performed on total colony coverage against cell counts for 30 independent flasks (and 0,0 as 
an extra point). Using 50 images acquired with systematic sampling, and cell counts from the Cedex 
counter using 6 repeated measures only the cell counts from Cedex automated counter. The predicted 
model assumes a linear relationship of equation y = 81289x + 6317. (n=30)  
Coverage is loosely correlated to cell number, shown by an R-squared value of 47.4% assuming a 
linear relationship as shown in ‎Figure 27. There is significant noise, or confounding factors in the 
relationship reducing the accuracy of the correlation. ‎Figure 27 shows that in order to replace 
invasive cell counting with an image derived metric, coverage, the correlation needs further 
improvement. The first step to an improvement is to ensure that the correct model is used to 
correlate to the data. This is achieved by assessing the biology that the mathematics is predicting. 
Taking the first example with total colony coverage against counts the equation which linear 
regression is trying to fit takes the order of: 
         
Where:  
y = Cell Count 
C = Constants 
x = Coverage 
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Differentiating this will give the expected gradient or shape of the line of best fit. 
  
  
    
This suggests that there is a constant gradient of change of coverage with cell density. By applying 
simple linear regression models to our data for low densities the following assumptions are made: 
 Mean response varies linearly with predictor 
 Unexplained variation in the data is normally distributed 
 Unexplained variation is independently distributed with constant variance 
To test these assumptions ‎Figure 28 shows statistical plots relating to the regression shown 
in ‎Figure 27. 
 
 Plots of statistical measures from count against coverage graph seen in ‎Figure 27.. Figure 28.
These graphs show measures of normality, linearity and variation across the data set. By plotting the 
residuals on a normal probability plot an estimation of normality can be deduced. The points all lie close 
to the centre line suggesting that the data follows a normal distribution. By comparing the residuals 
against the fitted value an estimate for whether the data represents a linear or nonlinear fit can be seen. 
The slight spreading seen on the right suggests that this may not fit a linear model as the higher values 
lie further from the regression fit. (n=30)  
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‎Figure 28 shows a linear relationship for the residuals and therefore regression is a suitable method 
as the error is normally distributed in the Normal Probability Plot. To justify the aforementioned 
assumptions the Versus Fits plot shows the residuals against the fitted values. This plot should show 
a horizontal band of roughly equal width to prove a linear relationship. However ‎Figure 28 shows 
the width of the band increasing as the data moves from left to right, this suggests that the variance 
is also increasing. Therefore there is not a constant variance across the data set suggesting a non-
linear relationship between coverage and cell counts. There is also a weak ‘U’ shape to the data 
suggesting that the linear regression is not a representative model and actually the data may better 
be predicted with a non-linear relationship. 
‎Figure 28 has cast doubt over the use of simple linear regression to explain how cell density varies 
with coverage. Linear regression holds true for low coverage, and low cell densities where the 
colonies are in logarithmic growth without inhibition of space.  As proliferation increases this 
surface area becomes limiting, potentially forcing the cells to grow into denser regions and hence 
there are more cells per given area. This is witnessed through darker regions of colony in response 
to limiting area by production of morphologically different cells. This therefore suggests that at a 
low starting cell number there is a linear relationship between coverage and cell density, as cell 
count increases the relationship becomes non-linear. So a constant gradient over the entire range is 
unlikely; therefore suggesting the linear hypothesis is an inaccurate model.  
It is also true that from a biological view point a non-linear model is more logical as at higher cell 
density dark patches appear within the centre of a colony where an increase in cell number per area 
occurs. Therefore if a quadratic relationship is expected this would take the form of: 
     
         
y = Cell Count 
C = Constants 
x = Coverage 
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With the differential: 
  
  
         
This quadratic relationship provides a gradient which would change dependent upon the cell 
number.  This is more likely to occur due to the aforementioned reasons, and by fitting a suitable 
quadratic the following graphs can be produced showing the fitted line, normality and residuals 
plots. The non-linear model is based on an exponential curve increasing with increased coverage. 
 
 Non Linear exponential regression of cell counts against coverage. Scatter plot of Figure 29.
counts against coverage using a non-linear exponential regression model. As with the linear regression, 
30 coverage vessels are included with 0,0 point, using average of 6 counts performed on Cedex. A 
comparison of linear against non-linear is hard to judge which is the better predictor, in this state the 
error is too large to be useful for process control. (n=30)  
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 Plots of statistical measures from non-linear count against coverage graph seen Figure 30.
in ‎Figure 29. These graphs show measures of normality, linearity and variation across the data set. By 
plotting the residuals on a normal probability plot an estimation of normality can be deduced. The 
points all lie close to the centre line suggesting that the data follows a normal distribution. By 
comparing the residuals against the fitted value an estimate for whether the data represents a linear or 
nonlinear fit can be seen. The slight spreading seen on the right suggests that this may not fit a linear 
model as the higher values lie further from the regression fit. (n=30)  
Due to the weak correlation it is hard to judge by eye whether a linear or non-linear model fits best. 
Often the r-squared (R2) term is used to compare best fits. The R2 or coefficient of determination 
indicates how well data points fit a statistical model. Similar to the R2 term, the standard error of 
regression is another measure of fit often depicted as ‘S’. Unlike r-squared however this error is 
measured in the units of the response (in this case cell count) and represents the standard distance 
data values fall from the regression line; therefore the smaller the value of S the better the fit. Using 
this S value the linear model achieves an error of 207544 with the non-linear model calculating the 
error as 210820. Therefore from a mechanistic point of view and an analysis perspective the linear 
model fits better, however there is still an unexplained residual error, likely due to biological 
response with the differences noted being far too small to select one over another. 
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So neither ‎Figure 27 nor ‎Figure 29 are fit for purpose as a direct correlation to determine cell 
number from coverage with accuracy, in which the imprecision of prediction of cell density from 
coverage outweighs any non-invasive benefit from image analysis over sacrificial cell counts.  
The lack of correlation comes from neither an error in the cell counting nor the image analyses 
ability to identify total colony coverage as shown in ‎Figure 20 and ‎Figure 25. We know intuitively 
that if all cells were the same size and not overlapping they would correlate. Therefore this must not 
be the case. There is a requirement to identify ways to measure this lack of coverage homogeneity 
to improve the correlation. The ability to measure coverage precisely allows us to use these images 
for further analysis and provide novel information on cell culture relative to a count. There are 
changes in contrast that we hypothesise represent changes in density/quality, average colony size, 
shape, circularity etc. These measurable traits potentially have the ability to improve the 
relationship of coverage to cell counts by addressing a change in cells/area relationship.  
3.4 Identifying Further Non-invasive Image Derived Metrics that Relate to 
Cell Quality 
Observation of the pluripotent cultures shows that there are colony areas that have a different 
morphology and density. Therefore the logical position that the cell/area is variable within a colony 
is supported. ‎0‎Figure 31 shows where these thoughts have developed from, highlighting 4 separate 
colony regions that can be distinguished where the cell number per area is predicted to vary, along 
with a schematic of these areas. 
Chapter 3 
91 | P a g e  
 
 
 Acquired Image and schematic showing further metrics for analysis A) Image of a Figure 31.
colony showing a dark centre within the colony, and single cells on the periphery, showing the 
heterogeneous morphology within a single colony. B) A schematic of the 4 different regions that can be 
identified in a phase contrast image of a colony; background, edge cell, core periphery and dark colony.  
As seen in Section ‎3.3.2 the total colony coverage can be precisely measured using the Threshold 
Method, this successfully separates the background from all cells. From ‎0‎Figure 31 it is possible to 
appreciate that the total colony area can be further segmented into 3 areas representing varying 
degree of cells per area. The ‘dark colony’ areas represent dark, dense areas where the cell number 
per area is increased either due to different cell morphology or due to multi-layering of cells. 
Another area is the monolayer of cells around the periphery of the colony. These cells, hereafter 
called ‘edge cells,’ are much larger in surface coverage than the compacted cells making up the core 
of the colony. The third and final area to be identified is the remaining colony. This represents the 
morphology that is most abundant in pluripotent culture, coined ‘core periphery’ as it makes up the 
periphery of the dark colony area. The morphological variations seen from images provide a list of 
observable metrics from images that may provide further information on culture state (‎Table 13). 
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Table 13. List of measurable characteristics from image analysis. Possible measurable metrics 
which could be useful for predicting colony quality, along with evidence for their usefulness and ability 
to determine quality.  
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Each of these traits is initially tested to ensure they can be identified using the analysis software. 
Following this the metrics can be assessed for their ability to be predictive of cell quality and 
potentially correlate image derived metrics to cell counts. Further analysis will allow the behaviour 
of all these metrics over time providing their rate of change which may provide further novel 
information regarding culture state. It is further hypothesised that continual monitoring of the 
metrics may provide predictive evidence of culture state, which would be extremely powerful for 
online process control. 
3.4.1 Coverage of total colony 
Total colony coverage has already successfully analysed images previously using the threshold 
method to identify the total coverage of culture surface which is inhabited by cells. This includes 
dark areas and edge cells but successfully removes the background and debris within the culture 
system as shown in ‎Figure 32. 
 
 Analysed image for total colony coverage.  Image analysis of total colony coverage Figure 32.
using the Cell-IQ analyser software’s Threshold Method to calculate the area covered by cells. The 
purple boundary represents where the colony ends and the background begins, this successfully 
measures the total colony coverage.   
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3.4.2 Dark Coverage 
The dark coverage will detect areas of colonies that are denser and therefore have a higher 
threshold value. This increase in density is likely to appear due to a modification of biological 
properties; a change in phenotype relating to a denser cell,  a change in morphology causing tighter 
packed cells, the formation of cells on top of each other thus appearing denser or any combination 
of these factors. All of these attributes would lead to a change in cells per surface area.  
Numerous scientific reports suggest varied opinions and observations with regard to the dark 
central areas. Lijun Ji et al. reported in 2012 that embryonic stem cells grown on silica colloidal 
crystal microspheres form central pits that appear dark under white light illumination (112).  Further 
growth of the colonies caused these cavities to increase in size for colonies with a depth of greater 
than 80 µm measured by scanning electron microscopy. These central pits appear to have a defined 
edge unlike the continuum seen in the phase contrast image of ‎0‎Figure 31. Therefore it is likely that 
these central pits are an artefact of the surface substrate used and do not appear in the cultures 
reported in this work. Another report publicised in ‘Human Embryonic Stem Cell Protocols’ (113) has 
reported that within the core of colonies neural rosettes are capable of developing,  thus changing 
phenotype. ‎Figure 33 identifies these dense regions within a human embryonic colony on a 
brightfield image reproduced from Turksen et al (113) and a phase contrast image taken with the 
Cell-IQ.  
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 Comparing dense areas of colony from brightfield and phase contrast.  A) shows Figure 33.
developing neural rosettes (arrows) within an embryonic stem cell aggregates with in the colony centre. 
Re-produced with permission from Humana Press. Bar =50 µm (113). B) shows H9 embryonic colony 
with similar dense area taken on the Cell-IQ as a phase contrast image.  
In comparison the dense areas seen from the Cell-IQ has an increased contrast due to the use of 
phase contrast to capture the images. But a similar morphology can be noted. Reubinoff et al (114) 
also report seeing high density areas in colonies undergoing neural differentiation. Therefore in 
conjunction with these studies and the appearance of user defined neurones in culture (shown 
in ‎Figure 34) it is concluded that the dense areas within the centre of a colony identify a population 
that is differentiating, and therefore could provide a direct link to cell population quality. 
 
 Identification of neuronal growth from dark centred colonies. The dark centres of Figure 34.
colonies are often debated to what they represent, either compact pluripotent centres, or 
differentiating cells. This image shows neuronal outgrowth growth from the colony with a dark centre 
(arrows), with the surrounding colonies remaining with the pluripotent morphology. This suggests that 
these dark centres are indeed neuronal rosettes as described by Turksen et al. (115).  
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By measuring these dark areas the cell density to coverage correlation might also be improved, but 
more importantly the dark areas may provide a measure of pluripotent status. There are two image 
analysis methods that have the ability to identify dark areas of colony; the Threshold Method (used 
to measure total colony coverage) and Area Finder, each are discussed in the following sections. 
3.4.2.1 The Threshold Method 
The ability to identify total colony coverage utilised the Threshold Method by choosing a threshold 
value that was able to distinguish the background from the denser cells. The same method with a 
higher threshold value can be used here to differentiate the dark areas of colony to the light areas of 
colony. By increasing the threshold level only the darkest areas are identified, therefore selecting 
the dense dark colony coverage. Representative images of using the higher threshold value are 
shown in ‎Figure 35. 
 
 Threshold Method identifying edges and dark background Due to the variation Figure 35.
across an image as the illumination of the centre of an image is brighter than the edges means that 
increasing the threshold value to identify dark areas of colony also includes the dark edges. This 
method therefore wrongly identifies the dark colony.   
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The threshold method built to isolate dark regions within a colony also distinguishes dark areas of 
background. The edges of the images are darker due to the circular illumination of light as it passes 
through filters to create a cone of light. This basic principle within light microscopy often means 
that the outer edges of an image are darker, often unobservable to the eye, but the more powerful 
resolution of image analysis detects this change in pixel intensity. This therefore creates a high level 
of noise in the output, where the edges are deemed part of the dark colony. The Threshold Method 
analysis therefore is not useful for identifying dark areas due to the lack of precision in identifying 
only the dark areas, another method must be developed.  
3.4.2.2 Area Finder Method 
Area finder uses both threshold and pattern recognition to identify areas. By ’teaching’ the software 
a pixel pattern the software then has the ability to detect further areas of similar pixel patterning in 
future images. Rather than shades of grey that is seen on the screen, pixel recognition uses 
numbers. Each pixel is given a value representative of its colour as shown below in ‎Figure 36. 
 
 Area finder method utilises pixel patterning.  Instead of using shades of grey the Figure 36.
analyser uses the raw data of numbers, each which are represented by a shade of grey as a phase 
contrast image. After teaching a pattern of pixels to the software this can then be used to search for 
similar patterns.  
By teaching the software groups of similar pixels a library of images is created which the Area 
Finder tool then compares to batch images in order to identify similar areas. This technique is 
shown in ‎Figure 37 where a 3x3 grid of pixels has been taught, therefore allowing identification of 
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this pattern elsewhere in the grid. The output then is to highlight this area red. This can been seen 
on a phase contrast image of a colony in ‎Figure 38 where dark areas have been taught previously 
and then recognised in this image. 
 
 Using Area Finder’s pixel pattern recognition to highlight common areas. By Figure 37.
assessing groups of pixels the software can be ‘taught’ similar area shown with red numbers in B) and 
therefore identify these area and colour them separately C). This protocol can then be applied to future 
images such as D) where the same pattern of pixels can be identified E) and coloured in the analysed 
image F).  
 
 Acquired image and analysed image with area finder method. Comparison of the Figure 38.
stock image and the analysed image using the Area finder tool identifying the dark regions of a colony 
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within a single image, the dark area is coloured red. This method better assess the dark area in the 
centre of the colony without measuring the edge factor as previously described due to the illumination.  
The area finder successfully detects the pixel pattern of dark colony in the centre core of a colony 
compared to background and remainder of the colony (‎Figure 38). Further ‘teaching’ and 
refinement of this method would enable the darker areas around the periphery core not to be 
detected. Visual evaluation of both methods concludes that Area Finder provides a more accurate 
assessment of dark colony coverage than the Threshold Method. 
3.4.2.3 Evaluating the Accuracy of Area Finder  
It is important to assess the accuracy of Area Finder as a method of image analysis. Previously work 
was carried out to assess the threshold method for accuracy, see Section ‎3.3.2. Area Finder utilises 
known images of cell morphology to ‘teach’ patterns of recognition in order to evaluate ‘new’ 
images for each of these metrics. In order to use this method, image libraries must be made with 
independent pixel patterns and thresholds. This is created as the depiction shown in ‎Figure 39. By 
selecting representative areas of dark colony as identified previously, and areas of background, a 
library of each pattern is built. 
 
 Sample of 2 libraries identifying dark colony and background.  Depiction of creating Figure 39.
an image library which can then be used with Machine Vision technology to further identify similar 
regions to those identified in the image library. Shown here are examples from background and dark 
colony coverage.  
After creating the library of images the analysis can be run on multiple images to assess the images 
for similar areas. If the library has been built with a wide range of pixel patterns and threshold values 
then the accuracy is reduced. Therefore it is imperative for an accurate analysis to ensure the library 
Chapter 3 
100 | P a g e  
 
is formed of representative images showing the pattern and threshold to which is being identified. 
The library must be of sufficient quality to accurately identify regions; however this quality is not a 
metric that can be measured. 
Taking the example of dark areas, it is hard to determine accuracy due to the spectrum of levels and 
the non-discrete data set. Instead the Area Finder tool was used to identify single cells, which in 
turn could be user identified and consequently the accuracy measured. This was completed using 
osteoblast cells that were identified as adhered cells, proliferating cells that have come off the 
surface, or background. These 3 libraries are shown in ‎Figure 40. 
 
 Snapshot of 3 libraries representing 3 morphologies from Osteoblast culture. A Figure 40.
selection of images that make up the libraries used to identify osteoblast populations, taking the 
adhered cells, proliferating cells and background.  
Using these libraries it is possible to analyse further images, and then user define the accuracy of 
this binary classification test. It is hypothesised that a larger library size of representative images 
will improve the overall accuracy of identifying these 3 populations. Accuracy is defined by two 
measures; sensitivity and specificity. Sensitivity relates to the tests ability to identify correctly, and 
is defined as: 
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In other words the number of correctly labelled red dots, over the same number plus wrongly 
identified red dots in ‎Figure 41. 
Specificity relates to the tests ability to exclude a condition correctly. It can be defined as: 
             
                        
                                                  
 
In other words the number of correctly labelled green and blue dots, over the same number plus 
wrongly identified green and blue dots in ‎Figure 41. 
The sensitivity and specificity of the libraries can consequently be determined by user verification, 
an example is shown in ‎Figure 41 using  library sizes of 100 and 1000 images where the purple circles 
determined increase in sensitivity, and the orange circles identify an increase in specificity with 
increased library size. 
 
 Analysed images using 100 and 1000 library size. Machine vision accuracy is Figure 41.
determined by the library size. Osteoblast cells are identified here using a library size of 100 or 1000 
images. The red dots represent where the software has measured a cell, the green dots represent 
background and the blue dots show a cell proliferating. The purple circled dots show where the 100 
image library is less sensitive than the 1000 image library, the orange circled areas show where the 100 
image library is specific than the 1000 image library.  
‎Figure 41 highlights the improved sensitivity achieved by using a larger library size. The errors are 
detected by visually assessing a number of images, and marked with purple and orange circles to 
show where using a library of 100 is less sensitive and specific respectively. This highlights the 
sensitivity of Area Finder to measure the proportion of actual positives. Specificity of the analysis is 
based on the percentage of negatives which are correctly identified, for this example the green and 
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blue dots. The algorithm initially identifies pixel areas based on threshold and following this assigns 
each detected area to one of the three possible categories from the libraries. Therefore in each of 
the images shown in ‎Figure 41 the number of dots are equal, the difference is to which category 
they are assigned. By analysing both of these accuracy metrics it is possible to determine the 
required image library size. 
 
 Graph of sensitivity and specificity for various library sizes. The sensitivity, shown Figure 42.
by red circles is increased from less than 60% to 90% by increasing the library size from 25 to 1000 
images. A similar result is seen with specificity shown with blue crosses.  
As hypothesised, increasing the image library increases the overall accuracy in terms of both 
sensitivity and specificity.  ‎Figure 42 allows the smallest library size to be chosen above which the 
accuracy returns for increased library size are trivial, this is with 200 images.  
Another important aspect of this analysis is the computational time to evaluate the images. For real 
time analysis it is important to determine an outcome as quickly as possible allowing timely process 
decisions. Using a stop watch the analysis time was measured for library sizes of 25 up to 1000 
images. It was found that all the library sizes produced the same analysis time (data not shown). 
This is due to how the algorithm is built, by taking the entire library and creating a rule with which 
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to work. Therefore it is the algorithm building that is time dependent on library size rather than the 
analysis itself. As the algorithm only needs to be built once then utilised, the library size has no 
effect on time for analysis. Therefore within a manufacturing setting a very large library size could 
be utilised to maximise accuracy with little disadvantage. 
Using the different library sizes it is then possible to plot a growth curve of cells measured by image 
analysis. ‎Figure 43 shows the accuracy of using various library image sizes over a time period for cell 
growth. The growth curve demonstrates the software’s ability to identify cell numbers, where 1000 
images is the most accurate, as determined from ‎Figure 42,  shown in orange and 100 images the 
least accurate shown in blue. 
 
 Comparison of using a larger library size to increase accuracy Growth curve of cells Figure 43.
using machine vision technology to identify cells with varying ‘taught’ image library sizes ranging from 
100 images in the library to 1000. This shows that a library size greater than 200 images provides very 
little improvement in detection of cell type.  
‎Figure 43 confirms plateauing of accuracy seen in ‎Figure 42 as once 200 images are used there is 
very little difference in identified cells. Interestingly this accuracy difference between library sizes is 
less noticeable at a high cell number. On reflection of the captured images this is due to the 
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complete monolayer and resulting lack of resolution in the identification of individual cells. 
Therefore evident from this data set is that the accuracy is reduced due to the overcrowding of cells. 
It is important to note that this is not seen when dealing with colonies due to the larger area they 
occupy, so the resolution between pixels can be reduced. 
3.4.3 Edge cells 
From the images of embryonic colony development there are 3 distinct cell morphologies present. 
So far total colony coverage along with dark colony coverage have been identified which describe 
different cell states. This third morphological population of cells, edge cells, appear at the edge of 
specific colonies and individual cells are larger than those found within colony cores allowing 
individual cell identification. In order to assume a linear relationship it was stated that ‘size of cells 
must be a constant,’ this is therefore contrary to this statement. These edge cells are more 
frequently seen during poor quality cultures and are often referred to as differentiating cells (116). In 
many methods these edge cells are removed by aspirating away the so-called differentiated cells 
prior to passaging (78). Within differentiation protocols this periphery banding has been noted, 
specifically Das et al see that an ‘area of morphologically differentiated cells, characterized by a 
cobblestone appearance, becomes visible at the periphery of the colony and progresses inward’ 
(117). However further papers quantify them as pluripotent due to their transcription factor 
expression (118). These morphologically different cells are seen in ‎Figure 44 around the periphery of 
colonies.  
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 Embryonic colony surrounded by edge cells. This raw image shows tightly packed Figure 44.
colonies with single cells surrounding the colonies, identified by white arrows; these cells are hereafter 
called ‘edge cells.’ These edge cells have a different number to surface area ratio compared to the 
tightly packed colonies. Therefore these cells could cause the cell count to coverage correlation to be 
poorly represented if lots of these edge cells are present.  
The centre of colonies show tightly packed cells, where it is not possible to distinguish one cell from 
another. Around the periphery of the colony lie individual cells which can be singularly identified. 
These cells clearly have a different number to area ratio when compared to the colonies. Therefore 
this could affect the coverage to count approximation either way dependent on whether there were 
many or few of these edge cells. 
These edge cells vary in contrast and cannot be successfully detected using the threshold method. 
As they have a very different morphology from the cells within the colony, Area Finder provides the 
best analysis to identify these. The same method as described previously in Section ‎3.4.2.2, with a 
new library being created for these edge cells. An example of a raw image and analysed image is 
shown in ‎Figure 45.  
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 Raw image and Area Finder analysed image.  This image shows the identification of Figure 45.
edge cells  as highlighted in green on the right image. This population represents a different count to 
surface area ratio, and therefore by assessing and quantifying edge cells an improved correlation of 
coverage to cell count might be made. The identification also has an impact on cell quality as these 
edge cells represent a differentiating population. Therefore it is possible to put a numerical value on 
pluripotent status non-invasively. 
Area Finder provides an accurate image analysis technique to identify these edge cells and quantify 
their coverage. As previously mentioned these cells may have an impact on both embryonic culture 
qualities, as they are reported to refer to early differentiating cells (78,116,117), as well as correlation 
to cell counts as they have an increased area to number ratio. 
3.4.4 Core Periphery Coverage 
Successful identification of the edge cells and dark colony allows the core periphery coverage to be 
calculated as the remaining area of total colony coverage. This also refers to the pluripotent region 
of a colony, and therefore by comparing the values of ‘Core Periphery’ to ‘Edge’ and ‘Dark’ a 
measure of pluripotency can be resolved. Prior to this analysis the new metrics are first correlated to 
cell counts to see if there is any improvement by using the 3 newly developed metrics. 
3.4.5 Correlating All Metrics to Counts 
Having assessed colonies for 3 metrics independently it is possible to combine the analysis into one 
single protocol. An example of all three metrics being measured at once in the same image is shown 
in ‎Figure 46.  
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 Raw image and Area Finder analysed image.  This image shows the identification of Figure 46.
3 populations of colony of dark colony (red), edge cell (green), remained of colony (blue). These three 
populations all represent different count to surface area ratios, and therefore by assessing all three 
together an improved correlation of coverage to cell count might be made.  
Area Finder provides a good measurement of these three areas, and it is hypothesised that these 3 
metrics all represent areas of a colony that have a different cell/area value. Therefore by completing 
regression on all three metrics to cell counts an improved correlation is expected. This is completed 
in the following sections. 
3.4.5.1 Statistical Resolution 
As previously mentioned, r-squared is an indicator of how well the data fits the model, however R-
Squared adjusted provides a better predictor as it is adjusted to account for the small number of 
data sets that are available. Here the data is taken from a sample of 30 flasks, with 400 images 
taken within each flask. Although it is calculated the same way as r-squared it is then adjusted using 
the degrees of freedom accounting for small sample sets. R-squared predicted is also calculated. 
This predicts the response for new observations, therefore providing a numerical output for how 
well new observations will fit rather than how well the current data fits, shown by r-squared. The 
final recorded statistical measure is S, standard error of the regression. As previously mentioned S is 
expressed in the units of the regression, providing a useful measurement of error for comparison. 
‎Table 14 summarises the correlation fit through statistical fit analysis values for each of the three 
metrics individually and then also a combination to identify any potential improvement. The total 
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colony coverage is a summation of the three metrics and therefore cannot be used in conjunction 
with any of the other metrics. For completeness it is included in the table below to show the 
correlation previously acquired. 
Table 14. Statistical measures of variance for metrics. The metrics can be used singularly or in 
combination to determine the most informative metrics that relate to count. As expected by 
individually assessing the metrics there is a poor correlation. By using metrics as doublets the 
correlation can be improved, but by using all three metrics (Core Periphery, Dark and Edge cell 
coverage) the best correlation can be made shown with the largest R
2
 value and smallest standard error 
of the regression (S).  
 
‎Table 14 shows that the best correlation can be made between cell coverage and cell counts by 
combining the three metrics compared to using only a single or double metric, showed by the 
lowest S value 143693. This was hypothesised as these three metrics all represent different 
cells/area and therefore all contribute separately to the overall cell count. By measuring the core 
periphery, dark and edge cell coverage and correlating all three metrics back to the cell count then 
an R-squared value of 75.8% can be achieved. This regression calculates the following relationship 
of all three metrics to counts: 
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Count/cm2 = 227404 + 9456 Core Periphery + 10403 Dark - 3137 Edge 
In order to use a linear model it is assumed that there are three stages of cell density that occur 
within the image. The dark areas represent the most dense area, the edge the least dense and core 
periphery in-between. Therefore the regressions of all three metrics are hypothesised to follow this 
concept, so that the dark colonies have the largest influence on cell count with the edge cells having 
the least. This is shown by the constant in front of each metric in the above equation being larger 
for the more dense area.  It is also worth noting that the dark/ core periphery coverage combination 
is nearly as good as all three metrics. This is not surprising as the edge cells have relatively low cell 
number per area and therefore have little effect on the total cell count in the pluripotent conditions 
utilised here. However in cultures with more edge cells this value would start to make more of an 
impact. As discussed however edge cell coverage may provide a measurement of cell quality, so 
although less useful in this example of correlating to cell count, it may be a powerful metric. This is 
discussed later in the Chapter.  
The equation generated from the triple regression can be used to show the calculated values using 
least squares regression, and is shown in ‎Figure 47. 
 
 Linear regression of 3 metrics against cell counts By performing a triple regression Figure 47.
over the 3 metrics (total, dark and edge cell coverage) these values are then plotted against the 
measured cell counts from Cedex. The plotted red lines shows where predicted is equal to the actual cell 
counts. This shows the over estimation of the model at low cell numbers. (n=30)  
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 ‎Figure 47 shows that at low cell numbers the model over predicts the cell count, however generally 
the model provides a good fit to the actual cell counts. This model has been fit assuming a linear 
relationship of count to coverage. By identifying each metric within the regression it is possible to 
highlight if this is a fair assumption. 
The edge cells are defined and each cell can easily be identified. There is little variation in the size of 
these cells during a culture period. Therefore there is a rationale for a direct linear relationship 
between cell counts and coverage of edge cells. This relationship is also true for the core periphery 
assuming that there is no change in density. The final metric of dark colony is used to account for 
this change in darkness and presumed density. As the colonies increase in size a dark centre 
appears, likely to represent a change in cell state. The change in threshold of this area implies an 
area of higher density then the surrounding colony.  As this surface area of darkness increases then 
so too will the cell number within the area. This would only be true and linear if there was only one 
level of darkness. In reality the darkness threshold level is variable that is to say within the identified 
dark region there are varying amounts of darkness. However the image analysis is given only one 
contrast value, therefore once this level has been detected any further darkening will not be 
detected. This suggests that this image analysis method can become saturated. Further work could 
introduce a range of dark level thresholds, however this would only be justified if further control was 
required. The current method of assessment first needs to be explored for process control utility 
before investing in further coverage classification.  
A further verification of the linear relationship utilised can be made by assessing the residuals of the 
regression to depict the error between observed and regression model values. This is shown 
in ‎Figure 48 along with a normal probability plot, and histogram of residuals. 
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 Residual plots of triple regression. Taking the residuals from the triple regression Figure 48.
allows a check for normality, linearity and bias. The Normal Probability Plot shows that all the residuals 
fir along the line of best fit suggesting normal statistics are valid. This is further demonstrated in the 
Histogram with a typically normal bell shaped curve. The Versus Fits graph provides a measure of 
linearity. The spread in residuals is fairly similar as the fitted values increase suggesting that the data is 
linear, although more data points at the high end would be needed to strengthen this statement. (n=30)  
The normal probability plot shows that the model error is normally distributed. The histogram plot 
allows the confidence interval to be determined. Using the mean and standard deviation as shown 
in ‎Figure 48 (mean = -2.00E-10 and standard deviation = 136319), it is possible to state that 95% of 
the time the data will deviate less than 150 thousand cells from the true value. This also agrees with 
the S value recorded of 143693 from ‎Table 14 previously. 
The ‘Versus Fits’ graph shows that the absolute error size is independent of the cell count value. At 
low cell density the percentage error is larger than at high cell counts. Therefore the error is 
dependent on when the imaging will be used as a decision tool. For high cell densities such as 
passaging the percentage error will be small as the coverage will be high. By assessing the Versus 
Order it is possible to see that there is no bias in the order of the data. 
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3.4.5.2 Correlating 3 Metrics of Coverage against Count 
Having shown improved statistical resolution it is possible to see if using 3 image derived metrics 
can improve the correlation to cell counting seen in Section ‎3.3.3. In ‎Figure 49 the initial correlation 
with one image derived metric is shown along with the new model utilising 3 metrics. 
 
 Comparison of single to triple image derived metric correlation to count. This figure Figure 49.
highlights the improvement made by using 3 metrics of core periphery, dark and edge cell coverage 
against the single metric of total colony coverage. (n=30)  
This data has shown the ability to improve the correlation by using more metrics to predict the cell 
count. This now allows image analysis to be used within a process to assess the number of cells to 
±150,000, 95% of the time. However of note is that the dark and edge cell coverage that can now 
accurately be assessed maybe direct measures of culture quality. These metrics are hypothesised to 
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measure the amount of differentiation within a culture and therefore provide a direct measure of 
quality. In order to assess this colony phenotype must be measured, this is completed with 
immunostaining. 
3.5 Embryonic Colony Culture State with Regard to Quality  
The ability to identify further image derived metrics has improved the correlation of coverage to cell 
counts. However as noted previously in Section ‎3.4, the ability to precisely measure these new 
attributes could also provide a measure of culture quality. The first stage is to understand the 
correlation of the recorded metrics to cell quality. Numerous techniques, as discussed in 
Section ‎3.1.1, can be used to assess the quality of embryonic cultures. One of the most prominent 
and widely used techniques is the evaluation with regard to cell markers, specifically Oct-3/4 and 
Sox-2. This can be achieved by flow cytometry; however this only provides a population 
assessment. It is therefore advantageous to be able to identify these markers within individual 
colonies, which can then be correlated back to captured phase contrast images.  This is achieved 
with immunocytochemistry, this allows the colony to be continually assessed through phase 
contrast imaging before end point marker identification through fluorescence microscopy. An 
example is shown in ‎Figure 50 with pluripotent colonies imaged over time before analysed for Oct-
3/4 expression.  
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 Pluripotent colony phase images with immunocytochemistry markers.  Phase Figure 50.
images are taken on Cell-IQ during culture and then imaging the same area after staining using the 
fluorescence on the Cell-IQ showing pluripotent marker Oct-3/4 as an end point analysis by 
immunocytochemistry. The blue shows Syto16, a nuclear staining for all cells. 
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‎Figure 50 shows that Oct-4 stains a colony maintained in pluripotent medium. It is worth noting the 
heterogeneity found across a colony as shown from the Oct-4 variation in expression. This is 
unsurprising as many articles claim a ‘phenomenon of metastability within the pluripotent 
compartment’ (96). That is to say ESCs fluctuate their expression of pluripotent markers as they 
transit between naive and a lineage primed states; with a certain plasticity (119), this is represented 
in ‎Figure 51. 
 
 Pluripotent marker metastability.  Diagram showing the transient states those cells Figure 51.
can fall between, with each colour representing a different population with regard to marker 
expression. In the centre, white cells represent those positive for Nanog, Oct3/4 and Sox-2. We then 
have each marker of Nanog (red), Sox-2 (green) and Oct3/4 (blue) as solo markers, followed by their 
intermediates represented as yellow (mix of red and green, so Nanog and Sox2 positive), magenta (mix 
of red and blue, Nanog and Oct3/4 positive) and cyan (mix of green and blue, Sox-2 and Oct3/4 positive) 
Cells have the ability to move between these states, as they approach the edge (grey cells) they 
beginning differentiation, with black cells in the gutter as fully differentiated cells. 
Within an embryonic colony there is a heterogeneous population with regard to pluripotent markers 
that have the ability to move between states of expression. However once the cells have moved 
from the ‘top level’ and begun to fall through differentiation there is no possibility to reverse into a 
pluripotent state without methods similar to those utilised in the production of induced pluripotent 
stem cells. 
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Once the embryonic colonies have begun to differentiate it is hypothesised that their morphology 
changes, seen with the production of edge cells and dark areas identified earlier in Section ‎3.4. This 
change in morphology can be precisely measured using image analysis it is therefore important to 
verify that this change in morphology relates to a change in culture state. ‎Figure 52 shows some 
examples of where the loss of pluripotent markers is related to the change in morphology. 
 
 Examples of pluripotent H9 embryonic stem cell colonies. Phase images were Figure 52.
captured using the Cell-IQ, then the same colonies were immune-stained and fluorescently imaged. 
Syto-16, Sox-2 and Oct-3/4 are shown both combined and individually. Syto-16 stains the nucleus of all 
cells and is used to identify the entire population. Sox-2 stains all cells, but Oct-3/4 is more specific to 
the colony core. This identifies that specific areas such as the centre of the colonies are phenotypically 
distinct for key markers and measuring these provides a relevant element of quality assessment.
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Three examples of embryonic colonies maintained in pluripotent media are shown in ‎Figure 52. The 
immunostaining identifies that there are discrete micro-environmental areas within the colonies 
expressing these key pluripotency related factors.  All cells within the population stain positive for 
Sox-2. However, the Oct-3/4 staining identifies a colony core that is phenotypically discrete, being 
relatively high expressing compared to the edge cells of the colony. This separation in phenotype 
suggests a mechanistic rationale for sub-division of the colony by morphology and investigating the 
value of monitoring of the different areas for a process analytical technology. A further example of 
this immunostaining in conjunction with the raw phase contrast image and analysed image using 
Area Finder is shown in ‎Figure 53. 
 
 Immunocytochemistry staining of differentiating colony. Red Sox2, Green Oct4, Figure 53.
Blue Syto16. This shows that the pluripotency markers are lost at different stages of differentiation. 
Oct-3/4 is lost first showing only the core of colonies still positive, whereas Sox-2 stains for more of the 
colony with only the far periphery negative. Syto-16 is used to stain the nuclei of all cells.  
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‎Figure 53 shows that it is possible to mark colonies at different stages of differentiation. Syto-16 is 
used to as a nuclear stain to highlight all cells. Sox-2 is positive for the majority of cells except those 
highlighted on the merged fluorescence image with a white circle.  These have lost all pluripotent 
expression and therefore are deemed differentiated. The next level of pluripotency is shown 
through the expression of Oct4, a much smaller population then those positive for Sox-2. These 
images provide evidence that there is a hierarchal level of pluripotency markers with Oct4 
expression lost first, followed by Sox-2 later into differentiation. This data shows that the change in 
morphology is related to the expression of colony pluripotency, which can be assessed using phase 
contrast image analysis. 
By introducing a cocktail of growth factors (FGF, VEGF, Activin-A and BMP-4) differentiation can be 
forced. Further staining for the differentiation marker heart and neural-crest derivative expressed 
protein-1 (HAND1) shows that the colony periphery is positive for the early mesoderm marker 
(‎Figure 54). 
 
 Immunocytochemistry for early mesoderm marker HAND1.  Colonies exposed to Figure 54.
mesoderm differentiation media for 48 hours then stained for HAND1 expression and subsequent DAPI 
staining for nuclei. This shows once again that the periphery of the colonies differentiate, leaving a core 
of pluripotency.  
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The expression of HAND1 in ‎Figure 54 represents differentiated cells into the early mesoderm 
lineage from embryonic colonies. The edge cells from the colonies all express the differentiation 
marker with the centre of colonies being less positive for HAND1, suggesting a core of pluripotency 
remains as differentiation occurs from the periphery inwards, described previously by Das et al. 
(117). 
The data presented here in ‎Figure 54 provides evidence that the edge cell morphology represent a 
population that is undergoing differentiation from embryonic stem cell colony. This therefore 
allows edge cell coverage to be a powerful metric to quantify the pluripotent status of a population. 
It is also possible to follow the metrics behaviour over time, rather than the spot analysis shown 
here, which may provide further information regarding the culture quality, and even deliver a 
predictive assay. 
3.6 Behaviour of Metrics over the Culture Process  
The previous sections have assessed metrics based on spot analysis, one point in time. This provides 
useful information at a single time point but it is also possible to assess these attributes (total 
colony coverage, core periphery coverage, dark colony coverage and edge cell coverage) with 
respect to time. This allows the change in these attributes to be measured and therefore any 
variation over a culture a period is measurable. The advantage of doing this is to potentially identify 
rates of change of coverage type that may be either more sensitive or provide more information of 
culture quality than spot analysis. It therefore allows a prediction of culture state allowing a feed-
forward approach to maintain a pre-determined culture state through process actions.  
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3.6.1 Total Colony Coverage 
During culture in pluripotent media embryonic colonies grow, increasing the number of viable cells, 
thus increasing the coverage overtime. This follows a standard growth curve represented by a 
sigmoidal function as described by the mathematical Monod equation (120). ‎Figure 55 shows a 
selection of colonies growth curves inferred from total colony coverage.   
 
 Total colony growth measured from colony coverage. Graph showing total colony Figure 55.
coverage change over time with feed times (vertical black bars) for multiple colonies imaged in the 
same culture vessel. (n=11)  
From this graph it is apparent that the colony coverage increases over time as expected. However 
as the colony grows there are cyclic growth drops where the colony coverage decreases. After these 
growth dips represented by a sudden gradient decrease, the following data points show a slow 
recovery back to the original growth gradient. The dips occur immediately after each media change 
represented by a black bar in ‎Figure 55. This highlights the effect that a media change may have on 
these cells. However by completing a media change the nutrients are replenished, waste removed 
but also there are physical effects derived from removing the culture plate from the environmental 
chamber including change in temperature, pH and CO2 concentration. These two effects either 
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nutritional, deemed chemical cues, or from environmental changes deemed physical cues both 
have the ability to cause the dips in growth seen. In order to assess the cause of the fluctuations, the 
process action of feeding on cell culture is discussed further in Section ‎3.7. These fluctuations can be 
further enhanced by plotting the change in total colony coverage over time, this is shown in ‎Figure 
56. 
 
 Gradients of total colony growth. The gradients from ‎Figure 55 show the growth Figure 56.
rate (dC/dT) between each image, against time. With spikes and dips throughout culture representing 
increased and decreased growth, although overall these balance out. Further understanding of these 
dips is required. (n=11)  
By assessing the growth rates it is clear that immediately surrounding a feed there is a sudden dip of 
growth from the colonies as described previously. ‎Figure 56 also highlights spikes in growth just 
after the initial dips suggesting that the colony shrinks immediately after feeding and then expands 
before settling back to the original size. These dips however seem to have very little effect on the 
overall growth curve, suggesting a contraction of colonies is then reversed as the colonies are 
exposed back to the incubators environment/protein concentrations.  This effect is further 
discussed in section ‎3.7. 
Chapter 3 
122 | P a g e  
 
After ~80 hours the growth according to coverage plateaus, this however ties in with the colonies 
reaching 100% coverage and therefore the image analysis is unable to identify further growth 
without taking a larger image area. At these higher coverage values the peaks and troughs of 
growth are again not seen, an effect due to the boundaries of the colonies not being present within 
the image. 
From user identification of the captured images it is interesting to highlight the colonies have a 
cyclic smooth to rough transition at the colony periphery. Either there is a tight boundary shown 
with a slight halo common for phase contrast images, or on the contrary there is a rough boundary 
with individual cell protrusions noticeable. The difference between these two states is shown 
in ‎Figure 57. 
 
 Smooth v Rough colony edge. A) Image of colony with the periphery as Smooth Figure 57.
versus B) the colony hours later that now has a rough edge. The rough edge often is regarded as a 
differentiating colony, although live cell imaging has shown that colonies fluctuate between the two 
states. This therefore shows the importance of continual monitoring over single time point analysis, 
which could give false outcomes.   
Similar to previous work assessing the growth rate declines in conjunction with feed points the 
rough and smooth can be user defined by individually assessing images. This is shown in ‎Figure 58 
with total colony growth shown measured by coverage, feed points and smooth and rough 
transitions. 
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 Example of colony growth with smooth/rough.  Measurement of attributes over Figure 58.
time (total colony coverage and dark colony coverage) including feed points and the transition of 
smooth to rough. This graph shows that there is constantly a conversion between smooth edges and 
rough edges which cycle around feed points, suggesting feeding may be effecting this transition. 
This cyclic effect shows the importance of feeds on cell behaviour and also shows that the time 
point when any analysis (one time image), including manual verification using a microscope, is 
taken can have an effect on the morphological assessment.  This is especially significant as the 
smooth edged colony is subjectively assessed by many users as undifferentiated embryonic colony 
(121), whereas the spikey, rough, indistinct colony border is regarded as inferior quality in many 
populations, often deemed differentiating (121–123). This provides significant evidence that a spot 
analysis is not sufficient for measuring culture state; rather a continual imaging portfolio is required. 
Having identified the traits of total colony coverage it is then possible to follow each of the defined 
metrics over time to assess the behaviour compared to the overall growth of the colony.  
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3.6.2 Core Periphery Colony Coverage 
The core periphery is regarded as the pluripotent morphological region, and therefore during this 
pluripotent maintained culture the core periphery is expected to follow very closely to total colony 
coverage discussed previously. 
 
 Core periphery coverage growth. Graph of core periphery colony coverage growth Figure 59.
for various colonies identified within the same flask and imaged over a 150 hour period. The continual 
growth of core periphery colony areas is due to the proliferation of pluripotent cells in the colony core. 
(n=11) 
As expected the core periphery colony growth follows a similar path to total colony coverage. This is 
due to very little edge and dark in pluripotent populations, which combine with core periphery to 
make up the total cell area. The slight difference with total colony coverage noted in ‎Figure 59 is 
that they do not reach 100%, again due to the other metrics being present as a small percentage of 
coverage. The dips seen previously are also shown here in core periphery coverage.  
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3.6.3 Dark Colony Coverage 
The next factor to assess is the dark area quantification with regard to growth. This is shown 
in ‎Figure 60, and follows a similar, although noisier, pattern to the total colony coverage.   
 
 
 Dark Colony coverage growth. Graph of dark colony coverage growth for various Figure 60.
colonies identified within the same flask and imaged over a 150 hour period. The continual growth of 
dark areas is due to the differentiating cells making up the dark area both proliferating and secreting 
factors promoting further differentiation in the surrounding population. (n=11)  
As with the linear increase in the total colony size, the dark colony coverage behaves in the same 
manner. As discussed previously in section ‎3.4.2, this denser area of cells is attributed to a 
differentiating population. Therefore an increase in this population is predictive of an increase in 
differentiated cells. Unlike total colony growth this dark region does not take a logarithmic growth 
curve which would be expected if the differentiated cells will both proliferate and release factors 
causing further differentiating in the surrounding population. Therefore there must be another 
effect occurring which is likely that the embryonic population is spontaneously differentiating, this 
is a common response seen as spontaneous differentiation in adhered embryonic cultures (124) and 
embryoid bodies (125). 
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The data presented in ‎Figure 60 shows large non-systematic fluctuations. Unlike for total colony 
assessment the image quality including contrast and focus are important in the identification of the 
dark area using the Area Finder protocol as pattern recognition is utilised. However for the work 
described here the current identification of dark colony coverage is sufficient to compare 
populations, and identify a difference in culture state. As before it is possible to plot the gradient 
changes with time to identify any common growth rate variations within the identified colonies, this 
is shown in ‎Figure 61. 
 
 Gradients from ‎Figure 55 which show the growth rate between images By assessing Figure 61.
the growth rates of dark colony coverage it is possible to see that the spikes and dips seen previously in 
total colony coverage are also present here. Additionally this cyclic growth continues past 80 hours, 
where total colony coverage could not be seen due to confluency. As dark coverage only takes a 
proportion of the colony it continues to be monitored and provides valuable data. (n=11) 
As with the total colony there is a change of growth rate following the feed points, a factor further 
investigated in Section ‎3.7 to determine whether this is an artefact due to feed and/or 
environmental changes. 
It is worth noting that these spikes and dips continue past 80 hours, where the total colony 
coverage metric was unable to accurately measure coverage due to the colony covering a greater 
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area then the image. As the dark coverage only takes a proportion of the image, commonly found in 
the centre of a colony, this metric can further measure the growth of a colony past image 
confluency. It may therefore be possible to use dark coverage as a metric for predicting colony 
growth at confluent conditions. An example can be seen in ‎Figure 62, where an increase in total 
colony growth is limited but could be correlated from the increase in dark area. It is important to 
note that this would only be possible if the dark area growth was representative of total colony 
growth, and that a separate growth rate exists for this dark area. 
 
 Colony with a dark centre showing continual growth past image confluency. By Figure 62.
continuing to monitor dark colony coverage further growth can be identified independent on total 
colony growth due to the colony being too large to fit within a single image. A) shows all dark area but 
colony larger than the image size. B) Increased dark area, although total colony coverage remains 
constant, dark area has increased allowing further analysis of growth. 
  
3.6.4 Edge Cell Coverage 
The cells on the periphery of a colony exhibit different cell morphology to those held within the bulk 
of the colony. These edge cells are deemed to represent a different state to the core colony cells, 
often associated with early phases of differentiation, with uncertainty regarding their capability to 
return to a pluripotent state. Many operators would therefore try to avoid the emergence of excess 
peripheral cells which therefore allow culture quality to be assessed based on the quantity of these 
cells. However in ‎Figure 57 it was shown that colonies continually move between a smooth to rough 
edge morphology, and therefore the timing of the assessment can be an important factor. The 
behaviour of edge cell coverage is shown in ‎Figure 63. 
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 Edge Cell coverage over time. Graph of edge cell colony coverage for various Figure 63.
colonies identified within the same flask and imaged over a 150 hour period. The graph shows very little 
growth of an edge cell population, as would be expected as edge cells are a differentiating population. 
The edge cell coverage declines overtime as the colony grows larger than the image area, therefore 
little edge is detected. (n=11)  
‎Figure 63 shows that the identification of edge cells in a pluripotent population is very little, and 
declines as the colony grows larger than the imaged area with the periphery lost. As with all the 
metrics there is a lot of noise surrounding the feeding points shown as black vertical bars. Further 
analysis will investigate the effect of feeding on all metrics. ‎Figure 64 highlights the loss of colony 
periphery during growth as the colony area succeeds the imaged area, and hence the decline in 
edge cell coverage over time. 
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 Image of a colony with analysed metrics. A) Initially the entire colony is in the field Figure 64.
of view, however over time as the colony grows unless the imaged area is also increased the colony 
grows outside the field of view, C). This therefore prevents the detection of cells migrating away from 
the periphery as shown in D) compared to C).  
The emergence of identified metrics over time has shown the power of being able to record the 
effects of external factors on each metric. Specifically the effect of feeding has had a noticeable 
consequence on all the metrics. The next section will analyse the metrics after a process action. 
3.7 Analysing Process Actions Effect on Cell Culture  
In order to assess how process actions can affect the culture procedure, it is possible to vary the 
nutrient renewal period and in turn the effect of removing the vessel from the incubator. As has 
been seen throughout section ‎3.6 the feed points create large disturbances within the quantified 
metrics. It is therefore important to see if these are a true deviation, or external noise from the 
system. The first experiment was set-up with feeding points at 12 hours, 24 hours and 48 hours. The 
resultant data from each metric, of selected colonies, are analysed in the following sections. 
Chapter 3 
130 | P a g e  
 
3.7.1 Total Colony Coverage 
By assessing the total colony coverage for cultures with different feed regimes it is possible to 
conclude the effect of feeding on the overall growth of embryonic colonies. ‎Figure 65 shows the 
effect on colony growth with 12, 24 and 48 hour feeding patterns with the removal of the cells from 
incubation every 12 hours. This therefore caused a cooling of the cells along with a reduction in CO2 
% and humidity. Form this data it is possible to conclude whether the variations in growth rates 
seen previously in Section ‎3.6, are due to environmental cues or media supplementation. 
By following the change in coverage over time where the cells are fed every 48 hours, but removed 
from the incubator every 12 hours it is possible to state that the observed dips in coverage are 
governed by environmental cues (‎Figure 65 C). All 3 conditions shown here were conducted on the 
same plate, therefore exposing the cells to the same external conditions independent of their 
feeding regime. Even when there is not a media change (only orange bars) there is still this dip 
proving that they are governed by environmental cues rather than any metabolic cues from feeding. 
This dip is only visible at some of the removal points, potentially when the flask was removed for a 
longer period of time than the others. The environmental chamber is temperature (37°C), CO2 (5%) 
and humidity (95%) controlled, on removal from the incubator all of these conditions can change, 
although it is most likely that temperature has the greatest short term effect due to the contraction 
of the cell cytoskeleton, a response discussed in depth by Almeida (126). 
Interestingly the dips in coverage are most notable in the 24 and 48 hour feed patterns rather than 
the 12 hour feed patterns. Although these dips are unrelated to whether the well has had a media 
change the dips are more noticeable at higher coverage’s. At 48 hours there is a large dip for all 
colonies in both the 24 hour and 48 hour feeding patterns,  however at 72 hours when only the 24 
hour feeding pattern plate had a media change both still have significant drops in coverage. This 
said the overall growth curve is unaffected by these dips with the colony growth continuing on the 
same trajectory if these dips were ignored. 
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 Total Colony Coverage measured over time with different feed regimes. By Figure 65.
assessing the coverage values with different feed regimes it is possible to identify the cause of coverage 
dips. This diagram shows 12, 24 and 48 hour feed regimes in graphs A), B) and C) respectively. The 
orange bars represent when the culture vessel is removed from the incubator, with the black lines 
showing when the cells were fed. From this data it is possible to see that dips occur even when there is 
not a feed, suggesting environmental cues rather than metabolic cues cause the dips. (n=20).  
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All the colonies begin with a coverage range of 0-20%, independent on the feeding pattern. 
However after 90 hours the 12, 24 and 48 hour feeding patterns have coverage ranges from 0-55, 0-
70 and 0-90% respectively. Although there are larger fluctuations due to environmental cues in the 
less frequently fed plates, the average growth rate is increased. This suggests that less frequent 
feeding has a positive influence in the growth of hESC colonies.  
This data has proved that rather than a chemical cue, the fluctuations in coverage are due to 
environmental factors. By assessing the individual metrics of a single image it is possible to identify 
the cause of these dips, ‎Figure 66. As the total colony coverage changed very little, but the core 
periphery coverage had large dips, potentially the colony is being wrongly identified after a feed. To 
further investigate this, a single colony was chosen, with the 4 metrics all plotted together in ‎Figure 
66. 
 
 Coverage values for a single colony.  By assessing single colony all the 4 metrics can Figure 66.
be plotted together. This shows that there is little deviation in the total colony growth, but the core 
periphery coverage and edge cell coverage are opposites with regard to peaks and dips. This suggests 
that surrounding the incubator removal points the image analysis is wrongly identifying core periphery 
as edge and vice versa. Overtime this wrong identification returns to the original growth curve for each 
metric.  
Apparent from ‎Figure 66 is that the dip in core periphery (blue) is offset by a spike in edge cell 
coverage (green). As the total colony coverage changed very little, but the core periphery and edge 
cell coverage have large dips, potentially the colony is being wrongly identified following a feed. To 
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further investigate both raw and analysed images surrounding an incubator removal point were 
further examined, an example of such a filmstrip is shown in ‎Figure 67. 
By assessing the images for those with the most noticeable dips in growth it is possible to see that 
often the first image following the culture vessel removal has an increase in edge cell identification 
replacing core periphery coverage identification. By assessing the raw images it is possible to see 
that the images directly after the vessel is placed back into the incubator and imaged is slightly out 
of focus. These out of focus images causes a poor identification of colony coverage, and appear to 
classify out of focus colony as edge cell coverage. This further highlights the importance of 
capturing high quality images for analysis with Area Finder. 
It was previously noted that these dips were more prominent in plates that were fed less often. Now 
it has been proven that these dips are due to incorrect identification it is possible to identify that 
those fed more often also grow slower. Therefore for image analysis the larger the colony the more 
of the colony is wrongly identified, causing a more prominent dip around the plate removal points. 
A number of solutions could be used to overcome this. Either a manual re-focussing of each position 
could be completed, although this would be time consuming and prone to human error. The better 
solution would be for the software to complete an auto focus of each position. This has been set-up 
within the software to allow a 50 µm scan to determine the optimum focus prior to imaging on all 
positions. All future work will utilise this auto focus feature of the software. 
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 Filmstrip of colony growth around a feed point. By viewing the analysed colony Figure 67.
overtime it is possible to identify that immediately after feeding the area of core periphery coverage 
(blue) is wrongly identified as edge cell coverage (green). By comparing to the raw images it is possible 
to identify that the images after feeding are out of focus, and only as they become in focus is the 
analysis improved.  
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3.8 Karyotype Assessment 
Following culture and analysis representative samples of H9 embryonic stem cells were sent away 
for karyotype analysis. The results are shown in ‎Figure 68. 
 
 Karyotype analysis of representative hESC populations. This image identifies a Figure 68.
normal female karyotype with no chromosome abnormalities reported.  
‎Figure 68 highlights a normal karyotype analysis for female embryonic stem cells. There are no 
signs of chromosome defects reported in this report. 
3.9 Conclusions 
This chapter has shown the potential of measuring image derived metrics from phase contrast 
images. Initially image analysis has been shown to be more precise then traditional cell counting, 
with 4 novel metrics derived. Total cell coverage was initially used to correlate image analysis to cell 
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counts, but it was shown that unless all cells occupy the same area that further metrics are required. 
Following this dark colony areas, edge cell morphology and the remaining colony were determined 
as further image derived metrics. These metrics helped to account for the heterogeneity within an 
embryonic stem cell population, and therefore provided a better correlation to cell counts. However 
, during analysis it was seen that these metrics were directly linked to quality, and capable of 
quantifying the population state. Further development of how these metrics behave over the 
culture period allows them to be used as a tool for process control. The next stage will be to assess 
the utility of these image derived metrics to provide a quantitative output to inform a process 
action. 
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4.  DEMONSTRATI ON OF USE IN 
PROCESS CONTROL AND 
DEVELOPMENT  
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4 Demonstration of Use in Process Control and 
Development 
A hurdle currently preventing the development and commercialization of many therapeutic 
products is the current cost of manufacturing (4). There remains a vast technological challenge to 
translate processes which originate largely as laboratory-based, into clinically appropriate larger 
scale production techniques that are reproducible, safe, clinically effective and economically 
acceptable. Failure in this area has been the root cause of many commercial problems of early 
companies in this field (127). Developing and using scalable automated systems that consistently 
generate a product with predetermined acceptable variations and at increasing production volumes 
offers the path to affordable production (4).  
Kino-Oka (128) accurately describes the current situation with regard to automated mammalian cell 
culture: 
 ‘The term “automation” has been used to describe some bioreactor systems developed so far. Because 
of the fluctuating nature of the tissue culture process, “automated operation” implies manipulation 
directed by operator decision or pre-set schedules without numerical warrant, in other words a passive 
or rigid system. Whereas an intelligent bioreactor system, one incorporating sophisticated tools not 
only to determine fluctuating culture properties but also to predict growth profiles, is required to realise 
fully automated operations.’  
Because the characterization of human cells is especially challenging, the automated analysis of 
material throughout bioprocessing will be critical (28). The only reported use of online process 
monitoring was from Balis et al. within their bioartifical liver development, and then this was ‘the 
minimum entry level for process control’ (129).  As discussed previously, there is a growing need for 
a routine, high-throughput, in-process monitoring and evaluation platform to make informed 
process decisions and therefore direct quality control (130). 
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In order to prove utility for the metrics developed previously the non-invasive imaging must be 
applied within a process which in turn can provide information for process control. A key aspect of 
embryonic culture is maintaining pluripotency across the population before directing differentiation 
through the use of chemical cues. It is therefore important to be able to initially measure a 
difference between a pluripotent colony and a differentiating colony. This can be achieved either as 
a population response (sampling multiple images) or individual colony units within the culture. The 
former analysis will be the most useful process tool to apply process control as it does not require a 
separate step of target identification. The latter will be more informative in determining target 
colony characteristics across the population in order to develop and optimise differentiation 
response. Therefore two separate sampling techniques can be applied to gather population or 
individual colony behaviour.  
In order to prove utility of the image derived metrics a number of in process monitoring steps can be 
evaluated in the chapter. The first procedure to compare current process monitoring to the newly 
identified image based system is to evaluate cell counts. Initially a sacrificial, invasive technique is 
compared to using the image metrics in order to better predict cell number within a culture vessel. 
Following on from this both pluripotency and differentiation will be evaluated using invasive 
imaging and flow cytometry techniques whilst evaluating the non-invasive image derived metrics as 
a predictor of culture state. The final section investigates the effect of size on differentiation yield. 
This allows for real-time analysis to continually monitor the size of the colonies and determine an 
optimum size to make a process action in the form of differentiation stimuli. These varied culture 
processes allow the utility of novel metrics to be analysed and determine if they can be successfully 
integrated into cell therapy manufacture through the following key areas.  
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 Using image derived Metrics to Predict Cell Counts 
 Using image derived Metrics to Predict Culture Quality 
 Using Image Derived Metrics to Measure Differentiation 
 Using the Metrics to Improve Differentiation Yield 
 Real-Time Analysis for Process Prediction and Improvement 
4.1 Using Image Derived Metrics to Predict Cell Counts  
As discussed previously in Section ‎3.3, count is one route to measurement of process state and 
potentially control, however unlike single passaged cells, colony culture requires sacrificial vessels 
rather than sampling. This is due to the colonies macro distribution and the requirement to break 
the colonies down into single cells prior to count, image analysis therefore removes the need for 
sacrificial counting. Also due to colony culture there are many microenvironments that are not 
represented by count, compared to monolayer cultures where a single microenvironment is 
represented fairly well by count. The variation from cell counts can be seen in ‎Figure 69 by taking 12 
vessels that have been equally seeded with colonies and cultured for 4 days prior to sacrificial 
counting. 
 
 Variability in cell counting of embryonic colonies. By measuring the cell counts of 12 Figure 69.
wells, this work has demonstrated that there is a large variation, therefore taking just a single count and 
assume the other wells contain the same number produces a large variable within a process (Error bars 
standard deviation of the population, n=12). 
Chapter 4 
141 | P a g e  
 
‎Figure 69 shows 12 samples that were seeded with the same volume of a well-mixed suspension of 
embryonic colonies, grown for 4 days followed by a sacrificial count on each culture vessel. This 
demonstrates the variation that occurs within colony culture. Comparing sample 4 and 8, the 
extremities, there is more than 100% difference in these two samples, with the entire population 
giving a standard deviation of 40,000 cells/cm2, shown by the error bars in ‎Figure 69. This variation 
may come from a number of sources including; poor mixing, variation in growth characteristics, size 
distribution and the counting method itself. It is common practice, as used by many collaborators, 
to sacrifice one flask and assume that count to the other flasks that were seeded at the same 
density. This data highlights how using a single sample to predict the count of an entire population 
can provide a large error.  
Therefore another method would be to use the image derived metrics developed previously to 
estimate the cell counts. This allows every culture vessel to be imaged non-invasively, followed by 
analyse of the images to make a prediction of count as shown in Section ‎3.3.3. This was completed 
using both the original method of analysing the total colony coverage, deemed single metric, and 
also using the combination of three metrics ‘core periphery’, ‘dark’ and ‘edge’ coverage, deemed 
triple metric. 50 images from each culture vessel were taken, as previously mentioned one of the 
key advantages to non-invasive imaging is the ability to tailor the error in measurement by taking a 
set number of images. 50 images were chosen due to the statistical resolution shown in 
Section ‎3.3.2. Producing an estimation of count using coverage allows a non-invasive application of 
the same control algorithms currently used for count but using coverage. The correlation of single 
and triple metrics data to predict count and the actual counts are shown below in ‎Figure 70. 
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 Correlating cell counts to image metrics using pre-defined relationships.  Taking the Figure 70.
same cell counts as previously shown in ‎Figure 69, these can be correlated to a non-invasive predicted 
cell count. This is achieved by taking the percentage coverage derived in ‎3.3.2 to produce a predicted 
cell count based on one metric, or by taking the regression equation from section ‎3.4.5. This therefore 
allows every vessel to have its own cell count, reducing unknown variation within a process.  A linear 
correlation is shown with an R
2
 value of 0.753. The red line highlights where prediction would equal the 
true value. (n=12)  
‎Figure 70 shows that using either the single or triple metrics produce very similar predictions of 
count. This is due to the variation seen over the data set where these equations were developed 
from. All of the culture vessels analysed here were of a low cell number after the 4 days culture 
experiment. From ‎3.4.5, it is clear that at low cell numbers the image metrics over-estimate the 
count, a feat shown here by all the predictors lying above the red true fit line. It was also noted 
previously that at low cell coverage’s the metrics are less precise then at higher cell densities, so this 
experiment operates at the reduced precision range for the image derived metrics.  
Having calculated the predicted cell counts from triple metric image analysis it is then possible to 
compare these to a typical process where a count is performed on one culture vessel, and 
extrapolated for the remaining vessels. Using this example it is possible to randomly select one 
vessels count and assume this to the remaining 11. Using a random number generator 1.85x105 
cells/cm (vessel 7) was chosen to represent the other vessels. Following this the error between true 
and predicted count that arises by using the single count is calculated. This single vessel error can 
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then be compared to the error sustained by using imaging to predict the count in each vessel. The 
errors are shown in ‎Figure 71, where there is an error to the single vessel predicted count in blue, or 
an error to the image analysis predicted count in red. 
 
 Error of single vessel predictor with error of using image analysis.  The blue bars Figure 71.
represent the error in the real cell count to using a single count, whereas the red bars represent the 
image analysis error to the true cell count. (n=12) 
‎Figure 71 shows that there are errors greater than 50,000 cells/cm2 in both the single vessel 
predictor and image analysis. The largest errors occur in the single vessel predicted analysis, 
however it is possible to average the errors for each predictor which highlights that the single vessel 
predictor has an average error of 3.36x104 cells/cm2, whereas the image analysis has an average 
error of 2.85x104 cells/cm2. This suggests that image analysis is a more accurate predictor of cell 
count than using the current single vessel predictor method. It is important to note that this is using 
only 12 culture vessels; a larger study would be required to test the validity of using image analysis 
over a predictive single vessel count. This would also need to be tested over a range of cell counts, 
although this was completed at low cell numbers where coverage was shown to be least precise, 
suggesting improvement with higher coverage. Also there is a probability that one of the culture 
vessels from the extremities would be selected and therefore produce a large error in predicting the 
counts of the other vessels. 
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This data has shown that using the image derived metrics in their least precise range, an 
improvement on the current practise is noted. It was seen in ‎Figure 47 that under 300,000 cells/cm2 
the model is a poor predictor, especially noted in the regression equation on page 109 which has a 
constant of 227404. This highlights that the model is only valid of cell numbers above 300,000 
cells/cm2 and becomes more powerful the larger the cell number. This is due to the effect that edge 
cell and dark colony metrics begin to have a more prominent effect at higher cell densities. By 
operating at a higher cell number and ultimately higher cell coverage range the image analysis is 
predicted to be further enhanced and the magnitude of error further reduced compared to the 
single vessel predictor.  
4.1.1 Conclusions 
As stated, colony culture counts are not representative of the microenvironment in which they 
habituate which suggests counting is a poor measurement for colony quality. This chapter has 
shown the variability in counts from vessels seeded with the same volume of a well-mixed solution 
of cells. Following on from this variation image analysis has been used to predict the cells counts, 
although an over-estimate is made, the error in image analysis compared to the current method is 
reduced in this example. The images also provide further information regarding the culture state 
than cell counts alone. By developing image derived metrics this novel measurement technique is 
also more informing about colony culture and therefore a promising method for process control.  
4.2 Using Image Derived Metrics to Predict Culture Quality  
An important aspect of optimised cell culture is feeding regime. In order to improve cell production 
and quality the feeding regime and media development are crucial factors to optimise (131,132). For 
embryonic cells, as per manufacturer’s instructions, cultures should be fed with pluripotent media, 
mTeSR-1, every 24 hours in order to prevent differentiation (78). This feeding regime is also 
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designed to maintain concentrations of growth factors, nutrients and buffer reagents to maximise 
homogeneous quality growth (78). Alongside this the replenishment of media daily removes waste 
products to maintain these levels within an optimum range, specifically ammonia and lactate (132). 
It is therefore hypothesised that by decreasing the feeding frequency the quality of the culture 
deteriorates with regard to its pluripotency status and growth. Using the image derived metrics 
developed previously the culture can be assessed and correlated back to traditional end point 
analysis using flow cytometry pluripotent markers Nanog, Oct3/4 and Sox-2. Cultures are fed every 
12 hour, 24 hours or 48 hours with pluripotent media. A less frequent feeding regime is expected to 
decrease the pluripotency measured as a drop in pluripotency markers and an increase in the 
differentiation metrics of edge cell coverage and dark colony coverage. 
4.2.1 Image Analysis Pluripotency Verification 
By using the 4 metrics developed previously it is possible to see if culture state can be identified and 
monitored through phase contrast image analysis. ‎Figure 72 shows graphs for all 4 metrics of total, 
core periphery, dark and edge cell coverage that have been averaged for the population expressed 
to each feeding regime. For this experiment imaging was restricted to user defined areas where 
colonies were visible. This equated to 19 images per well with 2 wells of each feeding regime in a 6-
well plate, giving a population of 38 samples per condition. The data shown here is all normalised 
for colony size to remove any artefacts that size may provide on the behaviour of the metrics. 
It is possible to see that feeding less frequently has increased the total colony coverage, shown by 
the red line above that of the green and blue in ‎Figure 72 A). This was expected as research suggests 
a 100% media change may remove autocrine factors that are potentially ‘instructive for cell 
proliferation’ (132).  Dividing the total coverage into the 3 categories of Core periphery, Dark and 
Edge cell coverage shows that the 48 hour feeding also has a higher core periphery B) and edge cell 
coverage D). The dark cell coverage C) is low for all feed regimes and therefore a poor predictor of 
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culture state in this experiment. Identifying total colony coverage 12 and 24 hour feeding regimes 
show little difference, with 48 hour growing faster, assumed due to the reduced removal of 
autocrine factors. Core periphery coverage is slightly separated following the same pattern of 48 
hour feed regime having the most and 12 hour the least. 
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 Behaviour of 4 metrics with feeding regimes normalised for colony size. It is Figure 72.
possible to compare 48, 24 and 12 hour feeding regimes (red, blue and green respectively) with respect 
to the 4 identified metrics; A) Total colony coverage, B) Core periphery coverage C) Dark colony 
coverage and D) Edge cell coverage. The total colony coverage increases greatest for the less frequently 
fed cultures, suggesting there may be an effect of removing autocrine factors in the more frequently 
fed cultures reducing their growth rate. The core periphery colony coverage follows a similar 
relationship to that seen for total colony coverage. The dark area remains a very small percentage of 
the total colony coverage (<5%), and therefore is hard to comment on the relationship. Edge cell 
coverage again is highest for the 48 hour feed regime, suggesting increased differentiation, however it 
started higher than the other feed regimes which may cause a bias on the results. This said comparing 
the gradients of the 3 feed regimes, 12 hour is much flatter than 48 hour suggesting a slower growth of 
edge cell coverage. (n=38) 
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Due to the low values for dark coverage this metric is not further analysed, however edge cell 
coverage appears to show a greater amount for those fed less often. The edge cell metric which is a 
measure of differentiation is clearly separated between the 3 feed regimes. Although all this data 
has been normalised for size, the increased growth of 48 hour could be artificially providing larger 
edge cell coverage due to the analysis. The larger the colony, the larger its circumference and 
therefore more absolute edge cell coverage will be detected using the analysis protocol. To remove 
this bias it is possible to take colonies of the same size in each regime and analyse them, therefore 
removing the effect of both time and size on the cultures. In order to accomplish this 3 diameters 
were chosen at 879, 971 and 1158 µm then the edge cell coverage was recorded for each condition 
when the average colony distribution reached this diameter. This is shown in ‎Figure 73. 
 
 Edge Cell Coverage for 3 colony sizes in each feed regime. This shows that for a Figure 73.
given colony size, those fed least often will have the greatest amount of edge cell differentiation. n=38  
From ‎Figure 73 it is possible to see that the edge cell coverage is greater for the less frequently fed 
even when all the colonies are the same size. This further suggests that the different feed regimes 
effect the growth of edge cell coverage within the population. There is also an increase in the 
percentage of edge cell for larger colonies. This would be expected if the thickness of edge cell 
depth remain unchanged, as the circumference would be greater. As has been mentioned before 
the reasons behind this response require further work especially around media development which 
sits outside of this works scope. 
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To ensure that the starting size is not biasing the analysis, this experiment was repeated. This time 
38 images were taken from each well in a systematic sampling pattern as identified in Section ‎3.3.2. 
The average values from 2 wells composed of 76 images in total are shown in ‎Figure 74. 
‎Figure 74 confirms that feeding less regularly increases the edge cell coverage of the population. 
The previous results seen in ‎Figure 72 were compiled from only imaging in areas where colonies 
were present. This time systematic sampling was used, taking 38 images within each well of a 6-well 
plate. Each condition had 2 wells, so a total of 76 images per condition were captured and analysed.  
Immediately it is possible to see that the coverage percentages are much lower in this experiment 
compared to the previous, due to some images containing little or no colonies. However the 
relationship of edge cell coverage remains the same with 48 hour feeding producing more edge cell 
coverage then both 12 and 24 hour feeding. Also worth noting in this experiment is that unlike 
previously the 48 hour feeding regime did not start with the largest colonies. In fact the 12 hour 
feeding regime started with the most edge cell coverage, and ended with the least. This provides 
further encouraging results that edge cell coverage can be used as a metric to determine culture 
state. To determine if this change in edge is predictive of pluripotency state end point flow 
cytometry was conducted in the next section. 
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 Repeat of colony coverage growth with different feed regimes.  This figure confirms Figure 74.
that feeding less regularly shown by the 48 hour feeding red line, that edge cell coverage increases. This 
shows that edge cell coverage can be used as a quality metric for embryonic cultures. (n=2)  
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4.2.2 End-Point Traditional Pluripotency Verification 
After the culture process was finished analysis by flow cytometry was conducted to assess if there 
was a change in 3 pluripotent markers, Nanog, Oct-3/4 and Sox-2. Example flow cytometry data is 
shown in ‎Figure 75. 
As shown with immunostaining previously in Section ‎3.5, Sox-2 remains the most positive 
throughout the culture as a proportion of the expressing population. Both Nanog and Oct-4 are lost 
earlier during differentiation, and represent a smaller positive population. By comparing the feed 
regimes, it can be seen that the positive peak decreases on all the markers shown here with less 
frequent feeding, shown by a decrease in the y-axis. As well as the peak decreasing showing a 
decrease in positive cells, there is also a drop in the median fluorescence. This is seen by the positive 
peak shifting in the x-axis. The median fluorescence intensity can be used to accurately describe a 
population of cells in culture. It has been reported that the median can provide a more accurate 
representation of a population as it is not governed by a negative control such as the positive cells 
percentage (133). Also deviations in median measurements can be important indications of subtle 
changes within the population, with progression of differentiation or down regulation of marker 
expression changing the median value prior to being noted in the positive cell fraction (133). For 
both experiments the medians have been normalised based on the 24 hour feed regime and are 
shown in ‎Figure 76.   
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 Flow cytometry data based on feeding regimes Showing the histograms of Nanog, Figure 75.
Oct-3/4 and Sox-2 with varying feeding regimes of 12, 24 and 48 hour feeds. (n=2)  
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 Flow cytometry data of normalised median value of positive cells from various Figure 76.
feeding patterns on pluripotency markers Nanog, Oct-3/4 and Sox-2. The left 3 columns show data 
from ‎Figure 72 where invidiual colonies were selected and image. The right 3 columns show the data 
from ‎Figure 74 where systematic sampling was conducted in each condition. (n=2) 
The median values are suitable here as the flow distribution is normalised without outliers as shown 
in ‎Figure 75. ‎Figure 76 highlights the decrease in median fluorescence across all the pluripotent 
markers that occurs with less frequent feeding. This suggests that pluripotency is better maintained 
by feeding every 12 hours compared to 24 or 48. The greatest change is seen in Nanog, again this is 
unsurprising as this is one of the first markers to be lost during differentiation, with Sox-2 remaining 
the longest during differentiation, and showing the least change over the feed regimes. 
The decrease in pluripotency with decreasing feeding frequency correlates to the effect seen 
through phase contrast imaging, an increase in edge cell coverage. This increases confidence in the 
ability to use these two metrics to identify the pluripotent state of a population.  
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4.2.3 Conclusions 
By varying the feeding regimes, image analysis has been able to monitor a change in metrics which 
have then been correlated back to conventional flow cytometry pluripotent markers. This highlights 
the merit of using non-invasive imaging to continually monitor the pluripotent state of cultures and 
quantitate an output of pluripotency state. This work has highlighted that the resolution of the Cell-
IQ system is able to accurately identify a change in culture state using image derived metrics. The 
next process to evaluate is the suitability of measuring a directed differentiation with a chemical cue 
within the Cell-IQ system.  
4.3 Using Image Derived Metrics to Measure Differentiation  
Embryonic differentiation can be directed down each of the germ layers by introducing known 
growth factors (134), however ‘differentiation in vitro is consistently disorganised and frequently 
variable’ between colonies (135). When colonies are removed from adhered surfaces and placed in 
suspension they form embryoid bodies which spontaneously differentiate into multicellular 
aggregates (135). This uncontrolled differentiation method produces inconsistent results due to the 
variable micro- environment surrounding the embryoid bodies. Therefore by keeping the colonies 
adhered and introducing known growth factors, it is hypothesised that the 3 metrics described 
previously (core periphery, dark colony coverage and edge cell coverage) will predict a response to a 
differentiation stimulus and correlate to the extent of that differentiation. This allows the Cell-IQ to 
be useful to continuously monitor, predict and provide a measure of culture state in order to make 
informed process decisions to improve differentiation efficiency. 
For this example of in-process monitoring the epithelial-to-mesenchymal transition (EMT) is 
studied. The complex nature of the EMT causes a change in tissue architecture, cell morphology, 
adhesion and migration capacity (136) and plays a pivotal role in the germ layer formations (137). 
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This morphological change is a key process through which it is anticipated that the Cell-IQ can be 
utilised to monitor and quantify metrics related to such changes in morphology.   
H9 human embryonic stem cells were cultured for 24 hours in mTeSR-1 culture media. Following 
this a daily media change of mTeSR-1 with 10 ng/mL of BMP-4, FGF, Activin A and VEGF is carried 
out. These growth factors have previously been shown to induce mesoderm differentiation 
(134,137–139). This daily replenishment is continued for 4 days with continual imaging using the 
Cell-IQ imaging platform. By day 4 the colonies morphology have dramatically changed creating a 
ring of single cells on the colony periphery. The difference between a colony maintained in 
pluripotent media and differentiation inducing media is shown in ‎Figure 77. 
 
 Embryonic colony with and without differentiation stimuli Image A) remains in Figure 77.
pluripotent media (mTeSR-1-1, StemCell Technologies), maintaining a tight boundary edge with a 
similar morphology throughout the colony. The colony in image B) however has been exposed to 10 
ng/mL of BMP-4 FGF, VEGF and Activin A for 3 days prior to imaging. This colony has a ring of edge cell 
morphology as the differentiated cells migrate away from the colony.  
Following the 4 day culture period the captured images were analysed for the 3 metrics developed 
previously in Chapter ‎3.4. The metrics were then plotted over time to identify the colony response. 
This is shown by taking two representative colonies, one in ‎Figure 78 A) where no differentiation 
stimulus was added and ‎Figure 78 B) where a differentiation stimulus was added. 
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 Trio of metrics measured for pluripotent and differentiating colony. A) Dark colony Figure 78.
coverage, Edge cell coverage and Core periphery coverage of embryonic colonies cultured in 
pluripotent media. There is continual increase in core periphery and edge cell morphology as the colony 
increases in size, roughly doubling in coverage every 24 hours. Dark colony coverage tends to be seen 
later in culture as the colony continues to proliferate prior to passaging. B) Dark colony coverage, Edge 
cell coverage and core periphery colony coverage of embryonic colonies cultured in mTeSR-1 for 24 
hours before including BMP-4, FGF, VEGF and Activin A in the daily feeds. It can be seen there is a 24 
hour delay before any effects of the addition of BMP-4 are seen. At 48 hours the edge cell coverage 
dramatically increases exponentially, whereas the other metrics remain stable.  
‎Figure 78 A) shows the behaviour of an embryonic colony that is maintained in pluripotent media, 
whereas ‎Figure 78 B) shows the effect of adding bone morphogenetic factor 4 (BMP-4), Activin A, 
fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF). This stimulates a 
morphological change that can be measured using the Cell-IQ. For a colony maintained in its 
pluripotent state the core periphery coverage grows faster than the edge cell coverage, represented 
as the blue line outperforming the green line in ‎Figure 78 A). This suggests that the core periphery 
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coverage is indicative of pluripotent morphology whereas In the presence of a differentiation 
stimulus there is a delayed increase in edge cell morphology. 24 hours after the addition of the 
differentiation stimulus the green line exponentially increases, the overall effect of more edge cell 
morphology being present then core periphery. The difference in morphology can be seen in ‎Figure 
79 shown with analysis of the 3 image derived metrics successfully identified. 
 
 Raw image and analysed image of pluripotent and differentiating colony. Colony Figure 79.
morphology difference between A) control (maintained in pluripotent media) and B) differentiating 
colony (induced with BMP-4, Activin-A, FGF and VEGF). There is a clear band of monolayer edge cells in 
the differentiating stimuli conditions, this is represented in the analysed images as a band of green (D), 
this is not seen in image C where the colony is maintained in pluripotent conditions.  
‎Figure 79 shows the accuracy of analysed images in detecting the 3 metrics. Following this analysis 
it is possible to identify the edge cell population with immunostaining. The cocktail of growth 
factors were used to induce mesoderm differentiation, and therefore early mesoderm markers were 
used to identify the population. Heart and neural crest derivatives-expressed protein 1 (HAND1) was 
found to be positive in the edge cells as shown in ‎Figure 80, with 4',6-diamidino-2-phenylindole 
(DAPI) counterstaining. 
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 Phase and fluorescence image of embryonic colonies post differentiation. After 2 Figure 80.
days of being exposed to differentiation media. DAPI is shown in blue with HAND1 shown in red. The 
core of the colonies is negative for HAND1 whilst the periphery cells are positive. This therefore agrees 
with the morphological analysis where the edge cells are in a different culture state to the colony core.  
The immunostaining shows that around the periphery of the colonies there is positive staining of 
the edge cells for HAND1, whereas the central core of the colonies are predominantly blue, showing 
DAPI staining. This shows that our cocktail of growth factors induces mesoderm differentiation, 
with the image analysis correctly depicting this differentiation in measuring edge cell growth.  
The data in ‎Figure 78 is taken from only 2 colonies exposed to different conditions; however it is 
possible to average the data from all the colonies to see the overall effect of edge cell coverage and 
core periphery coverage. The average data is taken from 3 wells of each condition capturing 9 
images per well, giving a total of 27 images per condition. This is shown in ‎Figure 81 as a growth 
curve of edge cell coverage over time. 
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 Averaged edge cell coverage for pluripotent and differentiating colonies. This graph Figure 81.
visualises the mean difference between colonies kept in a state of pluripotency; where the edge cell 
coverage increases at a much slower rate than that of colonies exposed to differentiation media 
(mTeSR-1 with growth factor addition). The fluctuations show the feed points roughly every 24 hours 
during culture. (The error bars represent the standard error of the mean, n=27).  
Colonies are passaged and left for 24 hours to attach before any treatment is started. Zero hours 
represents the time that imaging begins which is 24 hours after passaging and the same time as a 
differentiation stimulus is introduced to half of the cultures, pluripotent colonies remain in 
pluripotent media.  
There is a 12 hour delay before any effects are seen with the differentiating colonies, after 12 hours 
there is an exponential growth in edge cell coverage, this is in stark contrast to the pluripotent 
maintained colonies that remain with edge cell coverage of less than 5%.  
From ~20 hours there is a marked difference in the edge cell growth rate which allows a distinct 
discrimination between the differentiating population and the population not exposed to a 
differentiation stimulus. It is important to draw a quantitative value from the data that predicts this 
morphological difference at the earliest time point with the highest resolution. At 20 hours the 2 
lines including error bars separate from each other. This is the earliest time point where the 
resolution is sufficient to quantitate a difference in the two populations. A key aspect of this 
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separation is the error bars. This is conducted with a sample of 27 selected colonies, to be useful for 
process control the sample size can be tailored for a given error, and therefore resolution can be 
tailored to the process requirements.  
The spikes seen at ~40 hours and ~65 hours are due to the auto focussing that occurs when the plate 
is removed from the incubator, the media is replenished and the plate is returned. As discussed 
previously the first image was given a 50 µm Z-stack to focus the first image. This is suitable when 
only a small deviation from the focal point is made, a much larger Z-stack to find the focal point is 
required though should the culture vessel be placed back into the Cell-IQ further than 50 µm from 
the original placement. From the spikes it is possible to see when 50 µm was not adequate, 
producing variable time periods of erratic data. For this data set these spikes do no interfere with 
the overall trend, and such is the resolution they do not disturb the result. However further 
hardware improvements could address this issue by better autofocussing following the plate 
removal. 
4.3.1 Conclusions 
By using growth factors to initiate differentiation in a pluripotent population it is then possible to 
monitor differentiation thorough the change in morphology detected predominantly with the edge 
cell coverage metric. After the addition of a differentiation stimulus the morphology begins to 
rapidly change after a 24 hour lag period. This is detected as an increase in edge cell morphology 
which can be used to calculate a percentage of differentiation. This provides a tool to monitor and 
measure the rate of differentiation. With this information it is possible to use image derived metrics 
to improve differentiation processes, an example of this is shown in the next section.   
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4.4 Using Image Derived Metrics to Improve Differentiation Yield  
It has previously been reported the importance of embryonic colony size on differentiation 
induction (140,141). This work aims to provide an optimum colony size for differentiation as 
measured by complete differentiation to a homogenous morphological state. 
4.4.1 Colony Size Distribution 
The first stage is to identify the size distribution that follows from a passage. Due to the macro 
growth and distribution of colony size it is hypothesised that colony sizes are very variable, and are 
affected by many factors including, previous growth rates, pluripotent status and pipetting 
technique. A typical distribution from passaging H9 colonies as disclosed in the methods 
section ‎2.2.3 is shown by ‎Figure 82. 
 
 Colony size distribution following a passage. This shows a lognormal distribution, as Figure 82.
measured from image analysis, centred around a peak colony diameter of ~350 µm for 58 identified 
colonies 24 hours after passaging. This allowed colonies to adhere to the surface prior to imaging, n=58  
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A lognormal distribution centred around a peak colony diameter of ~350 µm is recorded from a 
sample of 58 colonies analysed 24 hours after a passage. The 24 hour delay allows for colonies to 
adhere to the plastic surface prior to imaging and analysis. This data shows that as predicted there 
is a large variation of colony sizes that are produced following passage. This provides one variable 
which may affect the differentiation efficiency, and therefore is further analysed. 
The initial diameter of a colony can be plotted against its diameter of a later time point. This 
therefore shows if all colonies grow at the same rate independent of size, or if there non-linear 
growth with respect to diameter. ‎Figure 83 shows colonies at 24 and 36 hours in both pluripotent 
media and differentiating media. The differentiation media is added at 24 hours, therefore taking a 
36 hour time point neglects any morphological response. 
 
 Diameter of colony at 24 hours against 36 hours  By comparing the first 36 hours of Figure 83.
data for differentiating colonies (BMP-4, Activin-A, FGF and VEGF addition) and pluripotent conditions 
the same trend is seen. The growth rate overall of each colony therefore remains the same initially, the 
difference in gradient of the two best fit lines shows differentiation colonies grow slower. (n=58)  
‎Figure 83 shows a linear relationship between initial and colony diameter after 36 hours during 
culture in both pluripotent and differentiation conditions. It is important to note here that diameter 
is used as a predictor of growth, which is an area. The relationship between diameter and area is 
squared. This data therefore suggests growth is slowed in larger colonies, although due to the 
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tailing off at large diameters, is can be assumed that this effect is negligible and within the error of 
calculation when used within the range of 200 µm to 1200 µm. It is clear from this that the line of 
best fit for differentiating colonies falls below that of pluripotent conditions, suggesting that 
differentiating colonies grow slower. However this slow in growth rate could be due to a change in 
culture state that is not morphologically measureable until later in the culture. Now that the growth 
of colonies has been shown not to be influenced on size it is possible to evaluate the colonies 
differentiability. 
4.4.2 Effect of Colony Size on Differentiation Efficiency 
It has been highly documented that extensive dissociation of hESC colonies into single cells during 
serial passage severely compromises the survival and propagation of these cells in vitro (114). ROCK 
inhibitor is used to prevent differentiation of embryonic single cells (142), but routinely for 
established embryonic culture protocols cells are passaged as clumps rather than single cells 
(91,114). This work has suggested that the size of the hESC colonies is an important factor in 
maintaining their viability and pluripotent status, although to date there are no reports of being 
able to monitor or control the size. Mechanical dissociation used to be the only dissociation method 
to control colony size with varied estimates of clump sizes of 100 cells being optimum (114). 
Recently tools have been developed to help control colony size during passage which include the 
STEMPRO EZPassage from Life Technologies (143) and ReLeSR from StemCell Technologies (144). 
Although these are reported to help control colony size EZPassage tool is not suitable for scale-up 
or for use in culture flasks and on testing ReLeSR it has no effect on the removal of embryonic stem 
cells from matrigel. This work aims to test the importance of colony size whilst producing a method 
of quantitative analysis of colony sizes, whilst maintaining mechanical dissociation.  
In order to evaluate if size affects the ability of colonies to differentiate, colonies are initially 
measured and then after differentiating can be assessed for edge cell colony.  This provides a 
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measurement system for evaluating the differentiation capabilities of colonies of varying size, and 
to identify if control of size is an important factor. The results of 58 colonies are shown in ‎Figure 84. 
 
 Relationship of colony starting diameter to final edge cell coverage. Colonies Figure 84.
diameters are measured prior to the addition of a differentiation stimulus, then after 3 days of being 
exposed to differentiation media the edge cell coverage is recorded as a percentage of the total colony 
coverage. The relationship shows that as colonies increase in size they are poorer at complete 
differentiation. This is shown by a decreasing percentage of final edge cell coverage as the diameter 
increases. This data suggests that smaller colonies are required for homogeneous differentiation. 
(n=58)  
‎Figure 84 shows a range of colony diameters from 150 µm to 900 µm, measured prior to adding 
differentiation stimuli in the form of a cocktail of growth factors (BMP-4, FGF, VEGF and Activin-A). 
After 4 days of culture the edge cell coverage is measured as a representation of differentiation. 
There is a decline in the percentage of edge cell coverage with increasing colony diameter. For this 
experiment edge cell coverage is expressed as a percentage of the total colony, previously it was 
reported as a percentage of the total image. This data therefore suggests that the larger colonies 
maintain a morphologically pluripotent area, whereas the smaller colonies completely differentiate. 
This is validated by assessing the images, the small colonies differentiate causing single cells to 
migrate from the colony periphery causing the pluripotent colony to shrink and eventually 
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disappear. The larger colonies follow this as well but due their size a core of pluripotent 
morphological colony remains as shown in ‎Figure 85. 
 
 Comparing the effect of small and large colonies differentiating.  The small colony Figure 85.
in image A) appears to completely disintegrate into single cell morphology in image C), whilst larger 
colonies, such as the one in image B), remain with a core of colony morphology with just the periphery 
showing signs of differentiating in image D).  
The difference in disintegration of small colonies and a remaining core in larger colonies is size 
dependent and can be correlated back to their starting diameters prior to the addition of 
differentiation stimuli. There is a clear divide between colony size in ‎Figure 85 A) and ‎Figure 85 B), 
200 µm and 900 µm respectively. Then after differentiating ‎Figure 85 C) shows a colony that has 
disintegrated into a homogeneous morphology whereas ‎Figure 85 D) maintains a central core of 
pluripotent morphology as well as edge cell coverage around the periphery. This therefore provides 
evidence that there is critical colony diameter where complete differentiation of a colony occurs 
based on morphology. The data in ‎Figure 84 suggests that this decline in homogeneity is immediate 
with increasing diameter. This experiment was completed over 3 days, by increasing the time it 
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would be hypothesised that there would be a decrease in the line of best fits gradient as less central 
core remains. However it is important to consider that the longer the period of time during 
differentiation may cause further phenotypic changes, and a further lack of homogeneity. 
Therefore a trade-off between time, number of cells and homogeneity exists. This difference in 
reaction to differentiation stimuli is important for controlling homogeneity, where clearly the larger 
colonies have at least 2 cell morphologies, whereas the smaller colonies only have a single 
morphology present. The effect of size on differentiation potential has been noted previously by 
many groups that have had trouble culturing and passaging single embryonic stem cells. Peerani et 
al. showed that ‘endogenous signalling and pluripotent gene expression change with colony size’ 
(141). Furthermore Watanabe et al. reported that a critical colony size was required to antagonize 
pSmad1 activity which in turn prevented differentiation (142). The data also suggested that ROCK 
inhibitor, which is often utilised to permit single ESC growth (92,145,146), may have similar function 
in pSmad1 regulation (142). Heng et al. studied the effect of split ratios during passaging on the 
differentiation capacity of hESCs, they found that higher split ratios increased differentiation ability 
(124). However this study did not look at colony size although their images suggest that the higher 
split ratios produced smaller colonies, likely to be due to mechanical dissociation. 
4.4.3  Conclusion 
In conclusion this section has shown that the smaller colonies have a greater tendency to 
differentiate, whilst the larger colonies are able to prevent differentiation within a central core. This 
is likely to be governed by microenvironments (140,141,147), with larger colonies producing more 
factors into the surrounding media to maintain pluripotency. However in order to fully understand 
this further analysis needs to be conducted, especially assessing media components in the 
microenvironment. This could be particularly useful for complete differentiation where the cells are 
to be used within therapy where pluripotent cells are undesirable due to side effects such as 
teratomas production which have been seen after injected into mice (101,114,148,149). 
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One hypothesis that contradicts the homogeneity statement above would be that this core of 
pluripotency is critical for certain lineage development, and therefore is required. This method 
therefore allows a measure of pluripotency core; either stimulating differentiation in large colonies 
to retain a pluripotent core or differentiating small colonies to retrieve a more homogeneous 
population. 
Here a tool to quantitate the level of differentiation within a colony has been utilised to show how 
image analysis can be used to improve the homogeneity and/or yield for stem cell differentiation. 
4.5 Real Time Analysis for Prediction and Process  Improvement 
The post image analysis of data provides useful information to link responses to causalities. For the 
manufacture of cell therapies an online version of this tool would provide an improved mode of 
operation to make informed process decisions. After consultation CM-Technologies, the company 
that developed the Cell-IQ, built an online analysis tool that provides real-time data, Real-Time 
Analyser. Using the Cell-IQ Real-Time analyser, captured images can be immediately analysed 
rather than post image analysis. This allows for real time measurements to be made in order to 
make informed process decisions. In order to test the reliability and suitability of the new software 
colonies were continually assessed for their diameter based on the threshold method discussed in 
Section ‎2.7.1.1. 
This allowed for colonies to grow to a given diameter before a differentiation stimulus was added to 
the media in the form of growth factors, as used previously. It was seen previously that the small 
colonies differentiate to a single population whereas with larger colonies a core of pluripotent 
morphology remains. To further test this colonies were plated and then a differentiation stimulus 
was added to colonies that reached 300 µm or 750 µm. The results are shown in ‎Figure 86 from 
averaged colony data. 
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 Edge cell coverage of colonies exposed to differentiation stimulus at different sizes, Figure 86.
along with undifferentiated colonies. This graph highlights the effect of providing a differentiation 
stimulus when the colony is small (<300 µm) in comparison to larger colonies (>750 µm). A control of 
average colonies maintained in pluripotent media is also shown as dotted line. This highlights the core 
of pluripotency that remains in the larger colony as the peripheral edge differentiates, whereas the 
smaller colony has complete differentiation shown by the rapid increase in edge cell coverage and 
remaining core periphery detection. This data is taken form an average of 16 colonies of each type 
spread over 2 wells in a 6-well plate. Insets show examples of colony morphology at specific places. The 
data is then smoothed using average of 3 time points. (n=20)  
‎Figure 86 shows that by using real time imaging colonies can be continually monitored and a 
process action can be taken when a certain criteria is reached. In this experiment the real time 
analysis provided size data of the colonies. Once the average colony diameter in a well reached 300 
µm a differentiation stimuli was introduced. The response can be seen as an increase in edge cell 
coverage 24 hours after the stimuli. Further colonies remained in pluripotent conditions until the 
average was 800 µm. After the addition of differentiation media an increase in edge cell coverage is 
also seen at 110 hours. However the difference in percentage of edge cell coverage can be seen by 
comparing the spike of edge cell growth. The smaller colonies reach ~80% edge cell coverage 
whereas the larger colonies reach ~60%. This difference is due to the remaining central core of 
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pluripotent morphology within the larger colonies, whereas the smaller colonies completely 
separate into single differentiated cells. 
These colony sizes were chosen to represent two different outcomes as identified in 
Section ‎4.4.2, ‎Figure 84. As can be seen the smaller colony differentiates with only a small amount 
of core periphery detected, which is actually due to larger colonies identified on the edge of the 
image as seen in ‎Figure 87.  
 
  Image of small differentiated colony with larger colonies on the image periphery Figure 87.
which will be identified in the analysis and therefore skew the data.  
The larger colony keeps this central core of pluripotency shown by the continual increase of core 
periphery coverage. The edge cell coverage drops off onwards of 150 hours due to the overcrowding 
of edge cells which begin to form a more core periphery like appearance. Importantly this data also 
correlates back to the previous experiment which identified edge cell coverage after 3 days of 
differentiation in a range of diameters in ‎Figure 84. Taking the diameters of 300 µm and 800 µm it 
can be seen that the edge cell coverage was ~80 and ~60% respectively in ‎Figure 84. This repeat 
therefore emphasises the effect size has on differentiation capacity. 
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4.6 Conclusions 
This chapter has highlighted the utility of using image derived metrics to analyse the culture state 
of a pluripotent and differentiating population. By following the behaviour of these metrics 
overtime it is possible to evaluate the response to different stimuli. The ability to measure colony 
size non-invasively has allowed feedback correlation to the differentiation ability of the colonies. 
This has provided evidence to highlight the importance of colony size on differentiation ability and 
therefore provides a measure of control. The final example in this chapter has shown how 
measuring one metric such as colony diameter can be used to improve differentiation yield, also 
measured non-invasively. By continually monitoring the size, the time point where colonies are at a 
suitable size can be used to improve differentiation yields. This chapter has highlighted the ability 
to do this initially with work providing evidence of the effect of size, and then consequently 
developing online monitoring software to allow such control. This therefore highlights the benefits 
of using image derived metrics to make process decisions and gather further data regarding the 
culture state of a population. 
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5 Quantitative Non-Invasive Image Analysis for Colony 
Forming Unit Assay for Functional Evaluation of 
Haematopoietic Progenitor Cells  
5.1 Introduction 
Hematopoietic stem cells (HSCs) are derived from ventral mesoderm, and the sequential sites of 
haematopoiesis during development include the yolk sac, fetal liver, placenta, and within adult 
mammals, the bone marrow (150). The properties of HSCs produced in each tissue differ, 
presumably reflecting diverse niches that support HSC expansion and/or differentiation (151). The 
primary function for primitive haematopoiesis is production of red blood cells (RBCs) that facilitate 
tissue oxygenation as the embryo undergoes rapid growth (152,153). The hemangioblast of the yolk 
sac is proposed to give rise to both blood and endothelial cells. Subsequent definitive 
haematopoiesis involves the colonization of the fetal liver, thymus, spleen, and ultimately the bone 
marrow. In definitive haematopoiesis, long-term HSCs (LT-HSCs) give rise to short-term HSCs (ST-
HSCs). ST-HSCs produce common myeloid progenitors (CMPs) and common lymphoid progenitors 
(CLPs). CLPs are the source of committed precursors of B and T lymphocytes, whereas CMPs give 
rise to megakaryocyte/erythroid progenitors (MEPs) and granulocyte/macrophage progenitors 
(GMPs). GMPs give rise to the committed precursors of mast cells, eosinophils, neutrophils, and 
macrophages (154–156), this is shown in ‎Figure 88.  
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 Lineage tree for haematopoiesis. This shows the lineage pathway from Figure 88.
haematopoietic stem cell through to fully differentiated cell types for blood development along with 
critical transcription factors. Abbreviations: LT-HSC, long-term hematopoietic stem cell; ST-HSC, 
short-term hematopoietic stem cell; CMP, common myeloid progenitor; CLP, common lymphoid 
progenitor; MEP, megakaryocyte/erythroid progenitor; GMP, granulocyte/macrophage progenitor; 
RBCs, red blood cells (150).  
5.1.1 Definition of human Hematopoietic Stem Cells 
As discussed previously blood cells are responsible for the maintenance and immune protection of 
every cell type in the body. The stem cells that form blood and immune cells are known as 
hematopoietic stem cells (HSCs). They are responsible for the continual production of billions of 
blood cells every day. Hematopoietic stem cells have been studied for more than 50 years (157), 
however there still remains challenges in their production, maintenance and detection in vitro. This 
therefore has a knock-on effect that if they could be produced rapidly, reliably and truly identified 
then research would progress on characterisation (157). 
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5.1.2 Haematopoiesis 
Mature blood cells are short lived and therefore there is a need for constant renewal throughout a 
lifetime. This is achieved by haematopoietic stem cells (HSCs) continual replenishment of 
multilineage progenitors and the precursors committed to individual haematopoietic lineages (150). 
HSC are defined by their operational capacity to reconstitute the entire blood system, with billions 
of red blood cells produced each day. HSCs therefore serve as a constant reservoir for the 
regeneration of haematopoietic lineages. 
Umbilical cord blood (CB) derived HSCs, have been shown to promote stronger immune recovery 
and show fewer instances of immune rejection (158). However, CBs have fewer stem cells and 
progenitors per unit, making a single unit insufficient for complete repopulation in an adult patient 
and limiting CB use mainly to paediatric cases. Various techniques have been proposed to boost the 
HSC potential of CB, including incubations with biological modulators or small molecule 
compounds as well as a novel fed-batch approach to cell culture. Several of these are in clinical trials 
now, and could show significant improvements in the HSC levels derived from CB allowing the 
technique to be used for adult transplants (158).  
5.1.3 Clinical Relevance / Need 
Stem and progenitor cells can be collected from the bone marrow, mobilised peripheral blood or 
cord blood and used to restore hematopoietic activity in patients who have undergone 
chemotherapy or irradiation, destroying their bone marrow. Worldwide there are over 60,000 HSC 
transplants annually (159), currently total nucleated cells (TNC’s) and the colony forming unit (CFU) 
assay are used as predictors of engraftment. However TNC’s are becoming less popular as further 
studies prove their lack of correlation to engraftment, suggesting that only CFU assay is a true 
predictor of hematopoietic quality in vitro (160–162). The CFU assay provides both a count and 
functional assessment of hematopoietic progenitors.  
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Another aspect where the CFU assay is utilised is in the manufacture of blood cells (163–166). More 
than 80 million units of whole blood are collected from donors worldwide every year (167). Supply 
constraints and uncertain screening for infectious diseases are of particular concern in developing 
and transitional nations. In wealthy nations the other side of the coin is the occurrence of multiple 
immunisations to RBC antigens in 0.1% to 0.5% of transfused patients, leading first to difficulty in 
finding compatible RBC concentrates and very high costs, and eventually to full transfusion 
blockade (168). In response to these concerns, ex vivo manufacture of RBC from stem cells makes 
sense to enable safe and quantitatively sufficient transfusion. This is the concept of cultured RBC 
produced ex vivo from hematopoietic stem cells originating from bone marrow, peripheral blood, 
cord blood or pluripotent stem cells. Research is already focused on the feasibility of this approach 
at the industrial level US Defence Advanced Research Programs Agency (USDARPA)’s ‘Blood 
Pharming’ program (169). Further work looks to build on this background with the identification of 
an unlimited source of RBC’s allowing the production of cultured RBC from the constraints of the 
supply of hematopoietic stem cells (168,170).  
5.1.4 Current Identification Methods 
The analysis of haematopoietic progenitors is complex and needs to be fit for purpose. Two types of 
assays can be used to identify haematopoietic progenitor cells, either phenotypic assays that 
measure a biological marker or functional assays which measure the cell’s capability.  
5.1.4.1 Phenotypic Assays 
Phenotypic assays measure physical properties, such as expression of cell surface antigen marker 
CD34, or expression of the intracellular marker of stemness such as the enzyme aldehyde 
dehydrogenase. These individual markers associated with specific cell types can be retained after 
functional properties are lost, and therefore an over estimate of the number of stem or progenitor 
cells is possible. So if cells that have already begun apoptosis are not excluded from the assay they 
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can over estimate the number of progenitors in a population, especially if the cells have undergone 
a freeze thaw cycle. 
Clonogenic cells are a minority of a routinely identified phenotypic subpopulation. Within the 
CD34+ population only 10-20 % have the potential to form a colony, a functional cell with the ability 
to proliferate and differentiate. Therefore using CD34+ cells as a measure of functional cells would 
also provide an over estimate. It has previously been identified that the population of CD34+ cells 
are heterogeneous containing a variety of maturation levels (171), and a variety of marker 
expressions including CD13, myeloperoxidase (MPO) and CD33 (172). This is further examined by 
Page et al. who conclude that CD34+ count is only weakly correlate to engraftment and function 
and that colony forming unit assay is a much better predictor although more time consuming with 
currently a 14 day wait time for results (161). 
A list of cell-surface markers of undifferentiated hematopoietic stem cells proposed in 1992 by 
Baum et al. are shown in ‎Table 15, however these markers are still disputed today (157) with CD34 
being the most widely used marker for HSC’s. 
Table 15. Cell-surface markers of undifferentiated hematopoietic stem cells. A list of positive and 
negative surface markers to define haematopoietic stem cells as proposed by Baum et al. (173) 
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5.1.4.2 Functional Assays 
Functional assays directly measure biological properties such as engagement with the niche, cell 
proliferation, differentiation or response to a stimulus. As the assay occurs over a period of time 
only viable stem and progenitor cells are detected, as the cells have to be alive and healthy over the 
entire assay period. Functional assays can either be in vivo or in vitro. An in vivo assay is the best 
method for identifying the most primitive with long term repopulating ability and often involve a 
transplantation (174). By irradiating a mouse of its HSC population, a population of cells can then be 
injected. If then there is a detection of lymphoid, myeloid and erythroid progeny within the host the 
population is deemed to have contained long term HSC’s (173). This typically is at least 5 weeks 
after transplantation, is very expensive, cannot be conducted on humans and is impractical for 
routine use in lab procedures found in cord blood banks or transplant labs. Therefore in-vitro assays 
are more commonly found in laboratories that use either liquid or semi-solid systems. In vitro 
culture assays are used to detect the proliferation and differentiation ability of haemopoetic 
progenitor cells. The ability of these progenitors to produce colonies is the basis for the colony-
forming unit (CFU) assay.  
5.1.4.2.1 Colony-Forming Unit (CFU) Assay 
Currently the gold standard to assess the frequency and number of hematopoietic stem and 
progenitor cells is the colony-forming cell (CFC) or colony forming unit (CFU) assay (175). This in 
vitro assay requires a small sample of cells to be placed into a semisolid culture medium containing 
a suitable cocktail of growth factors (176) and incubated for 14-16 days. The gel results in limited 
dispersion of replicating cells allowing locally dense populations to be visualised where cells are 
highly proliferative. The gel effects migration of the cells which is dependent on the cell character. 
The morphology is the key characteristic along with colour that is currently used to identify the 
starting cell population.  Progenitors in different stages of maturation produce colonies differing in 
size, morphology and composition. This assay directly measures the number of viable progenitor 
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cells, with 1 colony being formed from 1 CFU.  Examples of colonies produced are shown in ‎Figure 
89. 
 
 Haematopoietic progenitor colonies. Example of BFU-E (A) and GM (B) colonies Figure 89.
cultured for 14 days in MethoCult, followed by taking brightfield images. These images highlight the 
difference in morphology and colour which currently is user defined. Reproduced from (177) 
 The CFU assay has been shown to be the single best predictor of successful engraftment following 
a cord blood transplantation by a number of research groups (161,164,178). Prasad et al. showed 
that the number of CFUs infused is the best measurement and the only technique that correlates to 
the overall survival (178). Total nucleated cells (TNC) and CD34+ cell counts were seen to be less 
predictive then the CFU results, the same outcome was acknowledged by Page et al. (161). 
The CFU assay remains the gold standard tool for haematopoietic stem cell research in vitro, and 
provides the best measure of cord blood unit engraftment potential (179). There are several 
international standards that recognize the importance of the CFU assay including the FDA Guidance 
for Industry: Potency Tests for Cellular and Gene Therapy Products (2011), FACT: Draft 5th Edition of 
the NetCord-FACT International Standards for Cord Blood Collection, Banking and Release for 
Administration (2012) and AABB: Draft 6th Edition of the Standards for Cellular Therapy Products 
(2012) which states that ‘the colony-forming unit or equivalent functional assay shall be performed 
before distribution’ when discussing cord blood transplants (180–182). 
The CFU assay is abundantly used within research alongside numerous steps within cord blood 
banking and transplantation, as shown in ‎Figure 90. 
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 Time points in processing where CFU assay is commonly utilised. Within the cord Figure 90.
blood banking and transplantation procedures there are many points where CFU assay is often used to 
verify cell number and quality (179). In this figure five CFU assay points are identified from collection 
through to patient delivery. 
After the cord blood is collected and processed for storage, the assay is first used to determine 
whether the cord blood should be stored, if there are sufficient progenitor cells to warrant storage, 
which is determined from a minimum threshold. Cord blood can then be routinely thawed to check 
that the cryopreservation procedure has not had any adverse effects on the number of progenitors 
within the cord unit, and therefore be used as quality control test. A CFU assay is also required by 
regulatory bodies before a cord blood can be released to a transplant centre. 
The transplant centre itself may elect to confirm the results from the cord blood bank prior to 
transplantation, and then sometime after the transplant a sample of blood is taken from a patient 
to perform another assay to confirm unit engraftment. 
However even with the CFU assay playing a dominant role in measuring the quality of cord blood 
units there are many associated problems which include time for the analysis outcome, 
standardisation with measuring the colonies and variability connected with colony defining. 
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The Cell-IQ has shown previously (Section ‎3.6) that it has the capability to continually monitor and 
analyse cell cultures. By using ‘machine vision’ the colony types can be automatically identified and 
therefore the variability associated with user-definitions of colony populations is addressed. This 
also standardises the counting ability as well through the use of automation.  The last concern is the 
current 14 day period that is required before the results are known.  
Continual monitoring allows rates of change to be assessed such as those in Section ‎3.6. By 
assessing changes greater differentiation between heterogeneous progenitor populations may be 
distinguished. Potentially this permits the detection of sub-populations of colony forming cells 
based on growth attributes. This also could allow for colonies to be reproducibly identified prior to 
the current 14 days. 
As discussed by Pamphilon (183) in his review paper of current techniques across 105 researchers 
there are three commonly categorised colony species. These being burst forming unit-erythroid 
(BFU-E), colony forming unit – granulocytes, macrophages (CFU-GM), and colony forming unit - 
granulocytes, erythrocytes, macrophages and megakaryocytes (CFU-GEMM). It is therefore 
important that any automated system has the ability to detect these colonies to improve on current 
user defined categorisation. 
This chapter aims to: 
 Correlate the growth characteristics seen in a standard incubator to the Cell-IQ imaging 
platform. 
 Define quantitative, novel, image derived metrics to automate colony classification. 
 Measure metrics over time to correlate observed metrics to colony phenotype. 
 Identify sub-populations within each classification based on image derived metrics. 
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5.2 CD34+ Cell Separation from Fresh Cord Blood  
The first stage of developing the CFU assay was to isolate CD34+ cells from fresh cord blood. This 
was completed using the Ficoll-Paque method (Section ‎2.10) followed by magnetic-activated cell 
separation (MACS) as described in Section ‎2.11. Cell counts were conducted throughout the 
protocol as recorded in ‎Table 16. 
Table 16. NucleoCounter counts from CD34 separation procedure. Taking cell counts as the CD34 positive 
population is separated from fresh cord blood. This shows as expected that about 1% of the starting 
population is positive for CD34.  
 
Following the Ficoll-Paque method nearly 80% of the cells are removed. These are the erythrocytes 
which are abundant in the fresh cord blood, and the main use of Ficoll-Paque is to remove these 
surplus enucleated cells. The CD34+ population represented about 1 % of the mono-nuclear cell 
(MNC) population after Ficoll-Paque, this agrees with numerous papers that document similar 
percentages (184–187). Flow cytometry was completed after MACS to determine the population 
purities; representative data is shown in ‎Figure 91.   
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 Flow cytometry data from the MACS CD34 purified sample and waste stream. Figure 91.
Staining for CD34, CD45 and CD71 it is possible to compare the selected cells to the unselected cells 
from cord blood. The CD34 selected cells show 70% purity for CD34 in contrast to 0.63% positive in the 
waste stream. Both CD45 and CD71 are similar in both the selected MACS stream and the waste 
stream. Gating is based on 1% of the isotype control shown in blue. 
 
 Example dot plot of CD34 and CD45.  This plot shows that there are 3 distinctive Figure 92.
populations, CD45-CD34-, CD34+CD45+, CD34-CD45+The cd34 positive cells are nearly all CD45 
positive as well.  
The purified CD34+ population is 70% pure, which is the expected purification performance stated 
from literature (188,189). This purity could be increased further by passing the cells through another 
MACS column if required to receive purities closer to 98% (190). The increased purity is a balance 
between how pure the population required is and how much could potentially be lost through 
increasing the number of steps during purification. For this study 70% purity was deemed sufficient 
to analyse colony production. The CD45 positive population shows a double peak; the first peak 
shows the CD45+CD34+ whereas the second much smaller peak is the CD45+CD34- population. This 
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is more noticeable in the dot plot shown in ‎Figure 92. Following purification the CD34+ population 
was frozen into 250,000 cell aliquots. When required cells were thawed and cultured in suspension 
with samples taken and placed into MethoCult (Stem Cell Technologies) for the CFU assay. 
5.3 Equilibrating the Cell-IQ System to a Standard Incubator  
The environment in which cells are cultured is critical for development and can be used to change 
the pathway a cell is directed down. Haematopoietic stem cells are no different and the stem cell 
niche or microenvironment plays a crucial role in the phenotype characteristics. It has been shown 
that factors including O2 tension, O2 gradients, pH gradients, cytokine gradients, perfusion rates, 
flow-induced shear forces and biomechanical forces can all effect the decision of progenitor cell 
fates (191). It is therefore important to maintain a tight control on any assay that is used to 
functionally characterise these cells. 
To ensure the environment within the Cell-IQ is equal to a standard incubator the first experiment 
placed progenitor cells within MethoCult into both environments. After less than 4 days in the Cell-
IQ, the viscous gel is seen to have dried out preventing the formation and growth of colonies, as 
shown in ‎Figure 93. This drying is not seen in a standard incubator and therefore there must be an 
environmental difference between a standard incubator and the Cell-IQ culture conditions.   
 
 Colony forming unit assay before and after drying.  Images showing cells in Figure 93.
methylcellulose in a standard incubator and in comparison to that in the Cell-IQ. The Cell-IQ causes the 
methylcellulose to dry out and appears bright under phase contrast microscopy.  
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The Cell-IQ causes the methylcellulose to dry out; this is seen as a solid gel rather than the liquid gel 
that is seen within a standard incubator. Under phase contrast imaging the drying out causes the 
gel to become more translucent and therefore appear lighter in colour. Also the drying of the gel 
causes crystal formation shown by the speckled appearance seen in ‎Figure 93. There is a 
requirement therefore to measure this difference in environment in order to maintain consistency 
between incubators. 
5.3.1 Comparing Environmental Conditions in the Cell-IQ to that of a Standard Incubator 
Temperature and humidity sensors allow process monitoring overtime, by comparing sensors in a 
standard incubator to that of the Cell-IQ any discrepancy can be seen. This was achieved by 
adapting a 6-well plate to hold the sensor by removing the walls of the centre wells as shown 
in ‎Figure 94.  
 
 Adapted 6-well plate with humidity and temperature sensor MSR 145. By removing Figure 94.
the central walls if wells A2 and B2 on a 6-well plate the sensor can fit in the centre whilst wells A1, B1 
and A3, B3 can still be used for culture.  
By removing the walls from the centre wells on a six well plate a MSR 145 data logger can be placed 
within the culture vessel (‎Figure 94). This set-up retains four useable wells that can contain either 
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water or gel to study the evaporation rates. This set-up was used in both the Cell-IQ and a standard 
incubator to measure the humidity which is shown in ‎Figure 95. 
 
 Graph of humidity and temperature variation in a standard incubator (A) and Cell-Figure 95.
IQ (B). After placing a temperature and humidity sensor into a standard incubator the true value is 
quickly approached. There is then very little deviation from the set point. Within the Cell-IQ the sensor 
quickly reaches the true value, however once reached there appears to be fluctuation within the 
humidity over time. The gas was on for 5 minutes, off for 20 minutes cyclically during the period 
recorded here.  
‎Figure 95 shows that the culture vessel in which the probes were inserted quickly rise from room 
temperature and humidity to ~95% humidity and ~37°C, culture conditions in both the standard 
incubator (A) and the Cell-IQ (B). The data from the Cell-IQ, ‎Figure 95 (B), shows a ‘wavy top’ for the 
humidity, this shows that humidity levels drop but are quickly restored with a negligible effect on 
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the overall humidity condition. However this ‘wavy top’ is an important feature of the Cell-IQ 
conditions. A smaller time period from the humidity graph is shown in ‎Figure 96, which further 
details the fluctuations. 
 
 Re-scaled section of graph from ‎Figure 95 showing Cell-IQ humidity.  Enlargement Figure 96.
of humidity graph for hours 5 to 10 to highlight the ‘wavy top’ effect seen by turning the gas on and off 
on the humidity. This shows that when the gas is turned on for 5 minutes the culture vessel loose about 
1% humidity, this is then regained as the gas is turned off for 20 minutes. The re-humidifying of the 
vessel gas must come from the gel as there is no other water present in the system.  
This ‘wavy top’ can be seen as a decrease in humidity for 5 minutes before rising and plateauing 
over 20 minutes. This coincides with the gas being turned on and off within the Cell-IQ. Unlike a 
conventional incubator the Cell-IQ passes gas directly into the plate, and therefore every 25 
minutes there is a 5 minute period of adding in dry air. This ‘wavy top’ highlights that during the 5 
minutes of gassing the humidity drops as dry air enters. The humidity is then restored during the 20 
minutes whilst there is no gas flow. This re-humidification must arrive from evaporation from within 
the culture vessel. This explains why the gels dry out rapidly in the Cell-IQ when compared to a 
standard incubator. In-between the culture wells water is added to try to prevent the gel drying, but 
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there must also be evaporation from the gel itself to humidify the dry air. The relative effect is 
predictable as the gel surface area is larger than the surrounding water. 
‎Figure 96 shows that the relative humidity within the culture plate fluctuates around 93%. However 
dry gas that is pumped directly into the culture vessel and therefore this humidity must arise from 
the MethoCult gel and surrounding water reservoirs. To confirm this, the humidity within the 
culture vessel with no media or water was measured to assess the inlet gas humidity; this is shown 
in ‎Figure 97. 
 
 Humidity of the gas entering the culture vessel The humidity of the gas straight Figure 97.
from the gas cylinder is about 16%.Therefore as this is pumped directly into the culture vessel the 
humidity will drop causing the drying of the gel as the gas is humidified.  
‎Figure 97 shows that the humidity increases over the 20 minute period when the gas is turned off, 
and then drops as the dry gas enters. This shows that that the inlet gas has a very low humidity, 
with the culture vessel increasing humidity from the environment when the gas is turn off. 
Therefore the humidity values of above 90% highlight that water is continually evaporated from the 
culture medium. It is important to note that this would also have been the case for embryonic 
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culture in Chapter ‎3, however with a medium replenishment every 24 hours, and excess media used 
the evaporation rate was not seen to affect the culture. 
Within the Cell-IQ the temperature is controlled at 37°C. At this temperature using the vapour 
saturation pressure from thermodynamic tables the mass of water to humidifier the dry air can be 
calculated. 
Knowing that the relative humidity is the ratio of actual partial pressure to saturated vapour 
pressure, this can be assumed to be 0.9 or 90%. Then taking the saturated vapour pressure at 37°C 
as 6369 Pa (calculated from Appendix ‎8.1) the number of moles can be calculated from the ideal gas 
law. By multiplying the number of moles by the molar mass the mass of water within a humidified 
volume of air can be calculated. So within 150 mL of air 5.94 mg of water is held at 90% humidity at 
37°C (calculation shown in Appendix ‎8.2). During the culture period of 14 days, this equates to 6.70 
mL of water evaporating (Appendix ‎8.2) using the assumptions stated in Appendix ‎8.2. This 
calculation highlights the importance of being able to minimise evaporation to prevent the gel 
drying and keep the conditions stable for controlled colony growth. To combat these evaporation 
problems there are 3 methods which are possible: 
1) Reducing the gas flow 
2) Addition of liquid to the top of culture gel 
3) Humidify the gas inlet 
5.3.2 Reducing the gas flow rate 
Reducing the gas flow results in less dry air entering the culture plate and therefore there is less 
capacity for the air to strip moisture, so overall there is a reduction in evaporation. A reduction in 
the air flow will have a knock on effect for the culture conditions. The controlled 5% CO2 gas acts as 
a buffer to ensure the culture system remains at the correct pH. By reducing the flow rate the 
culture medium can become acidic and loose its gelation properties. This therefore changes the 
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culture conditions significantly and affects the assay measurement system. Although a reduction in 
gas flow rate will increase the time until the gel dries out it will lead to uncontrollable variation in 
colony growth over the 14 day period, and therefore is undesirable as an approach to reducing 
evaporation. 
5.3.3 Addition of Liquid to the top of the culture gel 
The drying gel occurs primarily at the surface as moisture evaporates into the surrounding gas, 
consequently adding water to the surface of the gel will help prevent the gel drying. The added 
water will then evaporate rather than the liquid from the gel itself. However similar to the previous 
method, over time this addition of liquid will mix with the gel and change the gelation properties. 
Specifically the viscous properties will vary overtime along with the growth factor concentrations 
within the gel. This again would cause uncontrollable variation during the culture period, and 
therefore is not a suitable method to prevent drying.  
5.3.4 Humidifying the Gas Inlet 
As previously noted the culture system within the Cell-IQ directly pumps conditioned air into the 
culture vessel. The gas is a pre-mixed 5% carbon dioxide / air medical dry gas mixture with a relative 
humidity of 0% as stated from the manufacturer. As the gas passes into the culture vessel it is 
humidified by stripping liquid from the gel and surrounding water reservoirs. By pre-humidifying the 
gas inlet the evaporation rate will decline rapidly with increasing humidity. This is most successfully 
achieved by passing the dry gas through warmed water. Within industrial applications this can be 
achieved with membrane technology or atomisers by bubbling through a column of water. In this 
set-up it is possible to place the gas inlet into a water reservoir leaving a 1mm end pipe submerged, 
and using the humidified headspace gas to enter the culture vessel. The then humid air entering the 
culture plate has less capacity for evaporation then dry air (192). Although humidifying the dry air 
prior to going through the culture plate is a technical issue this should provide the best conditions 
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for reducing evaporation. ‎Figure 98 provides a schematic of the proposed humidification set-up that 
can be used within the Cell-IQ. 
 
 Diagram of humidifying loop in the Cell-IQ. By passing the inlet gas through a flask Figure 98.
of water, the gas is humidified before entering the culture vessel. This therefore should help prevent the 
gel drying out.  
This humidifier takes the dry inlet gas and passes it through a reservoir of water held at the same 
temperature as the culture vessel. It is important to maintain this temperature equilibrium to 
prohibit condensation or further evaporation. The inlet then bubbles up through a column of water 
held in a t-25 flask, striping moisture and remains in the headspace of the t-25. As further gas is 
pumped in, humidified gas in the head space then travels into the culture vessel. The gas outlet on 
the culture vessel has a filter on the end to prevent any non-sterile air from the surrounding 
environment entering, and allows excess gas to pass out preventing pressure build-up within the 
culture vessel. This set-up was then tested by placing the empty 6-well plate with a humidity sensor 
Chapter 5 
191 | P a g e  
 
in to measure the relative humidity that is created by passing the dry air through the humidifying 
set-up; this is shown in ‎Figure 99.  
 
 Humidity of the Cell-IQ culture plate using the humidifier.  Using the set-up in ‎0 the Figure 99.
dry gas is passed through a flask of water before entering the empty culture vessel at a rate of 30 
mL/min on for 5 minutes, off for 20 minutes. This has increased the humidity from 16 to 26 %, but 
compared to 90% humidity from a standard incubator this is still low.   
These results show that the 5 minutes of passing the gas into the plate increases the humidity, but 
then by turning the gas off the humidity drops until the gas is turned back on. This is likely due to 
the outlet controlled by a filter; this therefore permits constant losses, returning the relative 
humidity to equilibrium with the room humidity. This demonstrates that in order for the culture 
plate to remain humid a constant gassing is required. So by using a constant gas flow rate of 30 
mL/min the humidity can be further increased as in ‎Figure 100. The data is fitted using a Pearl-Reed 
logistic fit, which provides an estimation of the asymptote as required. 
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 Constant gassing at 30 mL/min with humidifier. Previous data has shown that using Figure 100.
a cyclic on/off control of gas prevents a high humidity being reached. Here using a constant flow, a 
humidity of 50% is being reached, an improvement on 26% previously seen with cyclic gas flow.  
By supplying a constant gas flow rate though the humidifier the relative humidity asymptotically 
reaches 50%. This is about twice that seen by turning the gas on and off as seen in ‎Figure 99. 
However compared to a standard incubator which operates at 95% humidity further optimisation of 
the system is required. 
As the system is not reaching 100% humidity, the inlet gas therefore is not stripping enough 
moisture before it enters the culture plate. There are three possible factors that affect the rate of 
moisture gain to dry assuming a constant temperature; gas flow rate, size of gas bubble and 
residence time relating to both contact time of gas with liquid, and headspace within the humidifier. 
The first factor to investigate was flow rate. By reducing the flow rate there is a knock on effect by 
increasing the residence time for the humidified gas in the head space of the humidifier. It is 
therefore hypothesized that by reducing the flow rate the residence time increases, increasing the 
relative humidity of the gas. ‎Figure 101 shows the effect on humidity of reducing the gas flow rate 
to 6 mL/min. 
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 Constant gassing at 6 mL/min with humidifier. In order to try and improve Figure 101.
humidification of the dry air a slower gas flow rate is used to give the gas more time within the 
humidifying chamber to pick-up water. Using 30 mL/min 50% humidity was seen, but by lowering the 
flow rate a decrease in humidity is seen, only 20% humidity.  
‎Figure 101 shows that the culture plate approaches room humidity (~20%), and therefore by 
reducing the gas to 6 mL/min actually has a negative impact on increasing the humidity. It is 
hypothesised that this is either due to the losses experienced earlier, or 6 mL/min is outside of the 
measuring accuracy of the flow meter, with the potential of no air entering the culture vessel. Either 
way using a flow rate this low is not sufficient to humidify the system, therefore a variation of flow 
rates were tested and are shown in ‎Figure 102. 
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 Effect of flow rate on humidity in the Cell-IQ culture plate. Comparison of 5 Figure 102.
different flow rates of dry gas into the humidifier with the respective humidity profiles measured in the 
empty culture chamber. The highest humidity is produced with the highest flow rate of 50 mL/min.  
‎Figure 102 shows that as the flow rate is increased the humidity increases, the opposite to what was 
hypothesised. This therefore demonstrates that the residence time in the headspace is not the 
limiting factor for reaching a high relative humidity. Therefore the moisture must be acquired as the 
bubbles of gas pass up through the liquid rather than in the headspace of the t-25 flask. The higher 
flow rate is likely to cause a more turbulent flow regime, creating smaller gas bubbles.  
The increase in humidity related to an increase in flow rate has been attributed to an increase in 
turbulence. The Reynolds number (Re) provides a measure of flow regime characterisation. By 
comparing inertial forces to viscous forces the Reynolds number provides a dimensionless 
measurement of flow turbulence. The Reynolds number (Re) is defined as: 
    
   
 
 
Where taking the following values, the Reynolds number can be calculated for the various flow 
rates: 
 ρ, density of air at 37°C = 1.1384 kg/m3 (Appendix ‎8.1) 
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 v, velocity of fluid = 30 mL/min = 0.1592 m/s (Appendix ‎8.1) 
 D, diameter of pipe = 1 mm = 1x10-3 m 
 µ, dynamic viscosity of air at 37°C = 1.9795x10-5 kg/ms (Appendix ‎8.1) 
    
   
 
 
                    
           
      
By doubling the gas flow rate from 30 mL/min to 60mL/min (0.1592 m/s to 0.3185 m/s): 
    
   
 
 
                   
           
       
This shows that although both provide very low Reynolds number, suggesting laminar flow, there is 
a considerable difference as the flow rate is doubled from 30 mL/min to 60 mL/min. This increase in 
flow rate provides an increase in the turbulence instigating improved humidification. Although 
humidification does not happen in the tube itself, this increase in Reynolds number due to increases 
flow rate will have a similar effect as the gas passes from the end of the tube.  
Given the relationship seen in ‎Figure 102 the flow rate could further be increased, however it is 
important to note that the higher the flow rate the greater volume of gas passes over the gel 
surface. If this gas is not at 100% humidity then there will still be a loss of liquid from the surface. 
The greater volume of gas the more liquid will evaporate. Therefore it is more advantageous to 
increase the humidity of the inlet gas rather than increase the flow rate. 
This increase in turbulence is attributed with the bubble size and therefore leads directly into 
identifying the bubble size effect on humidity. In order to obtain a high rate of humidification the 
area contact between the gas and water needs to be as large as possible (193). Rather than just 
increasing the flow rate to increase turbulence, a more controlled method of decreasing bubble size 
is to pass the gas through a sparger or atomizer. These are designed to break up the gas and create 
smaller bubbles of air. So far a 1mm pipe end has been submerged. This pipe can be fitted with a 
bioreactor sparger used for fermentation reactors as shown in ‎Figure 103. 
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 20 µm fermentation sparger. Adapted from a fermentation bioreactor sparger, this Figure 103.
Sartorius sintered metal sparger can be sterilised and used to increase the surface area of gas bubbles in 
contact with liquid, therefore improving humidification. 
The sparger is sintered metal creating pore sizes of 20 µm. This therefore creates uniform small gas 
bubbles to increase the contact area of gas to liquid. Shown in ‎Figure 105 is the effect of using 
bubbles that come directly from the end of a 1mm diameter pipe end or by passing the same flow 
rate of gas through a sparger device with a pore size of 20 µm, termed humidifier versions 1 and 2 
respectively. 
 
  Images of gas bubbles from a submerged 1mm open bore pipe.  The bubbles that Figure 104.
come from an open bore 1mm diameter pipe shown in A) are much larger than those that come from 
the sparger in B). This decrease in bubble size increases the surface area for air to water contact, which 
improves humidification.  
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Using the same flow rate it is possible to see from ‎Figure 104 that by using the sparger much smaller 
bubbles are formed compared to the 1 mm open bore pipe.  This increase in surface area and 
therefore contact area of air to water means that there is a greater ability to strip moisture as the 
bubbles rise. This in turn relates to a higher humidity by using the sparger device. A comparison of 
the two humidifier types is shown in ‎Figure 105. 
 
 Comparing of achieved humidity using a single bore pipe (A) and a sparger (B). (A) Figure 105.
Measuring the humidity in the culture vessel using a 1mm bored pipe to pass dry gas through in the 
humidifying chamber produces a humidity of 50%, as shown previously. By replacing the 1mm bore 
pipe with a sparger (B) with many 20 µm pores the humidity can be increased to 90%, that found in a 
standard incubator.  
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As can be seen from ‎Figure 105 graph (B) by using the sparger a far higher humidity is reached than 
graph (A) with the 1mm pipe end. This has allowed a direct comparison between humidifier version 
1, an open pipe and version 2, the sparger. By decreasing the bubble size the humidity value can be 
nearly doubled. This also shows that the residence time or head space has less effect on 
humidifying rates compared to bubble size.  
The final effect to assess is the liquid depth. By increasing the depth of liquid that the gas passes 
through, the time that the bubbles can interact and strip moisture is also increased. This therefore 
may increase the humidity within the culture vessel. The effect of increasing the liquid depth is 
shown in ‎Figure 106 along with humidifier version 1 and 2 for comparison. 
 
 Effect of sparger and height of water column on humidity rates. All conditions used Figure 106.
30 mL/min gas flow rate. By varying the water volume in the humidifier the head space is reduced, 
therefore it is possible to determine if the gas is humidified by bubbling through water, or in the head 
space. Comparing the dotted line with the filled in lines it is possible to conclude that there is little 
difference in humidity with a half or full filled chamber of water.   
By atomising the gas, the relative humidity can be doubled from ~45% to ~90%, a result seen 
previously in ‎Figure 105, and noted again here in ‎Figure 106 by comparing the dotted line to the 
solid lines. The increase in liquid depth also increases the humidity; however this effect is less 
proficient, comparing the two solid lines. This again shows that bubble size has a more significant 
effect then residence time in this system on humidifying the inlet gas. 
Chapter 5 
199 | P a g e  
 
By using a sparger and a full tank of water it is possible to humidify the dry inlet gas to ~90% 
humidity.  This has all been achieved using a constant flow rate of 30 mL/min. However it was noted 
previously in ‎Figure 102  that the flow rate has a big impact on the humidifying rate. Therefore the 
flow rate can be varied to determine which flow rate is best suited for reaching high humidity levels 
with humidifier version 2; this is shown in ‎Figure 107. 
 
 Flow rate effects when using sparger. Using a full tank of liquid and the sparger the Figure 107.
flow rate is varied showing that a higher humidity can be reached with a lower flow rate when using 
humidifier version 2.  
Previously it was seen in ‎Figure 102 that by increasing the flow rate the humidity was increased, this 
was hypothesized that the higher flow rate was more turbulent with smaller bubble sizes and 
stripped more moisture.  However, now the gas is passed through a sparger constant bubble size 
independent of flow rate is achieved. ‎Figure 107 shows that a reduced flow rate is required for a 
higher humidity. This therefore shows that with equal bubble size from the sparger, the residence 
time is having a more prominent effect then previously seen. The lower the flow rate the greater the 
residence time, however the manufacturer suggest a flow rate of at least 20 mL/min to overcome 
losses in the culture vessel, and also to run within the specification of the flow rate controller. 
Therefore 20 mL/min is used to provide the improved conditions to the default 30 mL/min. 
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This work has successfully shown that it is possible to increase the humidity of the inlet gas by 
passing a continuous flow rate of dry gas through a 20 µm sparger at a liquid depth of 4 cm. So far 
all the experiments have been conducted under static conditions, that is to say the imaging 
platform within the Cell-IQ has not been moving. In order to conduct the CFU-assay this platform 
needs to be able to move freely. Within the environmental chamber there is a limited height which 
prevents the t-25 humidifier from standing upright during imaging. This requires the humidifier to 
be redesigned in order to fit within the system and humidify the inlet gas during experimental runs. 
5.3.4.1 Humidifier Development 
The Cell-IQ incubated area has a maximum height of 3cm. This limits the height of a humidifying 
system that can be accommodated into the incubation area. Previously the humidifier utilised a t-25 
flask with sparger filled with water standing upright as depicted in ‎Figure 108, named humidifier 
version 2.  
 
 Humidifier Version 2. Computer Aided Design (CAD) diagram of humidifying Figure 108.
chamber showing t-25 flask upturned with sparger inside.  
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This successfully humidified the inlet air, however the height restriction within the Cell-IQ during 
imaging requires the flask to lie flat, this was tested and the relative humidity reached a maximum 
of only 40%, as shown in ‎Figure 109.  
 
 Humidity using the humidifier with sparger lying down at an angle. Due to the Figure 109.
height restriction with the Cell-IQ the humidifier must be laid down during continual imaging. This 
reduced the depth of water with which the dry air bubbles pass though. The effect of this is a reduced 
humidity in the culture vessel of less than 41%.  
This reduction in humidity shows that both the water depth and sparger set-up are required to 
maintain a high relative humidity in the culture vessel. Another option would be to place the 
humidifying system externally to the culture chamber, but this would require a separate incubation 
device to ensure the humidifier was at the same temperature as the Cell-IQ system. Without this 
temperature equilibrium the saturation pressure changes which can lead to condensation as the 
humid gas enters the culture plate or increased evaporation rate from the culture vessel if it is 
cooler. 
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A new humidifier design was required which mimicked the properties of humidifier version 2 in its 
upright position, this data provided the necessary information in order to build a suitable 
replacement that fits within the space limitations. The key points are detailed below in ‎Table 17. 
Table 17. Humidifier’s necessary properties A list of key properties to include in new humidifier 
design in order to achieve humidity in the Cell-IQ representative of that found in a standard incubator.  
 
Given these required properties, humidifier version 3 was developed to fulfil all the requirements.  
Humidifier version 3 is shown in ‎Figure 110. 
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 Humidifier Version 3. The new design of humidifier that fulfils the attributes Figure 110.
in ‎Table 17 drawn in CAD showing a long tube shape with sparger present inside. Once filled with water 
there is a small headspace near the outlet to take humidified air into the culture vessel.  
Humidifier version 3 utilises a cylinder to increase the distance the bubbles travel through liquid to 
ensure a high humidity is reached. This shape also allows the cylinder to be laid at a slight angle to 
ensure it fits within the height restricted Cell-IQ culture system. This reduces the water depth 
slightly from humidifier version 2, but maintains a liquid volume of greater than 40 mL to 
accommodate for evaporation and slight temperature variations. After ensuring that the platform 
could freely move with humidifier version 3 installed, the humidity within a culture vessel was 
measured. This is shown in ‎Figure 111. 
 
Chapter 5 
204 | P a g e  
 
 
 Humidity of culture vessel using humidifier version 3. Using the new design of Figure 111.
humidifier (Humidifier version 2) continual imaging can take place and the humidity in the culture 
vessel is above 75%.  
Using a Pearl-Reed logistic fit an asymptote can be predicted. This is not possible using a quadratic 
model, and the significant information to gain from ‎Figure 111 is the asymptotic value. As predicted 
by reducing the water depth the asymptote predicted humidity has slight dropped to 80%. This is 
slightly less than a standard incubator but much improved on the dry gas inlet. The next series of 
experiments were to test the evaporation rate from the culture vessel using humidifier version 3 in 
comparison to the previous set-up without a humidifier. 
5.3.5 Assessing the evaporation rates using water droplets within the Cell-IQ  
Previous work has shown that during the CFU assay the gels rapidly dry out due to the Cell-IQ’s 
mechanism of dry air gassing. By adding a humidifying step prior to feeding the gas into the culture 
vessel holding the CFU assay this evaporation can be reduced. In order to determine the rate of 
evaporation droplets are placed within the culture vessel and continually imaged to show the 
decrease in size and therefore evaporation of water over time. Using the Threshold method 
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explained earlier in Section ‎3.3.2 the droplet size can be continually monitored to show the 
evaporation over time. An example is shown in ‎Figure 112. 
 
 Example of droplet size reduction analysis. By measuring the central diameter of Figure 112.
the droplet, the reduction in droplet size can be measured over time as seen by A)-F) taking at 1 hour 
intervals using a flow rate of 20 mL/min with 5 minutes on 20 minutes off. 
‎Figure 113 shows the rate of droplet size decrease using gas flow rate of 20 mL/min of dry gas 
cycling through 5 minutes on and 20 minutes off. This was the set-up used initially according to the 
manufacturer’s recommendation.  
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 Water droplet evaporation from image analysis without humidifier.  Using 30 Figure 113.
mL/min gas cycling on for 5 minutes off for 20 minutes with no humidifier 20 µL water droplet 
diameters decreases over time. The decrease in droplet size corresponds to evaporation, it can be seen 
that complete evaporation occurs by 7 hours, but the different wells have various evaporation rates. 
The 20 µL droplets rapidly evaporate when there is no humidification of the gas inlet, starting with 
those closest to the gas inlet (Wells A3 and B3), with all droplets evaporated prior to 7 hours 
elapsed. This data equates to 2.88 mL of moisture evaporating from the culture plate during the 14 
day assay period (14 days = 168 hours, with 120µL evaporating every 7 hours). Although slightly less 
than the ideal gas law calculations in Section ‎5.3.1, this is still a significant volume to evaporate 
during the assay. Previously it was shown that through the addition of a humidifier the inlet gas can 
be humidified to 80% using humidifier version 3 along with a constant gassing regime. This would 
therefore reduce the evaporation rate, showing an increase in the time it takes to fully evaporate 
the droplets, a result shown in ‎Figure 114. 
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 Water droplet evaporation from image analysis with humidifier version 3.  Using a Figure 114.
constant gas regime at 20 mL/min with humidifier version 3 the 20 µL water droplet diameters in each 
well decrease over time. This increases the time for complete evaporation from using no humidifier at 7 
hours to 15 hours. 
The evaporation rate is reduced by pre-humidifying the gas to 80%. By increasing the time for 
complete evaporation from 7 hours to 15 hours, the evaporation volume is more than halved to 1.26 
mL during the 14 day assay period. 
This work has also demonstrated that the wells closes to the gas inlet evaporate quicker than those 
near the outlet. As the gas flows over the wells near the inlet moisture will be taken up, so that by 
the time the gas reaches the wells near the exit the gas will already have been humidified. 
Therefore by filling these wells with water the evaporation from the MethoCult filled wells is 
hypothesised to significantly reduce, this is shown in ‎Figure 115. 
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 Water droplet evaporation with humidifier version 3 with water in wells A3 and B3. Figure 115.
Using 20 mL/min gas constantly on with humidifier version 3 and 20 µL water droplet diameters 
decreases over time (as measured from image analysis)and there is little increase in time until complete 
evaporation compared to no humidifier in ‎Figure 113.  
As was seen previously the liquid in the wells closest to the gas inlet evaporate first, by filling these 
wells with water the evaporation rate in the other wells is reduced. This is shown in ‎Figure 115, as 
hypothesised the liquid evaporates in these inlet wells reducing the evaporation rate in the 
remaining wells. This increases the time for complete evaporation from the wells to 50 hours, 
compared to the 15 seen previously in ‎Figure 114. This provides promising data that the 
environment in the Cell-IQ is equal to that of a standard incubator, and evaporation will not have a 
significant effect on the assay development.   
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5.3.6 Computation Fluid Dynamics 
In order to confirm the results seen it is also possible to use computation fluid dynamics (CFD) to 
predict the gas flow seen within the plate. This involves building a model of the culture vessel, then 
using the given flow rates a simulation can be run to model the fluid movement. In order to model 
the culture vessel a number of assumptions were made to simplify the model. These includes 
neglecting any loses from the vessel other than the outlet, and modelling the fluid as a uniform 
flow. The previous data highlighting the well order of drying out, suggests that the angle of the inlet 
provides a slightly skewed flow rate. With these key assumptions the following model can be built 
as shown in ‎Figure 116 using a flow velocity of 0.3 m/s as calculated in Section ‎5.3. 
 
 CFD model showing velocity streamlines within the culture vessel. The CFD shows Figure 116.
high flow rate at the inlet and outlet where the pipes narrow, shown by red/green streamlines. As the 
flow enters the culture vessel the velocity drops as the pressure drops due to the expansion from the 
pipe diameter, shown as blue streamlines.  
By assessing the streamlines it is possible to conclude that there is a sudden pressure drop shown by 
a decrease in velocity past the inlet. As seen from the evaporation of droplets the air enters the 
wells nearest the inlet first prior to moving onto the next line of wells. As expected the majority of 
the flow goes straight down the centre, the shortest route to the outlet where the pressure is much 
lower. Another way to depict this information is using the velocity vectors; this is shown in ‎Figure 
117 
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 CFD model showing velocity vectors within the culture vessel. The CFD shows high Figure 117.
flow rate at down the shortest path to the exit. As the flow enters the culture vessel the velocity drops 
as the pressure drops due to the expansion from the pipe diameter, shown as light blue vectors.  
‎Figure 117 has a different scale to ‎Figure 116 to focus on the flow change within the culture vessel. 
Therefore no vectors are shown on the inlet and outlet pipes. Again this diagram highlights the low 
velocity within each well with increased velocity as the air moves between wells. Similarly as before 
the air first enters the two wells nearest the inlet before moving down the plate towards the outlet, 
with the highest velocity noted through the centre and near the inlet and outlet pipes. This data 
shows how CFD modelling can be used to describe the flow regime within culture vessels. Although 
a simplified model is utilised here, further work could build on this and accurately model the flow 
patterns within the vessel. By placing water in the wells closest to the inlet the incoming air can be 
further humidified before passing over the wells containing MethoCult. 
5.3.7 Comparison of Cell-IQ to Standard Incubator on the CFU Assay 
Following the successful development of a humidifier to increase the water content of the inlet gas, 
the next stage was to compare the 14 day assay in a standard incubator to that in the Cell-IQ. By 
placing CFU assay samples from the same starting population it is possible to measure as an end 
point the number (‎Figure 118) and phenotype of the colonies (Appendix ‎8.3).  
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  Total colony counts from standard incubator and Cell-IQ. The colony counts Figure 118.
performed on day 14 of 5 samples held both in a standard incubator and in the Cell-IQ. Each sample 
represents  a MethoCult filled well, with different volumes of cell population. n=5  
Taking 5 samples from the cell population and placing those in MethoCult the CFU assay can be 
completed in both a standard incubator, shown in grey, and the Cell-IQ, shown in orange. The 5 
samples in each place were completed with various volumes of the starting population to ensure 
neither system had growth saturation, or influenced the total number of colonies. From user 
verification, as is the standard, the colonies could be counted and categorised (data not shown). 
Both incubator systems show very similar data suggesting that the environmental factors, 
highlighted earlier, are now at equilibrium. The total colony number shown in ‎Figure 118 were a 
mixture of CFU-GM, CFU-GEMM and BFU-E identified colonies, the ratios of each were also 
maintained in both systems (data not shown). This final experiment has shown that using humidifier 
version 3 within the Cell-IQ provides comparable end point results to a standard incubator and 
therefore suggests that using the Cell-IQ to continually monitor colony development whilst not 
affecting their growth characteristics.  
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5.3.8 Conclusions 
Initially the environments within the Cell-IQ and a standard incubator were different, largely due to 
the Cell-IQ passing dry air over the substrate to maintain pH and oxygen levels. As described by the 
manufacturer this would cause large variation within the CFU assay. It therefore was important to 
match the conditions found within a standard incubator to that in the culture vessel of the Cell-IQ. 
This was accomplished by pre-humidifying the gas inlet, to prevent the methylcellulose gel from 
rapidly drying. Through testing it has been possible to develop a humidifier which fits within the 
Cell-IQ imaging area and is therefore held at the same temperature as the culture vessel. In addition 
the use of a 20 µm sparger further increased the humidity, along with tailoring the gas flow rate in 
terms of flow rate and cyclic behaviour. All this development has allowed for the conditions in the 
Cell-IQ to match those found in a standard incubator, this allows for the CFU assay to be continually 
monitored without introducing unknown variation to the culture procedure. This has been shown by 
end point analysis of cultures in the Cell-IQ and in a standard incubator to be of similar colony 
phenotype and numeration. The next stage is to identify individual cells that make up a colony and 
any metrics which can be non-invasively measured to make informed decisions on colony 
phenotype. 
5.4 Colony Identification 
After plating purified CD34+ cells in methylcellulose gel into culture vessels the development of 
colonies is followed through continual imaging. This creates a continuum of images following 
colony formation over time. From these images it is possible, through the use of machine vision 
from the Cell-IQ analyser package, to successfully identify single cells from within a colony. This is 
completed by ‘teaching’ the Cell-IQ the image of a single cell, which is depicted as a group of pixels. 
This pattern of pixels can then be searched for throughout the image to identify further cells. A 
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technique similar to that employed previously in identifying coverage areas of various morphologies 
in Section ‎3.4.2.2.  
 
  Count/Classify protocol for identifying individual cells. By selecting individual cells Figure 119.
shown by the yellow boxed circle, the picked samples shown in the bottom right are added to the 
population library shown in the top right.  
‎Figure 119 shows the protocol for selecting exemplar images of individual cells using the yellow 
circle and box. Having built a library of exemplar images showing the background/debris and cells 
this protocol is then used to identify single cells in a colony as shown in ‎Figure 120. Once again 
library sizes of 200 images as used for the accuracy describe in Section ‎3.4.2.3. Identified cells are 
marked by a red dot, with cells that are slightly out of focus marked by a green dot. 
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 Raw and analysed images of a BFU-E and CFU-GM colony from the Cell-IQ at one Figure 120.
time point during development. A GM colony is shown in A) with the respective analysed image shown 
in C). A BFU-E is shown in B) with its analysed image in D). The red dots show where the analysis 
identifies a cell, whereas the green dots represent out of focus cells.   
‎Figure 120 has shown that it is possible to identify single cells during colony formation with images 
of both GM and BFU-E colonies used as examples. This successful identification then allows 
quantitative metrics to be determined during colony growth within the Cell-IQ system. From 
assessing captured images of colony development it is possible to identify possible metrics which 
may be characteristic of the originating cell. These are listed in ‎Table 18.  
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Table 18. HSC Identification Metrics. A list of potential metrics that could be used to classify colonies rather 
than the current user defined morphology identification.   
 
Each of these metrics can then be tested using a sample of colonies imaged over 200 hours, to test 
if they are predictive of colony phenotype. Purified CD34+ cells are added to MethoCult and left in a 
standard incubator for 72 hours as described in Section ‎2.13. This allows gelation to occur and the 
cells to begin proliferation. Following this 72 hour lag period the culture vessels are placed into the 
Cell-IQ to begin imaging. Colonies are then imaged continually for 200 hours before the captured 
images are analysed. After analysis the data is colour coded based on colony phenotype which is 
assessed through user verification on day 14 of the assay, as is standard practice. All times are based  
from when the cells are first placed into the Cell-IQ as t=0, as opposed to when they begin culture 
which is 72 hours previous.  
Following analysis of these metrics it is possible to analyse the population distribution to evaluate 
the most useful metric, or combination to achieve colony phenotype categorisation. 
5.4.1 Colony Growth 
After analysing all the images captured following colony development the number of cells present 
in each image can be plotted against time. 65 colonies from 5 separate experiments, each which 
have been imaged for 200 hours, are shown in ‎Figure 121. 
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 Haematopoietic progenitor Colony growth based on cell number. Number of cells within a colony over time as determined by Cell-IQ Analyser Figure 121.
program using machine vision technology. The red lines represent BFU-E, the blue GM and the green GEMM, all determined by post processing user defined assessment. 
Also highlighted are 4 colonies that have a different growth pattern to that expected. Post processing assessment drew conclusions noted in the coloured boxes that 
identified reasons for these colonies having properties that were outlying form the others. (Smoothed over 5 hour data sets, n=65)  
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In ‎Figure 121 the red lines depict burst forming unit -  erythroid (BFU-E) colonies, the blue lines are 
colony forming unit - granulocyte, macrophages (CFU-GM) colonies and the green are colony 
forming unit - granulocyte, erythrocyte, macrophages and megakaryocyte (CFU-GEMM) colonies, 
all which have been user-categorised at the end point of the assay. This user identification is 
currently the standard for CFU assay evaluation by reference to categorised colonies from CFU 
assay manufacturers. These are the three colony phenotypes that are most commonly categorised 
due to their value in determining the biological properties of the seeding population (183). The data 
shows that the number of identified cells increases faster and reaches a higher value for BFU-E 
colonies suggesting an increased proliferation over CFU-GM and CFU-GEMM colonies. It is 
important to note that the cells forming a CFU-GM colony are more motile then the tight ball of 
cells constructing a BFU-E colony, and therefore as the CFU-GM colony expands often cells will 
move out of both focus and the imaged area. This is especially noted as the cell count of CFU-GM 
colonies plateau out after 100 hours, which from evaluating the raw images is when the cells begin 
to occupy the entire image window; further proliferation occurs but due to the increased motility 
cells migrate out of the image window. This causes the cells to remain a set distance apart, 
therefore preventing a measured increase in cell number within the imaged area, (distance is 
another metric analysed later). This data suggests there is a continuous spectrum of colony growth 
rates, although growth rates are broadly grouped by colony type, there remains a variability of 
growth rates observed within a given colony type. It is inferred that this distribution of  growth rates 
relates to the maturity level of the seeded cell; with the fastest growing representing the least 
mature, and the slowest the most mature (194) . Some research groups also classify colony forming 
unit – erythroid (CFU-E) as another phenotype arising from a more mature BFU-E, with a similar 
morphology but typically less than 100 cells (195,196). This data suggests that the clarity between 
BFU-E and CFU-E becomes blurred, signifying there is a continuum through the classifications. 
Current methods for analysing hematopoietic progenitor cells categorise colonies into 3 or 4 
species. This analysis allows these categories to be subdivided based on growth rates, and provides 
Chapter 5 
218 | P a g e  
 
evidence of growth kinetics which could be related to population maturity. Further work could aim 
to measure this maturity based on gene expression from single colony picking. 
The BFU-E population also tends to decline as the assay progresses past 100 hours. In a standard 
growth curve this would represent cell death. In this image analysis this is due to the change in 
morphology of the colonies. As BFU-E colonies develop and mature there is a red colouring that 
develops which is seen as a dark area on a monochrome phase contrast image. Once this has 
occurred the image analysis loses the ability to identify single cells, and therefore a drop in cell 
number is recorded. An example of this is shown in ‎Figure 122. 
 
 Example of miss-identification as BFU-E colony develops. At an early stage of Figure 122.
development A), all cells within a colony are identified with a red dot. As the colony grows and 
develops, the core becomes opaque and individual cells are not identified B). On a growth curve based 
on image identified cell numbers this can be perceived as cell death.  
The decline of BFU-E cell numbers in the growth curves in ‎Figure 121 is due to the opaque colony 
cores not being identified as shown in Figure 33. It is important therefore not to see this as cell 
death but as a morphological change within the colony. 
Assessment of the growth curve from image analysis cannot provide sufficient separation of colony 
type. However it provides an assessment tool which can highlight any images which have unusual 
growth patterns. There are colonies present in this data set which have dissimilar cell number 
profiles to colonies of the same phenotype, such colonies are highlighted as the orange, purple and 
black growth curves. The orange profiles rise much faster than the other BFU-Es. From assessing 
the captured images it is possible to identify that these images contain more than one BFU-E and 
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therefore the cell count and proliferation is doubled. It is inferred that the multiple colonies 
identified may have come from a single colony that has been split due to plate movement prior to 
imaging. The purple line shows a CFU-GM colony which past 100 hours continues to increase in cell 
number within the image. This occurs due to a BFU-E entering the edge of the image at 100 hours, 
causing the identification of its own proliferation alongside that of the more spread CFU-GM 
colony. The final anomaly identified from ‎Figure 121 is the black line. This represents a BFU-E which 
has a sudden increase in cell number past 170 hours. This colony was out of focus for the majority of 
the imaging and only came into focus post 170 hours, where cells were then correctly identified. The 
capability of this process to identify these erroneous colonies from the population highlights the 
benefit and utility that these growth curves provide on a first stage of improved colony phenotype 
identification. 
As the cells differentiate down the lineage map shown in ‎Figure 88 the cells loose proliferation 
potential, shown by a reduction in growth rates, noted previously by Ogawa (194). This confirms 
that the growth rate or cell number is representative of cell maturity. This data confirms previous 
work (171,178) that there is a heterogeneous population within the CD34+ compartment of cells. 
However using growth rate alone the CFU-E and CFU-GM colonies cannot be distinguished 
successfully, due to an overlapping of growth rates. Therefore a further metric is required to 
improve the resolution of differentiating between colony phenotypes. 
5.4.2 Distance between Cells within a Colony 
Another proposed metric was the ability to measure the distance between neighbouring cells within 
a colony, it is hypothesised that CFU-GM colonies will have a far greater distance between cells then 
BFU-E due to their difference in morphologies. This was previously seen with the cell counts 
plateauing as the cells migrate from CFU-GM colonies out of the field of view. 
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The most common method for measuring distances between objects is through triangulation. In 
1934, Delaunay proved that when a dual graph is drawn with straight lines it produces a planar 
triangulation, Delaunay triangulation, which creates a triangle with points such that no point lies 
within the circumcircle of a triangle (197). Delaunay triangulation is widely used in scientific 
computing in many diverse applications (198). The fundamental property that favours Delaunay 
Triangulation over other triangulation algorithms is firstly the empty circumcircle criterion, stating 
that each triangle contains no other points within its interior. The second property is that triangles 
are created using the nearest neighbour point and triangles with large internal angles are selected 
over ones with small internal angles (198). For its application here the nearest neighbour 
triangulation property is the most important to measure the distance between points or in this case 
cells. The Delaunay triangulation of a CFU-GM colony is shown below in ‎Figure 123. 
 
 Delaunay Triangulation of a GM Colony. By mapping each cell with an x and y Figure 123.
position it is possible to calculate the nearest neighbours using triangulation, shown as yellow lines 
linking cells together   
This triangulation creates a relationship between cells allowing the nearest neighbours to be 
highlighted. However due to the triangulation there are 2 or more distances to the neighbours, it is 
therefore advantageous to get a single output for each cell. This is where the Voronoi Diagram is 
beneficial. Delaunay triangulation and Voronoi diagrams are dual structures of each other, that is to 
say they contain the same ‘information’ but it is represented in a different form. In ‎Figure 124 the 
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Delaunay triangulation from ‎Figure 123 with the ‘equivalent’ Voronoi Diagram superimposed is 
shown. 
 
 Voronoi diagram  superimposed on Delaunay triangulation  of a GM colony By Figure 124.
taking the Delaunay triangulation from ‎Figure 123 it is possible to divide the planes (yellow lines) into a 
set of areas based on the nearest neighbour measurements. This is achieved by creating an area around 
each cell in which no other cell lies. Delaunay triangulation and Voronoi diagrams contain the same 
information just represented in a different format. The Voronoi diagram creates a single area 
measurement for each cell, which is more useful for process control.  
The Voronoi diagram divides the plane into a set of regions or areas based on the nearest neighbour 
notation. In this example each cell is therefore specified an area, the closer the cells are together 
then the smaller this area is. This allows each cell to have a single output or quantitative value 
assigned. This then means a population average can be deduced from the entire image. In order to 
create a Delaunay triangulation and in turn a Voronoi diagram a number of steps must succeed to 
transform the original image captured by the Cell-IQ into a binary dot image. 
Firstly the cells are identified from the raw image (‎Figure 125 A) using the algorithm in the previous 
section ‎5.4.1. This places a dot on every cell, such as in ‎Figure 125 B. Due to the captured images 
taken on a monochrome camera, and the identified cells marked with red or green dots, a colour 
based threshold can be used such that only the identified cells with red and green dots on are 
visible, ‎Figure 125 C. This image can then be made binary, ‎Figure 125 D. Following this the Delaunay 
Chapter 5 
222 | P a g e  
 
triangulation algorithm can be applied, creating a triangle with the nearest neighbours for every 
cell, as shown in ‎Figure 125 E. The final part is to create a Voronoi Diagram from the triangulation as 
shown in ‎Figure 125 F. 
 
 Creating a Voronoi Diagram of a CFU-GM Colony. By first taking the raw image (A), Figure 125.
using Cell-IQ Analyser software each cell can be identified and marked with either a red dot(in focus) or 
green dot (out of focus) (B). For this analysis both red and green dots are included. The image is then 
threshold to only include red and green, therefore removing the background data (C). Following this the 
image is made binary so that each cell is now represented by a white dot on a black background (D). 
Using ImageJ the ‘Analyse Particles’ algorithm using threshold to measure all white objects, here the 
cells. Once this is completed each cell has an x and y position. Next the ‘Delaunay Voronoi’ algorithm is 
used to create images (E) and (F) where a triangulation around the white dots is created and then an 
area for each cell with which no other cell lies can be drawn.  
Completing this Voronoi analysis on colony development over time allows the mean distance 
between all the cells within a colony to be calculated at each time point of image capture. 
Completing this for a number of images shows how the distance between cells within a colony 
changes during colony growth. The macro written in ImageJ software is shown in Appendix ‎8.3. The 
same data as used in Section ‎5.4.1 is utilised here, with the same colour coding for anomalies. 
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 Mean distance between cells within a colony By using the Delaunay triangulation the mean distance between each cell can be calculated. By Figure 126.
completing this on every image of a colony a variation in distance between cells over time can be drawn. From this figure it is possible to see that BFU-E colonies, shown in 
red, over time get much closer together, forming the ball structure. GM colonies in blue however seem to keep separated. GEMM colonies, shown in green, initially behave 
as a BFU-E before suddenly bursting at around 100 hours. (Smoothed over 5 hour data sets, n=65)  
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The anomalies once again are highlighted here by using orange, purple and black. The orange line 
signifies the very high growth rate which related to two BFU-E colonies in the same image. For the 
distance between cells this has little effect, so does not appear as an anomaly. The purple line 
depicts a CFU-GM colony which is invaded with a BFU-E after about 80 hours, this is shown by the 
fluctuating line after this time period. The black line identifies a BFU-E that goes out of focus, due to 
the low cell count, this drops to zero and is cannot be distinguished in ‎Figure 126. This drop to zero 
is a current limitation of using the current Voronoi identification coding. If no cells are measured 
then the distance between cells goes to zero and forces the algorithm to stop measuring the 
remaining images in the series. This can be seen at the 100 hour mark, where previously it was seen 
in the growth curve that a computer malfunction caused no measurements to be taken, this 
malfunction registers zero cells and prevents further image processing. A new detected anomaly is 
shown by the pink line in ‎Figure 126. This represents a CFU-GEMM colony that past 100 hours 
quickly increases the distance between cells. This increase in distance is due to the colony going out 
of focus, and therefore less cells are identified, increasing the distance between them. Similarly to 
the cell counts the Voronoi diagram also offers a useful tool for the identification of anomalies, 
where the image capture and analysis are at fault rather than the colony development. 
On top of anomaly identification the data collected here provides us with evidence of how Voronoi 
triangulation can be used. The first 100 hours begins with a large distance between cells that 
reduces as time increases for all colonies. This is expected as at t=0 there are only a few cells 
forming each colony and therefore there is a large distance between them. This is further 
exaggerated as the Voronoi diagram uses the image boundary as a point from which to create a 
triangulation from. An example of the large effect this can have is shown in ‎Figure 127.  
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  Voronoi diagram showing boundary being used as a position. Figure 127.
A developing BFU-E colony is shown in ‎Figure 127, by creating a Voronoi triangulation in ‎Figure 127 
F) it is possible to see that the image boundary acts as another point with which to create an area 
with. Therefore the average of this image is far greater than the centre where the colony is 
developing as a tight ball. Therefore by including the entire area the mean distance between the 
cells is skewed. By taking a point later in time such as at 100 hours, where all the colonies have a 
tighter range of distance the edge effect has less of an effect due to the number of cells, this can be 
seen in ‎Figure 128. 
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 BFU-E colony at t=100 hours.  By taking an image at 100 hours there is a large Figure 128.
number of cells, thus the edge effect is negligible, as the mean area is only slightly skewed.  
By analysing the image at 100 hours there are now lots of cells present. This therefore means that 
the mean distance is skewed less, and therefore a meaningful value is calculated. This allows 
separation between the colony species at 100 hours, whereas earlier there was not a clear 
separation.  
Another option which would further remove the edge effect is to take a region of interest (ROI) in 
the centre of the image and use only that for the Voronoi triangulation. An example of this is seen 
in ‎Figure 129 by taking the centre 300 by 300 pixels. 
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 300 x 300 pixel region of interest (ROI).  Highlighting the effect of taking just the Figure 129.
centre of an image, the edge effect previously noted is neglected here as the image is full of cells.  
‎Figure 129 highlights that by taking the centre area the edge effect has very little overall effect on 
the mean distance between cells. However by taking a region of interest the colony must be in the 
centre of an image, if the colony is off-centre then the region of interest misses the colony, an 
example shown in ‎Figure 130 
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 Example of region of interest avoiding an off-centre colony. Using the raw image A) Figure 130.
a 300 x 300 pixels ROI can be taken shown in B). However due to the off-centre nature of the colony this 
is missed and therefore cannot be assessed using the Voronoi metric on a ROI. 
By taking a ROI as in ‎Figure 130 where the colony is off centre then the data cannot be used unless 
the colony is re-centred or the ROI can be centred around the colony. Currently both of these 
methods are outside the capable limits of the image capture and analysis software, although this is 
something that could later be implemented. This would permit the time of clear separation to be 
shortened as the edge has little effect. However until this is developed the full image will be used. It 
is still possible to separate the colonies at ~100 hour mark. The cells forming a BFU-E colony reduce 
this distance as the colony grows, however the CFU-GM colonies remain more spread out and by 
100 hours a difference can be seen in the distance between cells in a BFU-E to that in a GM colony.  
The CFU-GEMM colony shown by a green line also shows a sudden increase in distance. This data 
provides evidence that the Voronoi metric can be used around 100 hours into the culture to 
categorise colony species. However similar to the growth curve there is still a large variation on the 
colonies, and providing a complete separation is not possible with Voronoi. The next metric to 
assess is cell migration, as the cells in a CFU-GM are further apart, this would suggest that they 
migrate further than the cells assembling BFU-E colonies. 
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5.4.3 Migration - Cell Tracking 
Cell migration is a key biological process with a role in both physiological and pathological 
conditions (199). The ability to accurately analyse and quantify cell migration is important to 
understand development, homeostasis and disease; this includes embryonic development where 
exact positioning is essential for correct development in the organism. Failure for the migration of 
cells in such development can result in severe defects such as skull, limb abnormalities and 
defective wound healing for example (200).  
One of the key differences between haematopoietic colonies is the morphology which for a BFU-E 
is represented by a tight ball of cells, and for a CFU-GM is spread out with single cells. This variation 
has already been detected by measuring the distance between cells in the Voronoi diagram, but in 
this section the migration of individual cells is assessed. From user verification individual cells that 
make up a BFU-E colony move little and remain within a tight ball of cells, whereas the cells making 
up the CFU-GM lineage colony move rapidly and spread out from each other. Often the comparison 
of a tight ball for a BFU-E is in contrast to firework morphology of a CFU-GM colony. 
Due to the large migratory effect seen from some colonies it is important to image regularly. It has 
been acknowledge from user identification that imaging must occur every 10 minutes in order for 
the automated analysis to track the same cell. Using less frequent imaging the automated system 
has to guess where the cells move to and therefore is prone to large error in measuring the 
migration of cells. Using an increased frequency allows the algorithm for cell tracking to identify the 
same cell continuously.  
The tracking algorithm also identifies cells in the first image and then continually monitors the same 
cells. This means that if there are only 3 cells in the first image then only 3 cells are monitored for 
the entire image sequence. In order to increase the sample size that is measured the first image 
used is after 24 hours of imaging. By this point there are more cells visible to track in each image. 
The cells are then tracked every 10 minutes for 8 days. In order to normalise for the number of cells, 
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the mean speed of the cells within a colony can be calculated by dividing the total cell movement by 
the time period that was analysed. This therefore produces a chart of average speed for each 
identified colony (‎Figure 131). For this analysis 2 time period were chosen; 24-48 hours and 90-110 
hours. These were chosen to represent the initial speed of cells as the colony develops, and then a 
later point after which the colony is fully developed and a representative morphology is seen. These 
time points were judged using the cell count graph (‎Figure 121) and by reviewing raw images. 
Tracking cells over a 24 hour period between 24 and 48 hours in the Cell-IQ allows the speed of 
individual cells within a colony to be measured. The speed from all cells within the same colony can 
then be averaged (‎Figure 131). This forms the first column for each colony, the second bar the 
represents the same average speed taken between 90 and 110 hours. This is completed using 65 
colonies from 4 separate experiments. Once again there is significant variability both between 
colony phenotypes and between data sets. The fastest CFU-GM (blue) colony is over 80 µm and the 
slowest 9 µm, similarly BFU-E (red) colonies range from 50 µm to 7 µm. This range necessitates that 
it is not possible to separate the colonies on speed in this raw data form.  
The variation between data sets suggests that there is assay variability as the cells forming this data 
set are all from the same donor. In order to accommodate for this variation it is possible to 
normalise each data set to the mean speed. This allows for a comparison of the data sets to one 
another, acknowledging that there is assay variation that needs to be accounted for. The 
normalised data is shown in ‎Figure 132. One data set was not imaged past 60 hours, and therefore 
has no data for the 90-110 hour point. 
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 Average speed of cells that form a colony over a 24-48 and 90-110 hour period. After tracking the cells movement the speed that the cells move can be Figure 131.
calculated by distance over time. The colonies are coloured based on end point user identification, red=BFU-E, blue=CFU-GM, green=CFU-GEMM. The first column of each 
colony is based on 24 hour period between 24 and 48 hours, the second column between 90 and 110 hours in culture. This data suggests that the cells that form a GM 
colony shown in blue are more mobile than those making a BFU-E colony, shown in red (Smoothed over 5 hour data sets, n=65 from  5 experiments; separated by dotted 
vertical lines)  
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  Normalised average speed of over a 24-48 and 90-110 hour period. After tracking the cells movement the speed that the cells move can be calculated Figure 132.
by distance over time. The colonies are coloured based on end point user identification, red=BFU-E, blue=CFU-GM, green=CFU-GEMM. The first column of each colony is 
based on 24 hour period between 24 and 48 hours, the second column between 90 and 110 hours in culture. Due to assay variation each data set is then normalised to its 
mean, allowing a non-biased comparison between data sets. This data suggests that the cells that form a GM colony shown in blue are more mobile than those making a 
BFU-E colony, shown in red (Smoothed over 5 hour data sets, n=65 from  5 experiments; separated by dotted vertical lines)    
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Having normalised the data, a comparison between data sets is now acceptable. From this data 
there is a distinct increase in speed for CFU-GM (blue) compared to both CFU-GEMM (green) and 
BFU-E (red). This was hypothesised as from watching the colonies develop it is possible to see the 
rapid dispersion of CFU-GM colonies, and therefore the greater movement these cell exhibited. By 
assessing captured images it is possible to see that the firework action happens at different time 
periods, likely due to micro environmental conditions or maturity levels. This therefore influences if 
there is a greater speed, and at which time point this is seen. Once this initial burst has occurred the 
cells appear to slow their movement as they proliferate. It is therefore important to capture the 
time period when this burst occurs. Although as mentioned this is different for each colony which 
makes the time point critical for an accurate categorisation. This further suggests that a single time 
point measurement can be improved by assessing development over a time period such as seen 
here with each metric continually analysed. Distributions of the colonies are drawn to allow 
comparison of the phenotype categorisation resolution of each metric. 
5.4.4 Colony Distributions based on Identified Metrics 
Three metrics have been utilised to follow the development of haematopoietic colonies with the 
ambition to categorise the colonies. By plotting the distribution of each colony phenotype based on 
its metrics it is possible to decipher which metric is the most powerful at resolving the colony 
phenotypes. ‎Figure 133 shows each normal distribution plot for the metrics of count at 110 hours, 
distance between cells at 100 hours, speed of cells at 24-48 hours, and speed of cells at 90-110 
hours. Each of these time points represent when the greatest difference is observed, as verified by 
user identification. 
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 Distribution plots of colony phenotype based on 3 metrics. Identifying colony phenotype using cell count of colonies at 100 hours A), distance between Figure 133.
cells within a colony at 100 hours B), speed of cell movement within a colony between 24 and 48 hours C) and 90-110 hours D). The distributions are coloured based on 
colony type, BFU-E – red, CFU-GM – blue, CFU-GEMM – green.  n=65 
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‎Figure 133 shows the distributions of each individual metric which are colour coded based on user 
verification, with red for BFU-E’s, blue for CFU-GMs and green for CFU-GEMMs. As predicted 
previously both the count at 100 hours and distance between cells taken from Voronoi diagram at 
100 hours have overlaps of each colony phenotype, known as a mixed population. The clearest 
separation between colony phenotypes is seen using the speed measurement between 90 and 110 
hours, which shows distinction between CFU-GEMM and BFU-E to CFU-GMs. By taking the point of 
intersection in ‎Figure 133 D) between BFU-E and CFU-GM (red and blue) it is possible to calculate 
the confidence interval for the identification of a single colony to fall within the correct category. 
This intersection occurs at 1.11442 as shown in ‎Figure 134. 
 
 Distribution plot of speed between 90-110 hours, with intersection and standard Figure 134.
deviation markings. Marking the intersection of BFU-E (red) and CFU-GM (blue) the confidence of 
correct classification can be calculated.  
From ‎Figure 134 the intersection lies 1 standard deviation away from the mean of CFU-GM 
distribution. Therefore a confidence interval of ~82% (50% one side and 32% of the overlapping 
side) is defined. Given the difference in standard deviation and therefore shape of the distribution 
for BFU-E, this is 1.25 standard deviations from the mean to the intersection, relating to a 90% 
confidence interval for the correct categorisation of a BFU-E. Both of these confidence intervals 
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represent a high degree of classification however this is ignoring  the overlap of about 23% as 
calculated from the overlapping coefficient (201) shown in Appendix ‎8.5. This overlap represents a 
large potential error which must be accounted for to use the distributions for colony identification. 
The statistic required to calculate the confidence interval for a mixture of Gaussian distributions is 
known as the ‘Bootstrap Algorithm for Mixture Models’ (202). This requires extensive computer 
simulations to produce an accurate estimate and falls outside the scope and knowledge for this 
thesis. However it does form an interesting further work section to be able to provide a confidence 
interval for any given colony to fall within the correct categorisation. This will be discussed later in 
Section ‎6.2 
Using this distribution it is possible to measure the speed of cells within any colony and distinguish 
between BFU-E and CFU-GM colonies. This method does not provide a separation of the CFU-
GEMM phenotype, although as stated previously for the majority only BFU-E and CFU-GM colonies 
are often categorised. However the BFU-E population would also contain GEMM, and therefore the 
total number of categorised BFU-Es would be exaggerated. From ‎Figure 133 it’s possible to 
appreciate that using counts at 100 hours provides the best separation of BFU-E to GEMM. 
Therefore using the same method (bootstrap algorithm) as shown previously and the data in ‎Figure 
135, the confidence intervals can be calculated. 
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 Distribution plot of count at 100 hours, with intersection and standard deviation Figure 135.
markings. Marking the intersection of BFU-E (red) and CFU-GEMM (green) it is then possible to 
calculate the confidence interval for a single measured colony to fall into the correct category.  
These two examples identify an opportunity to use the image derived metrics to conclude the 
colony phenotype after 110 hours. It is important to remember that this 100 hours is from the point 
of imaging, rather than culture which occurs 3 days prior. Therefore in total the image derived 
metrics method of colony identification can be applied 182 hours into the culture. This is half the 
current time for the CFU assay, with the benefit of automated analysis and calculated confidence. 
5.5 Conclusions 
The first aim of this chapter was to evaluate and improve, if required, the environment found within 
the Cell-IQ imaging platform to that of a standard incubator. Initially it was found that due to the 
gassing mechanism within the Cell-IQ, the cultures were continually exposed to a very low 
humidity, causing significant drying of the methylcellulose gel assay. This rapid drying had major 
growth characteristic consequences that prohibited the use of the Cell-IQ for CFU assay monitoring.  
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In order to accommodate for this humidity issue, a humidifier was developed, improved and 
ultimately tested in order to ensure the humidity within a standard incubator was comparable. By 
passing the dry inlet air from the Cell-IQ through a 20 µm pore size atomiser in a 3 cm head of water 
the humidity in the culture vessels could be increased to 80%. This was further enhanced using 
water in the culture wells where the pre-humidified gas entered. This was seen to vastly reduce the 
drying time of 20 µl droplets that were used as a test mechanism. 
Following the successful pre-humidification of the inlet gas, it was seen that a comparable colony 
number and phenotype were noted within a standard incubator to the Cell-IQ samples 14 days after 
CFU assay. This allowed for continual imaging and monitoring of the growth of colonies within the 
Cell-IQ and led to the finding of measurable image metrics. 3 metrics of cell number, distance 
between cells and cell migration within individual colonies were noted to be informative and 
measurable within the system. Following colony development over time allowed time points were 
colony behaviour was dependent on phenotype. This was seen by correlating back user identified 
colonies to the image derived metrics. Taking the cell count at 100 hours, distance between cells at 
100 hours, and the migration of cells between 24-48 and 90-110 hours were deemed to be the most 
informative. By plotting distribution plots of each metric after categorisation of phenotype allows 
for the confidence in separation between phenotype to be measured. Due to the lack of clear 
separation this involves the use of computer algorithms using the bootstrap method to measure the 
probability of correct colony identification. There are mathematical methods available to address 
these issues which can be progressed as further work. 
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6 Conclusions and Further Work 
6.1 Conclusions 
Regenerative medicine represents a promising enabling technology to revolutionize healthcare. 
This has been highlighted through numerous publications (203–205), with regenerative medicine 
being highlighted as one of the UK’s Eight Great technologies (204) due to its potential for 
technological advancement and economic benefits. Further proof of regenerative medicines current 
momentum is expressed with John Gurdon of Cambridge and Shinya Yamanka from Japan recently 
being awarded a joint Nobel Prize for their work revealing the re-programming of mature cells to 
immature, pluripotent cells in 2012 (206). Also the establishment of the Cell Therapy Catapult in 
2012 as a centre of excellence in innovation (207) further shows the significant capital being 
invested into regenerative medicine. This said there are still major gaps between the commercial 
promise and the reality of the cell therapy sector of regenerative medicine (208).  There is a 
common consensus to ‘develop high through-put and automated technologies for safety assessment 
of cells, for pre-clinical work, and for the manufacture of clinical regenerative medicine products’ 
(3,4,204).  
Imaging has been quoted to have the capacity to contribute to this technological gap for cell 
therapies by the FDA’s Critical Path to New Medical Products (47) as well as the British Standards 
Institution (BSI) in PAS93:2011 (29). Furthermore imaging is particularly attractive to provide non-
destructive monitoring with high spatial and temporal resolution (48).  
With that in mind this thesis was aimed at developing and testing a novel imaging platform to aid 
the ability to monitor cell cultures during manufacturing. The work utilised an automated, non-
invasive phase contrast imaging platform to measure, analyse and ultimately quantify image 
derived metrics for 2 cell types, colonies of human embryonic stem cells and human haematopoietic 
stem cells.  
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This work has shown that image analysis has the ability to improve the precision of current 
evaluation methods, namely cell counting, with the best tested automated capable of a CV of 7% 
(Cedex, Roche) whilst manual counting is reported to have a CV of 11% (111). Non-invasive image 
analysis has the key benefit of being able to tailor the CV through sampling frequency. The initial 
work showed that for embryonic colonies taking 50 systematically sampled images produced a CV 
of less than 5%. Further sample increases the precision of this measurement tool. 
Using the 50 image sample set it was concluded that total colony coverage created a poor 
correlation to cell counts, which was deemed neither an error in the image analysis or cell counting. 
This gave grounding that there was heterogeneity within the culture which ensured that the 
cell/area varied across and between cultures. This was the core reason for why coverage and counts 
did not accurately correlate and therefore a measure of this heterogeneity was required. By 
assessing captured images overtime further image derived metrics were identified which separated 
total colony coverage into 3 separate regions; dark colony, core periphery and edge cell coverage. 
Using both thresholding and machine vision identification technology these areas could accurately 
be recognised by the software, as verified through user identification. Machine vision is the term 
given to duplicating the effect of human vision by electronically perceiving and understanding an 
image (83), this therefore permits the separation and measurement of each of these 3 ‘taught’ 
areas. These new metrics provided a measure of the heterogeneity prominent across cell 
populations, but often not measured. This is especially noted in cell counts, where a viability assay 
distinguishes viable to non-viable cells, but provides no further information with regard to the 
culture. Using regression of the triple metrics provided an improvement to the correlation of image 
metrics to cell counts, however immunostaining highlighted that these morphological distinct areas 
were representative of variation in markers. Predominantly the edge cell coverage was negative for 
Oct-3/4 a marker of pluripotency. This provided conclusive evidence that edge cell coverage was a 
measureable culture attribute which could be used to predict the culture state or quality. 
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Building on the emergence of image derived metrics to inform culture state, the behaviour of these 
metrics were assessed over time. It was hypothesised that a variation in these attributes would 
provide a timely method to determine population changes. This has been shown initially through 
varying the feed regime, which in turn changes the metric growth curves, and correlates to a 
median change in pluripotent markers. As a decrease in the pluripotent markers were seen over the 
population it was then theorised that these metrics could also be used for measuring the controlled 
differentiation of cells. The addition of chemical cues in the form of a growth factor cocktail of 
BMP4, VEGF, FGF and Activin A stimulated a morphological response around the periphery of 
adhered colonies detected as a change in the edge cell coverage metric. This ability to discriminate 
between culture conditions of embryonic colonies using non-invasive imaging permits the use of 
such a novel tool for in-process monitoring.  
After successfully developing such a tool the next phase was to prove the utility within a process. 
Initially this was completed by comparing embryonic culture which used a single vessel to predict 
the cell numbers in similarly seeded flasks to the Cell-IQ as a imaging platform. It was shown that 
the Cell-IQ increased the precision whilst maintaining non-invasiveness and therefore no flasks 
were required to be sacrificed at great cost to a manufacturing process. The advantage of providing 
a non-invasive tool permits real-time measurements to be continually gathered. By measuring the 
diameter of embryonic colonies it was possible to provide the afore mentioned differentiation 
stimuli at a timely point of culture. An example of this use was presented where monitoring the 
colony size, and acting on that information, has delivered differing differentiation yields. By 
exposing smaller colonies (<350 µm diameter) to the differentiation a more homogeneous 
differentiation occurs, whereas the larger colonies (>800 µm diameter) maintain a core of 
pluripotent morphology alongside the periphery of differentiated cells. These differentiated cells 
were shown to be HAND1+ through immunostaining.  
The work on embryonic stem cell colonies has provided strong evidence that image derived metrics 
can successfully be implemented into process development. Non-invasive imaging provides a 
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fantastic opportunity to create bespoke sampling frequencies to achieve desired precision for 
manufacturing cell therapies. Human embryonic stem cells formed one cell type of interest in this 
thesis due to their ability to differentiate into all 3 germ layers, along with their self-renewal 
potential (35,93). These properties make hESCs very attractive for the regenerative medicine 
industry, although any clinical use is still many years away. A cell type already used for regenerative 
capacity is the haematopoietic stem cell (HSC).  
The ability to restore haematopoietic activity in patients who have undergone chemotherapy or 
irradiation forms many of the 60,000 clinical uses each year (159). However there is still a need for 
an in-vitro method of assessing haematopoietic quality. Current methods include total nucleated 
cell count, CD34+ percentage and the colony forming unit (CFU) assay. All of these remain with 
limitations, with the CFU assay regarded to be the best predictor of engraftment (160–162). One of 
the key limitations of the CFU assay is the user defined end point analysis which incorporates large 
variation into the readout measurements. This thesis has aimed to enhance the CFU assay by 
measuring image derived metrics of the developing haematopoietic colonies which are predictive of 
colony phenotype and ultimately population quality. Prior to imaging such attributes the 
environmental conditions within the Cell-IQ and a standard incubator required balancing. This 
involved increasing the humidity within the culture vessel placed into the Cell-IQ due to its unique 
gassing mechanism. By directly pumping dry air into the culture plate, the Cell-IQ caused the 
viscous gel of the CFU assay to dry and prevent colony development. In order to maintain a 
constant environment to that of a standard incubator a humidification step of the gas was required 
prior to entering the culture vessel. This was completed by passing the gas through a fermentation 
sparger submerged in a 4cm depth of water. Computational fluid dynamics (CFD) along with 
droplet evaporation confirmed the presence and improvement of this humidity issue, and aided in 
the development of a solution. Following the successful humidification it was possible to continually 
image colony development within the Cell-IQ and identify possible attributes of the colonies to 
enable identification.  Cell number, distance between cells and cell migration within individual 
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colonies were noted to be both informative and measurable within the imaging system. By 
following the behaviour of each of these metrics specified time points or periods were identified 
that provided a degree of colony phenotype separation. Although the distance between cells was 
hypothesised to be the best separator due to the firework and tight ball morphologies of CFU-GM 
and BFU-E respectively, measuring the speed of cell movement between 90 and 110 hours provided 
the greatest separation.  With a 23% overlap coefficient for the Gaussian distributions, this provided 
encouraging data to suggest that such image derived metrics could be utilised to make informed 
colony categorisation 7 days prior to the current standard and more importantly in an automated 
fashion. Quantitative, novel, image derived metrics have been identified that improve the current 
recognition by improving reliability through computer automation, cost by removing user 
verification and time by reducing the assay time from 14 days to 7 days.  
6.2 Further Work 
This work has demonstrated the ability of using such an imaging platform as the Cell-IQ to 
automate the analysis and measurement of culture state. However to be fully functional and 
validated for manufacturing use further work is required. A number of proposed activities are 
outlined below. 
Concentrating initially on the in-process use for pluripotent manufacture further image derived 
metrics could be recognised. It was mentioned that dark colony coverage utilises a single threshold 
value, and further resolution could be aided by segmenting the dark colony into further categories. 
Initially work would be required to identify the benefit of further classification especially as only 
small coverage amounts were observed in this thesis. Potentially the threshold value for dark colony 
was too high, only capturing the very dark colony, whereas a reduced threshold may hold further 
benefit. 
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One of the key attributes of the Cell-IQ is to provide live cell imaging whilst maintaining 
environmental conditions. This work utilised this in measuring the behaviour of the image derived 
metrics over time and therefore detect morphological responses immediately as they occurred. It 
was shown that single time points could be misperceived especially when using the colony 
periphery roughness as a measure of differentiation, as this was seen to be cyclic. This does 
highlight how live cell imaging can be used in conjunction with image derived metrics to measure 
the response to stimuli. This thesis showed the effect of adding differentiation stimuli in the form of 
chemical cues, and also effect from feeding regime. Other stimuli that also warrant attention are 
mechanical stimulants to induce differentiation (209), migratory response to stimuli (210) and 
microparticles uptake (211). The Cell-IQ permits the behaviour of cell response to any stimuli and 
therefore is an important tool for measuring characteristic changes in a population. 
The measurement of edge cell coverage in a differentiating population was shown to be useful for 
measuring the yield and therefore optimisation of a protocol. This therefore allows a comparison of 
stimulant, be it chemical, environmental or/and mechanical. With embryonic stem cells becoming 
less favoured with the development and characterisation of induced pluripotent stem cells (iPSCs), 
it is also possible to utilise the same metrics unearthed in this thesis. The morphology of iPSCs is 
very similar to that of the ESCs, both with pluripotent colonies surrounded with a periphery of 
differentiating cells in a poor culture state. One of the interesting points to iPSC generation is the 
current inefficiency of producing such cells from differentiated adult cells (212). Although this 
harbours vast therapeutic implications if successfully achieved current poor generation leads to 
mixed reviews regarding their future (213). Image analysis could therefore be utilised in measuring 
the emergence of pluripotent morphology colony rather than measuring the emergence of 
differentiation as shown in this thesis. By observing the iPSC production timely process actions 
could be used to improve and direct improvements to the current procedure. 
All the measurements carried out overtime also require media exchange to occur. It was seen that 
this required accurate autofocus capabilities to ensure that peaks and troughs were not measured 
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due to out-of-focus images. This thesis used 50 µm auto-focus stacks to improve the time it took to 
find the focal point, although further improvement of the autofocus feature was shown to be 
required if colonies were more than 50 µm out-of-focus following an intervention. There is also a 
possibility to remove a period of time of data following these interventions, however if the 
measured metric immediately changes then this transformation would be missed. 
Within the haematopoietic culture further assessment is required to separate phenotypes using 
automated colony detection. The bootstrap method for measuring the confidence intervals of a 
mixed Gaussian distribution will provide a level of assurance. But the inherent inconsistency within 
the assay needs further investigation to assess where this variability comes from. Is it patient 
specific, due to inhomogeneity within the assay materials, Cell-IQ environment, or a combination of 
these factors? There is also an unanswered question regarding the maturity levels of colonies. It was 
stated that the slower growing colonies, although morphologically similar, were deemed more 
mature. BY following the growth and selecting colonies of similar morphology but growing at 
different rates would allow further characterisation with techniques such as gene expression using 
PCR. This may be able to sub-divide the populations and correlate these back to the observed 
growth rates.  
Again mentioned is the environment within the Cell-IQ. By pre-humidifying the inlet gas the 
conditions were made comparable to a standard incubator, but a measured difference in humidity 
still occurs. Through improved CFD modelling and humidification of the inlet gas this difference 
could be eradicated which may improve the CFU assays reliability. Following from the discovery 
that the humidity within the culture vessel is dependent on evaporation form the culture medium, 
further work is also required to assess the effect of this. Overtime evaporation of liquid from the 
culture medium would cause an increase in the media supplement concentrations along with any 
waste products produced from the cells. As stated for embryonic culture it was declared that due to 
the 24 hour feeding regime this effect would be negligible and was not seen to effect the culture 
behaviour. However in cell phenotypes where less frequent feeding is required, this effect could 
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become more dominant, especially of note would be mesenchymal stem cells, with fast 
proliferation and a media exchange occurring every 3 days. The environment for cell culture is often 
neglected with standard incubators trusted for maintaining humidity, temperature and CO2 
concentrations and therefore pH levels. The use of methylcellulose gel highlights the evaporation 
that occurs and the knock-on effect within the growth dynamics. The Cell IQ allows the growth 
kinetics to be monitored whilst also measuring any change in environment through the use of 
probes. 
Image automation has been instrumental in this work for the timely analysis. There is a wide 
consensus that automation reduces variability in measurement and often can increase productivity. 
The batch metric measurements have shown how automated analysis can be utilised to accelerate 
measured outcomes. Further to this work other, currently non-automated, image analysis uses can 
be developed. Such examples include the CFU assay from mesenchymal stem cells. Currently this is 
an end point, user based assessment, but further knowledge then number of colonies can be 
established from live cell imaging such as proliferation rates, migration and overall size of colony. 
Finally there is the capacity to repeat and gather further data to improve the confidence in this 
work. This is especially noted when using a single vessel as a predictor of further vessels. It was 
shown that image analysis improved on the error of this method, and could be utilised non-
invasively. A repeat with more samples, over a great confluency range would improve the reliability 
and credibility of image derived metrics to replace current identification tools. 
The culminating objective will be to get these tools into product manufacture, so the most 
promising methods need to be taken forward to be validated and have data sets collated that would 
be suitable for regulatory submissions to a make a real impact on product delivery and quality 
within the regenerative medicine industry. 
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8 Appendix  
8.1 Saturation pressure of water vapour  
 
 Saturated Pressure of water vapour at different temperatures (214). Figure 136.
When x=37 
                                                                       
8.2 Mass of Water in 150 mL of Air at 90% Humidity  
 ps = 6396 Pa (saturation pressure of water vapour at 37°C) 
 φ = 90% = 0.9 (relative humidity) 
 V = 150 mL = 0.00015m3 (gas flow rate of 30mL/min, gas on for 5 minutes) 
 R = 8.314472 Pa m3 / mol K (ideal gas constant) 
 T = 37°C =312.25 K (culture conditions) 
 M = 18 g/mol (Molar mass of water) 
Ideal Gas Law (215)  
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Assumptions: 
 The inlet gas is air (21% oxygen, 78% nitrogen, 1% argon and trace elements, (216)) 
 The dry gas reaches 90% relative humidity in the culture system 
 The inlet gas is at 37°C 
 The system is sealed with no losses other than the gas inlet and outlet 
 There is a maintained reservoir of water 
 Atmospheric pressure throughout the system 
5.94 mg of water evaporates for every 150 mL of gas. 150 mL every 25 minutes, in 14 days there are 
50400 minutes. 
         
      
       
                    
 302400 mL or 3.024 m3 of gas enters the culture vessel over the entire assay. Using this volume of 
gas in the previous equation gives: 
  
    
  
   
          
               
            
So over the entire culture period 6.70 g (~6.70 mL) of water will evaporate. 
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8.3 Colony Phenotype Comparison between Standard Incubator and Cell -IQ 
 
 Colony phenotypes from ‎Figure 118. Splitting the total number of colonies into Figure 137.
CFU-GM (blue) or BFU-E (red) stacked columns. The x-axis values show the sample, with the letter a) 
denoting those in  a standard incubator, and b) in the Cell-IQ. This figure shows comparison of both 
total number and phenotype of colonies. 
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8.4 Voronoi Macro 
  
//run("Threshold..."); 
//run("Threshold..."); 
// Color Thresholder 1.48f 
// Autogenerated macro, single images only! 
min=newArray(3); 
max=newArray(3); 
filter=newArray(3); 
a=getTitle(); 
run("HSB Stack"); 
run("Convert Stack to Images"); 
selectWindow("Hue"); 
rename("0"); 
selectWindow("Saturation"); 
rename("1"); 
selectWindow("Brightness"); 
rename("2"); 
min[0]=0; 
max[0]=255; 
filter[0]="pass"; 
min[1]=0; 
max[1]=160; 
filter[1]="pass"; 
min[2]=0; 
max[2]=255; 
filter[2]="pass"; 
for (i=0;i<3;i++){ 
  selectWindow(""+i); 
  setThreshold(min[i], max[i]); 
  run("Convert to Mask"); 
  if (filter[i]=="stop")  run("Invert"); 
} 
imageCalculator("AND create", "0","1"); 
imageCalculator("AND create", "Result of 0","2"); 
for (i=0;i<3;i++){ 
  selectWindow(""+i); 
  close(); 
} 
selectWindow("Result of 0"); 
close(); 
selectWindow("Result of Result of 0"); 
rename(a); 
// Colour Thresholding------------- 
run("Make Binary"); 
run("Analyze Particles...", "size=25-Infinity circularity=0.00-1.00 show=Nothing 
clear"); 
run("Delaunay Voronoi", "mode=Delaunay make showmeandistance 
inferselectionfromparticles"); 
saveAs("Results", "/C:/Users/cgds3/Desktop/Image J/B2_11/Voronoi-" + getTitle() + 
".txt"); 
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8.5 Overlapping Coefficient for Normal Distributions  
 
 
 Nomogram of percentage overlapping of normal distributions (201) Figure 138.
BFU-E Mean = 0.766 = M1 
BFU-E Standard Deviation = 0.2788 = SD1 
CFU-GM Mean = 1.487 = M2 
CFU-GM Standard Deviation = 0.3712 = SD2 
   
   
 
      
      
      
|     |
   
 
           
      
      
Using 1.33 (y-axis) and 2.59 (x-axis) the percentage of overlap is interpolated by eye as 23%. 
 
